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Enterohaemorrhagic Escherichia coli (EHEC) have recently emerged as significant 
zoonotic pathogens. O157:H7 is one of the most common EHEC serotypes associated 
with human disease, which is transmitted faeco-orally from a bovine reservoir. EHEC 
O157:H7 preferentially colonises the bovine terminal rectum (BTR). Injection of 
virulence factors by type-III secretion is necessary for colonisation of cattle and results 
in re-modelling of the host cytoskeleton. Flagella machinery is evolutionarily related to 
the Type III secretion apparatus and O157 strains lacking H7 flagella show reduced 
adherence to the BTR. Vaccination with FliC, the main component of H7 flagella, has 
the potential to protect cattle against E. coli O157:H7 infection. The focus of this work 
was to investigate the molecular basis for H7 flagella binding to the BTR, in order to 
understand the basis for FliCH7 being an immuno-protective antigen. H7 flagella were 
shown to adhere across the surface and penetrate into BTR epithelial cells. Both the FliC 
shaft and the FliD cap components of flagella filaments showed the capacity to adhere to 
BTR epithelial cells. Preliminary studies indicate that the current FliCH7 vaccination of 
cattle results in FliD-specific antibodies where oral challenge with O157:H7 does not. 
FliD is more conserved than FliCH7, which contains a predicted 88aa structural insertion, 
but variation occurs along the full length of the FliD protein. There was no evidence for 
post-translational modification of FliCH7. A number of actin binding proteins were 
identified as potential FliC and FliD binding partners from BTR epithelial cell lysates. 
From this, a panel of purified galectin-4, cofilin-1 and βγ-actin was used to compare 
binding of flagella from different pathogens. H7 flagella bound more to cofilin-1 than 
βγ-actin, whereas phase-1 and phase-2 flagella from Salmonella Typhimurium bound 
more to βγ-actin, than to cofilin-1. Size-exclusion chromatography indicated that cofilin-
1 alters H7 flagella filament polymerisation dynamics. αβ-ctin polymerisation and 
depolymerisation experiments indicate that H7, phase-1 and phase-2 flagella interactions 
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Bacterial flagella have fascinated scientists for more than 70 years. Their elegance, 
utility and complexity have shown that bacteria, previously thought to be very 
primitive, can be highly adapted to their niches. The flagellar systems of Escherichia 
coli and Salmonella enterica subsp. enterica serovar Typhimurium have served as 
paradigms for evolution, assembly and regulation of macromolecular machines, 
flagellar motility and host innate immunity. Yet despite such intensive study for 
many decades, there are aspects about these organelles that can still surprise us. 
 
In parallel, advances in molecular biology and genetic engineering have allowed the 
study of specific contributions of different genes to bacterial pathogenesis. Again, E. 
coli has served as a model organism for studies in commensalism, host adaptation 
and virulence. In particular, Shiga toxin-producing E. coli (STEC) continues to 
capture the attention of researchers and the public alike with outbreaks of diarrhoeal 
disease, an increasing proportion of which can be fatal. Barring the large 2011 
outbreak of newly emergent STEC O104:H4 in Germany, O157:H7 is the 
predominant serotype that causes human disease and is transmitted from a ruminant 
reservoir (Naylor et al., 2005a). Potential control strategies are currently being 
targeted at the bovine reservoir (McNeilly, 2012; Sargeant et al., 2007). 
 
This study investigates the possible mechanisms of flagellar adherence to bovine 
cells by STEC O157:H7, with a view to understand why H7 flagella can be a 
protective immunogen in cattle. In doing so, the intention is to refine which parts of 
H7 flagella are necessary for this. By bringing this understanding of bacterial 
pathogenesis together with this model flagella system, it is also hoped that this study 
will help to establish a new paradigm in flagella-associated bacterial pathogenesis.  
 
1.1    Escherichia coli 
1.1.1 A brief history 
First isolated as early colonisers of neonate bowels by Theodore Escherich in 1885, 
Bacterium coli commune was thought of as a normal part of human intestinal 





his own lifetime however, Escherich recognised that these bacteria caused acute 
disease in the intestinal and urinary tracts of children (Shulman et al., 2007). By the 
time this genus was officially renamed after Escherich, specific Escherichia coli 
serotypes had been linked to outbreaks of infant diarrhoea in hospitals (Giles & 
Sangster, 1948; Taylor, 1952). Since then, E. coli has been recognised to persist in 
human intestinal tracts as commensals able to cause a wide range of opportunistic 
infections, or as pathogens that cause serious diseases after acquiring particular 
combinations of virulence genes (Sussman, 1997).  
 
1.1.2 Basic properties 
E. coli are facultative anaerobes that do not form spores, but grow vegetatively as 
single or paired short rod-shaped Gram-negative bacilli. They are normally motile, 
usually expressing multiple flagella uniformly on their surface (peritrichously). E. 
coli can also express multiple types of fimbrial adhesins and capsule 
exopolysaccharides. They are commonly serologically defined by the combination of 
their lipopolysaccharide outer membrane (O-antigen) and flagella (H-antigen), but 
are sometimes also defined by their capsule (K-antigen) and fimbriae (F-antigen) too 
(Kauffmann, 1947).  
 
Despite its adaptation to the intestinal tract of mammals and reptiles, and its lack of 
sporulation, E. coli survives for long periods in the environment, in soil, liquids and 
on surfaces (Sussman, 1997). It is easily cultivated in or on many different kinds of 
simple culture media. Generally it can be phenotypically distinguished as 
facultatively anaerobic, non-pigmented, circular colonies of Gram negative rods that 
can produce indole (Madigan et al., 2003). They can also generally reduce nitrite to 
nitrate, are oxidase negative and also unable to use citrate as a fermentative carbon 
source. 
 
1.1.3 E.coli commensals, opportunistic pathogens and pathogens 
Commensal bacteria are bacteria that are adapted to live at non-invasive sites, are the 





mutually beneficial, as commensal bacteria get access to nutrients while preventing 
host pathogens from occupying the same niche. Additionally, the microflora appears 
to be essential for immune system development and even stimulates wound healing 
(reviewed in Abreu, 2010). However, if introduced to a site that is normally 
inaccessible to them, commensal bacteria can harm their host. For example, sepsis 
can be caused by intestinal commensal bacteria after intestinal injury (Ayres et al., 
2012). These commensals may lack the virulence factors necessary to be invasive, 
but once through the intestinal barrier, have factors that allow them to persist in the 
peritoneum. In this case these bacteria are also known as opportunistic or facultative 
pathogens. 
 
E. coli is a major part of the aerobic microflora of the human intestinal tract, and a 
proportion can act as opportunistic pathogens. Generally speaking these bacteria 
have few virulence factors, but those they do have may allow them to persist at extra-
intestinal sites (Siitonen, 1992). However, certain intestinal E. coli have acquired 
combinations of virulence genes that are more competitive in the intestine or 
favourable for extra-intestinal colonisation, making them specialised pathogens 
(Croxen & Finlay, 2010). 
 
The pathogenesis underlying different types of disease caused by E. coli is 
multifaceted; there is no one virulence factor responsible, and many combinations of 
virulence factors are capable of causing each disease. For example, the K1 capsule 
antigen can protect E. coli from phagocytosis (Agüero & Cabello, 1983). 30% of E. 
coli isolates from the microflora of healthy hosts have K1 capsules (Siitonen, 1992). 
Therefore, K1 strains are not necessarily pathogenic. However, K1 allows neonatal 
meningitis E. coli (NMEC) or uropathogenic E. coli (UPEC) to survive in the blood 
by protecting them from the host immune response. For NMEC, this increases the 
likelihood of successful tropism to the brain (Kim et al., 2003). However, without 
other virulence factors, such as type-1 fimbriae and a cytotoxin, NMEC would not be 
able to cross the blood brain barrier (Khan et al., 2002, 2007). In contrast, UPEC that 
don’t down-regulate the expression of type-1 fimbriae after bladder colonisation tend 





Gunther et al., 2001). This illustrates the importance of not just possession of a 
virulence-associated factor but also its appropriate regulation.  
 
1.1.4 Intestinal pathotypes of E. coli 
Pathogenic E. coli that do not tend to cause diarrhoeal disease, such as NMEC and 
UPEC, are also known as extra-intestinal pathogenic E. coli (ExPEC, (Russo & 
Johnson, 2000)). Diarrhoeagenic E. coli have been categorised into a number of 
groups that refer to the type of pathology they cause and/or their HEp-2 cell 
adherence pattern (figure 1.1, (adapted from Croxen & Finlay, 2010; Kaper et al., 
2004)). The pathology caused by these E. coli depends on their repertoire of 
virulence factors. Certain virulence factors have been used as the sole defining 
characteristic of a pathotype, as with STEC. However, this system of classification 
was originally based on clinical pathology (Nataro & Kaper, 1998). Pathotypes often 
contain common combinations of virulence factors, which individually may be 

















Figure 1.1. Intestinal pathotypes of E. coli. 
(A) Enteropathogenic E. coli (EPEC) 
initially adhere by flagella and bundle-
forming pili (BFP) then form attaching and 
effacing (A/E) lesions. (B) 
Enterohaemorrhagic E. coli (EHEC) 
produce Shiga toxin (Stx), causing 
haemorrhagic disease. Initial adherence 
involves flagella and haemorrhagic coli 
pilus (HCP). Intimate attachment is similar 
to EPEC. (C) Enteroinvasive E. coli (EIEC) 
are translocated across M-cells into 
mucosal macrophages, escape, then 
induce their uptake into enterocytes. From 
here they can laterally infect other 
enterocytes. (D) Enteroaggregative E. coli 
(EAEC) adhere in aggregates using 
aggregative adherence fimbriae (AAF). (E) 
Diffuse-adherent E. coli (DAEC) sparsely 
adhere using Dr-adhesins, causing host-
decay accelerating factor (DAF) to 
elongate microvilli. (F) Enterotoxigenic E. 
coli (ETEC) initially adhere with 
colonisation factor antigens (CFAs) then 
intimately with Tia and TibA and produce 
heat-labile toxin (LT) and heat-stable toxin 
(ST). Adapted from Kaper et al. 2004 and 
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Entero-toxigenic E. coli (ETEC) is a common cause of infant diarrhoea and 
traveller’s diarrhoea in the developing world (Wennerås & Erling, 2011). ETEC can 
use flagella or colonisation factor antigens (CFAs) for initial adherence to 
enterocytes in the small intestine (Evans & Evans, 1978), then intimately attach with 
Tia and TibA (figure 1.1(F), (Fleckenstein et al., 1996; Lindenthal & Elsinghorst, 
2001)). Disease is primarily caused by production of the large multi-subunit heat-
labile toxin (LT) and a small heat-stable toxin (ST) peptide (Sack, 1975). These 
toxins increase the intracellular levels of host cGMP, dysregulating ion secretion 
Figure 1.2. Venn diagram of 
defining virulence factors for 
intestinal E. coli pathotypes. 
Adapted from Naylor et al. 






channels, which causes watery diarrhoea (Field, 1979). As ETEC are defined solely 
by their production of LT or ST, they are a very diverse group of pathogens and 
therefore present a challenge to vaccine development (Roy et al., 2009a). 
 
Diffusely-adherent E. coli (DAEC) cause diarrhoea in young children but not infants 
and have been implicated in nosocomial diarrhoea in adults (Jallat et al., 1993; 
Levine et al., 1993). These bacteria are defined by their sparse pattern of adherence 
to HEp-2 cells (Cravioto et al., 1979). In general, these strains express Dr-family 
fimbriae, such as F1845 (Bilge et al., 1989). These fimbriae concentrate the host-
expressed complement decay accelerating factor (DAF) to discrete areas of 
membrane, which causes elongation of microvilli (figure 1.1(E), (Betis et al., 2003)).  
 
Entero-aggregative E. coli (EAEC) were also defined by their adherence pattern on 
HEp-2 cells. This aggregative phenotype is caused by the expression of aggregative 
adherence fimbriae (AAF, figure 1.1(D), (Nataro et al., 1992)). AAF and its master 
regulator AggR are co-encoded on a virulence plasmid known as pAAF (Nataro et 
al., 1994). As a result, EAEC are another very diverse E. coli pathovar. They range 
from apparently non-pathogenic, to strains capable of causing high rates of 
haemolytic uraemic syndrome and mortality, depending on their repertoire of co-
expressed virulence factors (Muniesa et al., 2012; Nataro, 2012).  
 
Entero-invasive E. coli (EIEC), which includes Shigella (Chaudhuri & Henderson, 
2012), are defined by their ability to invade the small intestinal epithelium and cause 
dysentery (Nataro & Kaper, 1998). EIEC are translocated across M-cells into 
mucosal macrophages as part of normal antigen sampling at that site (Wassef et al., 
1989). Once in mucosal macrophages, EIEC can escape and induce their baso-lateral 
uptake into enterocytes (Croxen & Finlay, 2010). Inside enterocytes, these bacteria 
can escape the phago-lysosome, multiply in the cytoplasm and spread to adjacent 
enterocytes by polymerising host cytoskeletal proteins (figure 1.1(C), (Sansonetti et 
al., 1986)). To invade in the manner described, EIEC use an Inv-Mxi-Spa type-III 
secretion system (T3SS, (Schroeder & Hilbi, 2008)). The T3SS is like a ‘molecular 





cytoplasm directly into the host cytoplasm (Gauthier et al., 2003). In this case, the 
type-III secreted (T3S) effector proteins IpaA, IpaB, IpaC and IpaD are essential for 
the manipulation of the host cytoskeleton necessary for the invasion phenotype 
(Buchrieser et al., 2000). EIEC also express a selection of entero-toxins, such as 
Shiga toxin 1 (Stx1), ShET-1 and ShET-2 (Croxen & Finlay, 2010).  
 
Attaching and effacing (A/E) E. coli are defined by their ability to cause A/E lesions. 
These lesions are characterised by bacteria intimately attaching to actin-rich 
pedestals on enterocytes with shortened or absent microvilli (Knutton et al., 1987). 
This phenotype is due to possession of virulence factors within the locus of 
enterocyte effacement (LEE, (McDaniel et al., 1995)). The LEE region contains 
genes that encode a Ssa-Esc T3SS and a number of type-III secreted effector proteins 
(Elliott et al., 1998; Tobe et al., 2006). These type-III effector proteins are secreted 
into enterocytes to manipulate them, effacing microvilli and disrupting tight 
junctions. This reduces the absorptive surface area and barrier function of the 
epithelium and is thought to cause diarrhoea (Dean et al., 2006). The dominant 
pathotypes of attaching and effacing E. coli are entero-pathogenic E. coli (EPEC, 
figure 1.1(A)) and entero-haemorrhagic E.coli (EHEC, figure 1.1(B)). 
 
Typical EPEC is distinguished from EHEC by the presence of the EPEC adherence 
factor plasmid (pEAF, (Knutton et al., 1987)). pEAF encodes bundle-forming pili 
(BFP), which along with flagella, are responsible for initial attachment of EPEC to 
intestinal epithelial cells prior to A/E lesion formation (Girón et al., 1991, 2002). 
Atypical EPEC is distinguished from EHEC by the absence of Shiga toxins (Stx) and 
particular isotypes of certain LEE-encoded effector proteins, as it does not harbour 
pEAF (figure 1.2, (Kaper, 1996; Naylor et al., 2005b)). EPEC do not express Stx but 
are still an important cause of young infant diarrhoea in the developing countries 
(Chen & Frankel, 2005). EHEC on the other hand is more associated with diarrhoea-
associated disease in developed world, as a result of contamination due to intensive 
farming (Valcour et al., 2002). EHEC also produce entero-haemolysin (Ehx), and 
Stx1 and/or Stx2 of various subtypes, which cause local and systemic haemorrhagic 





fimbriae such as haemorrhagic coli pilus (HCP) prior to A/E lesion formation 
(Mahajan et al., 2009; Xicohtencatl-Cortes et al., 2007). 
 
1.2    Entero-haemorrhagic E. coli 
EHEC causes watery diarrhoea in humans, followed by haemorrhagic colitis, the 
symptoms of which include severe abdominal cramps and bloody diarrhoea. Initial 
symptoms are likely to be caused by the action of type-III secreted effector proteins. 
Haemorrhagic colitis and more serious systemic complications such as haemolytic 
ureamic syndrome (HUS) are due to Shiga toxin production (Richardson et al., 
1988). HUS is a major complication of EHEC infection and Shiga toxin release, and 
disease can involve multiple organs including the lungs and the brain (Richardson et 
al., 1988). Shiga toxins bind to globotriaosylceramide (Gb3) and so targets Gb3-rich 
tissues such as the colonic epithelium and blood vessel endothelia, particularly of the 
kidneys and the brain (Jacewicz et al., 1994; Lingwood et al., 1987; Richardson et 
al., 1988). HUS is defined as the combination of acute renal failure, 
microangiopathic haemolytic anaemia and thrombocytopaenia (Karmali, 2004). A 
small percentage of HUS cases are fatal and many HUS cases result in long-term 
morbidity. HUS mainly occurs in the old and young, and rates of HUS morbidity, 
fatality and resolution in EHEC outbreaks vary according to EHEC strain and Shiga-
toxin type (Neupane et al., 2011; Ostroff et al., 1989). On average 5-10% of EHEC 
O157:H7 cases progress to HUS, with <10% fatality rate, and 30% of cases have 
serious long-term effects (Paton & Paton, 1998). 
 
Shiga toxin is encoded on a lambdoid prophage, which can infect and integrate into 
the genomes over 100 serotypes of E. coli (Hermos et al., 2011; O’Brien et al., 
1984). Shiga toxin is released upon bacterial lysis due to phage induction from 
lysogeny (Mühldorfer et al., 1996). However, manipulation of host cells by T3SS is 
important for bacterial adherence, and the degree and success of EHEC colonisation 
impacts upon how much Shiga toxin is produced and therefore the severity of 
disease. This was aptly demonstrated by the 2011 outbreak of the LEE- STEC 
O104:H4, which caused high rates of HUS (22%) due to the very successful 






EHEC O157:H7 strains have emerged in the last 30 years as important pathogens, 
particularly in the USA and UK, as they tend to be associated with greater prevalence 
and more severe outcomes in these countries. Other serotypes responsible for 
significant disease burden include O26, O111, O103, O121, O45 and O145 (Brooks 
et al., 2005; USDA/FSIS, 2011). While overall incidence of haemorrhagic disease 
tends to be quite low, the social and economic burden is high due to the seriousness 
of complications and long-term effects. Supportive care and treatment of 
complications is very expensive (Bavaro, 2012). In the US alone, it is estimated that 
EHEC O157:H7 costs $405 million per year and $6.2 million for each patient that 
dies of HUS (Frenzen et al., 2005). Additionally, the cost of screening and product 
recalls is high; there are costly surveillance programs across Europe and the US, and 
the last meat recall in the US involved 38,200 tonnes of ground beef (USDA/FSIS, 
2012). 
 
1.2.1 EHEC epidemiology  
EHEC are an important set of pathogens that cause disease most notably in northern 
Europe, the USA, Canada, Argentina, Australia and Japan (Chase-Topping et al., 
2008).  Around half of human cases are sporadic, with a seasonal pattern favouring 
summer and autumn (Lal et al., 2012). However, the outbreaks that do occur can be 
dramatic, as with the 1996 outbreak of EHEC O157:H7 in a small community in 
Lanarkshire, Scotland, where there were 512 cases (279 confirmed), and 20 fatalites 
(Cowden et al., 2001). Outbreaks of EHEC with unusual genotypes or phenotypes 
can be particularly problematic, as with the 2002 sorbitol-fermenting EHEC O157:H- 
outbreak in Germany, as it takes longer to detect and prevent its transmission, 
resulting in more cases (Alpers et al., 2009).  
 
EHEC is spread faeco-orally, generally from cattle sources, though transmission 
from other ruminant sources, like sheep, also occurs (Matthews et al., 2006; La 
Ragione et al., 2009). The infectious dose can be as low as 50 organisms (Tuttle et 
al., 1999). Therefore transmission can occur through direct contact with ruminants, 





produce (Rangel et al., 2005). Humans appear to be incidental hosts to EHEC, as 
EHEC seem more adapted to persist in adult ruminants without causing disease 
(Naylor et al., 2005b). Prevalence in cattle herds can be as high as 100% (Gyles, 
2007). Due to intensive farming practices, the density of asymptomatic cattle 
proximal to human populations to seed EHEC infection is greater than with other 
ruminants, such as sheep. This may explain why EHEC is more of a problem in the 
developed world and why cattle are the primary reservoir of spread.   
 
EHEC O157:H7 have been shown to preferentially colonise the last 5 cm of the 
intestinal tract in cattle, at the bovine terminal rectum (Naylor et al., 2005a). This site 
presumably allows its efficient spread. There are many hypotheses for why EHEC 
O157:H7 shows such a specific tissue tropism in cattle. These include nutritional 
availability (Snider et al., 2009), mechanisms or repertoire of type-III effector 
proteins (Girard et al., 2005), regulation of type-III secretion (Roe et al., 2004; Tree 
et al., 2009), binding or regulation specificities of surface adhesins (Erdem et al., 
2007; Mahajan et al., 2009; Mundy et al., 2007), or the availability of host receptors 
(Mundy et al., 2007; Robbe et al., 2004). 
 
1.2.2 On-farm control measures 
Knowledge of the principle site and mechanisms of EHEC O157:H7 colonisation 
creates specific targets for control strategies in cattle, and new ways to assess their 
efficacy. This is necessary because proper implementation of Hazard Analysis and 
Critical Control Point (HACCP) principles to process beef has so far been 
unsuccessful in limiting transmission to humans (ECDC, 2011). Epidemiological 
modelling indicates that sterile immunity in cattle would not be necessary to prevent 
transmission to humans. Preventing faecal shedding of more than 104 CFU.g-1 could 
significantly reduce transmission and prevent maintenance within herds (Matthews et 
al., 2006).  
 
In their 2007 paper, Sargeant et al. concluded that targeted interventions such as 
probiotics, rectal washing with sodium chlorate or vaccination showed the potential 





in feed (Callaway et al., 2009) are very cheap, but their effectiveness is still 
debatable (Sargeant et al., 2007). Targeting EHEC colonisation of cattle by 
vaccination has been cited as one of the most cost effective strategies to control 
EHEC (McNeilly, 2012). However, there are a few drawbacks to this approach. 
Proven vaccine efficacy has not yet been achieved, as experimental trials conducted 
have given variable results (Potter et al., 2004; Sargeant et al., 2007). As there is 
currently little incentive for meat producers, vaccination would also have to be low-
cost for it to be adopted (McNeilly, 2012).  
 
Vaccines and other control strategies need to be at least partially tailored to 
transmission routes, which are varied. For example, transmission of EHEC to 
children in petting zoos could be prevented simply by effective animal and human 
surveillance measures (HPA, 2011). Yet in the USA, pre-harvest controls would be 
effective in preventing spread from feedlots to meat during processing (Potter et al., 
2004). In contrast, an effective control strategy in Scotland would have to last 
throughout the lifespan of the cattle to reduce environmental contamination (Chase-
Topping et al., 2008).  
 
1.2.2.1 Vaccination against EHEC in cattle 
Vaccines trialled so far include those that target iron acquisition by vaccination with 
bacterial membrane-bound components from iron restricted cultures (Epitopix), T3S 
with culture supernatants (Bioniche Animal Health, (Potter et al., 2004)) or 
recombinant LEE-encoded proteins (Dziva et al., 2007; McNeilly et al., 2010a) and 
killed bacteria (Van Diemen et al., 2007). These vaccines were designed to generate 
mucosal antibodies, either to inhibit bacterial growth, as with Epitopix, or to prevent 
epithelial attachment of EHEC. These vaccines are not currently licensed for use in 
Northern Europe. 
 
Vaccination strategies with T3S proteins and SRP® Epitopix technology have been 
shown in general to reduce faecal shedding of EHEC O157:H7 in cattle that were 
naturally exposed (Snedeker et al., 2012). Natural exposure as a trial infection route 





beef production. However, it does not give the quantitative proof of concept that 
deliberate challenges do, as times of exposure and infectious doses are unknown.  
 
Deliberate challenges with O157:H7 have also been trialled. Antibody-mediated 
protection is not immediate, because it is an adaptive response, but it is also transient 
(Naylor et al., 2007). Therefore, for vaccine strategies based on generating EHEC 
O157:H7 neutralising antibodies to be protective, the efficacies of different dose 
regimens and times between vaccination and exposure have had to be investigated. 
Many different schemes were used for these trials, varying the number and timing of 
doses. This had key implications for how such a vaccine could be used. For example, 
current vaccine technologies need multiple doses for full efficacy (Snedeker et al., 
2012), and still only provide transient protection, but they may serve as an effective 
pre-slaughter control in the USA. 
 
For vaccines using T3S proteins, multiple antigens have to be used to be protective. 
For example, calves vaccinated with recombinant EspA or Intimin were no less 
colonised by EHEC than controls (Van Diemen et al., 2007; Dziva et al., 2007). This 
is one of the benefits of the T3S supernatant vaccines; many antigens are included at 
very little cost. However, key antigens may be variably present at different 
concentrations, depending on expression conditions (McNeilly et al., 2010a). Also, 
this vaccination only includes secreted factors, not membrane-bound proteins such as 
intimin, which is important for intimate attachment at the bovine terminal rectum 
(BTR, section 1.3, (Cornick et al., 2002)).  
 
In contrast to T3S supernatants, EHEC recombinant T3S vaccines, while more 
expensive, allow logical antigen selection and their inclusion at defined amounts 
(McNeilly et al., 2010a). Vaccination with the combination of recombinant Intimin, 
EspA and Tir has been shown to reduce colonisation rates and shedding of Stx- 
EHEC O157:H7 in cattle (McNeilly et al., 2010a). This strategy is known as 
sequential antigen targeting, as it targets antibodies towards 3 sequentially involved 





flagella were later added to this vaccine, because flagella can be produced cheaply 
and are involved in initial colonisation of the BTR (Mahajan et al., 2009). 
 
1.3 Bovine terminal rectum colonisation model  
 
The current model of EHEC bovine colonisation involves flagellar-based motility to 
the BTR, where flagella and other suface factors mediate initial attachment (figure 
1.3, (Tree et al., 2009)). The BTR is an epithelial site, organised into villi. Villi are 
made of intestinal epithelial cells that are differentiated from crypt somatic stem cells 
in villi troughs (reviewed in (Abreu, 2010)). Therefore epithelial cells at the bottom 
of villi are young and as they mature, they end up at the tips, before sloughing off 
after about 5 days. In addition to absorptive epithelial cells, villi contain different 
secretory cells, which secrete mucus, hormones and antimicrobial peptides, and 
antigen-sampling microfold (M) cells.  
Figure 1.3. A current model of EHEC colonisation of the bovine terminal rectum (for full 
review please see Tree et al. 2009). Briefly, heterogeneous expression of surface factors 
allows initial attachment of EHEC and stress induces the Stx-phage dependent lysis of a 
subset of bacteria. Shiga toxin (Stx) induces surface expression of host receptors that 
EHEC is able to bind to intimately during A/E lesion formation. Type-III effectors also 
disrupt tight junctions and cause effacement of the intestinal epithelium as cells are shed. 
A) Widefield fluorescent micrograph of EHEC O157:H7 adhering to bovine rectal epithelial 
cells. B) Transmission electron micrograph of EHEC O157:H7 A/E lesion formation in an 
experimentally infected calf. C) Scanning electron micrograph of EHEC O157:H7 
microcolony formation on primary bovine rectal epithelial cells. Arrows indicate bacteria, 






This initial attachment of bacterial surface factors to villi is then superseded by T3S-
based adherence (Mahajan et al., 2009). At the same time, bacterial stress triggers an 
SOS response in a subset of bacteria close to the intestinal epithelium (Tree et al., 
2009). This induces Stx-phage activation, production of Shiga toxin (Stx), bacterial 
lysis and release of Stx from this subset of bacteria (Toshima et al., 2007). Stx 
enriches the host apical membrane with Intimin receptors such as nucleolin 
(Robinson et al., 2006). Intimin is a member of the auto-transporter family of 
secreted proteins and is targeted to the outer membrane of the bacterium. Surface 
localised Intimin binds nucleolin and annexin II (Sinclair & O’Brien, 2002; Zobiack 
et al., 2002), and meanwhile the T3SS delivers translocated Intimin receptor (Tir) 
and other effector proteins into host cells to manipulate the cytoskeleton (Dziva et 
al., 2004). This results in a characteristically intimate attachment to the intestinal 
epithelium. Intimin binding clusters Tir, causing the formation of actin-rich A/E 
lesions in the cytoplasm under bacteria, which are tightly tethered to the host 
membrane by this interaction (Chen & Frankel, 2005). However, type-III secreted 
proteins not only allow EHEC to bind effectively, but also to persist and cause 
enough pathology to allow shedding into the lumen, facilitating its spread (Smith et 
al., 2002). 
 
The selective advantages of a T3SS in EHEC bovine colonisation models have been 
demonstrated by reduced colonisation of LEE4, escN and type-III secreted effector 
mutants (Dziva et al., 2004; Naylor et al., 2005a; Ritchie & Waldor, 2005). More 
recently, possession of specific Stx2 sub-types have been suggested to be 
advantageous for colonisation of the BTR due to the positive regulation of host 
receptors, delayed down-regulation of virulence factors and host inflammation 
(Moxley, 2004; Robinson et al., 2006; Xu et al., 2012). However, the role of flagella 
is less clear.  While H7 flagella have been shown to mediate initial adherence of 
EDL933 to the bovine terminal rectum in vitro (Mahajan et al., 2009), isogenic fliC 
mutants in ATCC 43894 have a selective advantage over WT in experimentally co-
infected cattle (Dobbin & Hovde, 2006). It is likely that this reflects a balance 





survival signalling, against the disadvantages of energetic costs and immune 
surveillance. 
 
In addition to remodelling the apical membrane of host epithelial cells, EHEC type-
III effector proteins affect numerous other cell functions. For example, Map affects 
tight-junction integrity (Dean & Kenny, 2004), EspZ affects cell survival (Shames et 
al., 2010), and NleB reduces innate immune signalling (Newton et al., 2010). Table 
1.1 details the general complement of type-III effector proteins in EHEC and their 
known binding partners and functions.   
 
Table 1.1. Summary of EHEC type-III effector protein functions, adapted from (Wong et al., 
2011). Shaded areas indicate non-LEE encoded effectors (Nle). Guanine exchange factor 
(GEF), p21 activated kinases (PAK), integrin-linked kinase (ILK). Other abbreviations are 


















Translocation pore component, 
apical junction disruption, binds 












Receptor for intimin adherence, 
actin pedestal formation, 
downregulates Map-dependent 


















Mitochondrial disruption, NHE3 
inactivation, SGLT-1 
inactivation, tight junction 
disruption, disrupts nucleolus, 
disrupts intermediate filaments, 
activates SNX9 to induce 
membrane remodelling, binds 







Cdc42 GEF that induces 
transient filopodia formation, 
mitochondrial disruption, SGLT-








Disrupts microtubules, blocks 
ARF GTPase signalling and 
stimulates PAKs to inhibit 
endomembrane trafficking 
















RhoGEFs and antibody-mediated 





CD98 None known 
Enhances β1-integrin and FAK 
signalling to inhibit apoptosis 

















Inhibits COPII-dependent protein 
export from endoplastic 






Inhibits antibody-mediated and 
complement-mediated trans-
phagocytosis 
EspK Unknown Unknown GogB Unknown 
EspL Pedestal Annexin 2 OspD 
Enhances F-actin bundling 





RhoA IpgB, SopE 
RhoA GEF that induces stress 
fibre formation 






EspO Unknown ILK OspE Unknown 
EspR Unknown Unknown SF1757 Unknown 
EspV Cytosol Unknown AvrA1 Modulates cytoskeleton 









EspY Unknown Unknown SopD Unknown 
NleB Cytosol Unknown SseK 





p65 (RelA), p50, 
c-Rel, IκB 
AIP56 
Metallo-protease that cleaves 
p65 (RelA), c-Rel, p50 and IκB 














NleD Cytosol JNK 
HopAP1, 
HopH1 
Metallo-protease that cleaves 
JNK to inhibit AP-1 activation 
NleE Cytosol Unknown OspZ 
Blocks IκB degradation to inhibit 
NF-κB activation 
NleF Unknown Unknown None known Unknown 










Binds Bax-inhibitor 1 to block 
apoptosis, sequesters RPS3 to 






Relieves N-WASP autoinhibition 




1.4 Subversion of the actin cytoskeleton by bacterial proteins 
Like EHEC, other pathogenic Gram-negative bacteria use type-III secreted effector 
proteins to create niches. For example, Pseudomonas syringae, Shigella flexneri, S. 
Typhimurium, Chlamydia trachomatis, Xanthomonas campestris, Burkholderia 
pseudomallei, Yersinia pestis and Vibrio parahaemalyticus all contain related T3SS 
(Büttner, 2012). The actin cytoskeleton is fundamental to many of the cellular 
processes manipulated by the bacterium. As such it is heavily targeted by secreted 




The actin cytoskeleton is made up of cytoplasmic actin and the factors that regulate 
it. Actin has three isotypes; cytoplasmic actin is a mixture of beta and gamma actin 
isotypes (Dos Remedios et al., 2003). Monomeric actin is globular and referred to as 
G-actin, whereas polymeric actin is filamentous, and referred to as F-actin. G-actin 
and F-actin exist in a dynamic equilibrium with one another, and it is well 
established that this equilibrium is fundamental to the function of actin 





with polarity; the faster growing end is known as the barbed or (+) end and the 
slower growing end is known as the pointed or (-) end (Hanein et al., 1998; Tilney & 
Kallenbach, 1979).  
 
Mature F-actin filament formation involves nucleation, elongation and steady states 
or phases. Spontaneous actin nucleation most likely involves two steps - formation of 
dimers that can easily dissociate, followed by formation of stable trimers (figure 
1.4(A), (Jégou et al., 2011)). These steps are distinct but both thermodynamically 
unfavourable and therefore rate limiting. As a result, nucleation is also known as the 
lag phase. Once trimers, or ‘critical nuclei’, are formed, the addition of monomer to 
the ends of the actin polymer is thermodynamically favourable, allowing elongation 
(figure 1.4(A), (Jégou et al., 2011)). This is also known as the growth phase. The 
steady state occurs when equilibrium is reached between actin polymerisation and 
depolymerisation and is also known as the equilibrium phase. Because of the polarity 
of the actin filaments, the equilibrium phase generally involves net depolymerisation 
at the pointed end and net polymerisation at the barbed end (figure 1.4(B), (Pinder & 
Gratzer, 1983)). The length of filament remains the same, in a dynamic equilibrium 
of directional subunit flux known as actin tread-milling. The concentration of free 
monomers at which this occurs is known as the critical concentration (Dos Remedios 
et al., 2003). 
Figure 1.4. Actin assembly and filament dynamics. (A) Nucleation 
of an actin trimer from monomers (G-actin) is a rate-limiting step in 
assembly of actin filaments (F-actin. (B) F-actin filament polarity 
and tread-milling; see text for details. Thickness of arrows 
indicates favoured state. Figure is adapted from Jegou et al. 2011 






Actin tightly binds to ATP or ADP and divalent cations, such as Ca2+ and Mg2+ 
(Grazi & Trombetta, 1985). When G-actin is bound to Mg2+ it binds ATP more 
easily. G-actin-ATP is favoured for polymerisation due to the increased stability 
afforded by the third phosphate (Korn et al., 1987). After polymerisation, Actin-ATP 
is quickly hydrolysed into actin-ADP-Pi (figure 1.4(B)). Dissociation of the 
inorganic phosphate occurs more slowly, at random (Jégou et al., 2011). However, 
once this happens, F-actin-ADP is much less rigid and more likely to dissociate from 
actin filaments (Dos Remedios et al., 2003). F-actin is unable to exchange ADP for 
ATP, whereas G-actin is, which allows monomers to be recycled (figure 1.4(B), 
(Hegyi et al., 1988)). F-actin is therefore generally a mixture of newly polymerised 
actin-ATP at the barbed end, capped by older actin-ADP-Pi which is increasingly 
unstable at the pointed end due to Pi release (Jégou et al., 2011). These properties, 
and how they are regulated, are responsible for the polarity of actin filaments (Dos 
Remedios et al., 2003).  
 
1.4.2 Host actin regulatory proteins 
Actin is regulated by a number of host proteins, in order to co-ordinate and harness 
actin filaments for use in host-cell processes. Actin-binding proteins control actin 
dynamics and arrangement by binding to G-actin and/or F-actin. Another layer of 
regulatory control is added by changing the levels of expression, activation and bio-
availability of the actin-binding proteins and their regulators (Scott & Olson, 2007). 
This allows global and spatial fine-tuning of actin dynamics at a cellular level, which 
is necessary for such eukaryotic processes as adherence, motility and cytokinesis 
(Van Troys et al., 2008). 
 
Figure 1.5 shows different examples of how actin-binding proteins interact with actin 
for local control of actin arrangement and dynamics. There are many proteins that 
interact with actin to change the arrangement or anchorage of its filaments (figure 
1.5, bottom). Actin can be bundled into stress-fibres, spikes or cables (Fimbrin, α-
actinin and myosins respectively), cross-linked into lattices (Filamin), or branched 





Hammer, 1988; Maciver et al., 1991). Actin can be anchored to plasma membranes 
by ERM proteins, (ezrin, radixin and moesin (Arpin et al., 2011)), and in the case of 
microvilli, myosin-I with Calmodulin (Mooseker, 1989). Actin is also anchored to 
tight-junctions (via cadherins, (Brooke et al., 2012)) and the cellular matrix (via 
integrins, (Wehrle-Haller, 2012)). 
 
 
Some actin-binding proteins regulate actin by changing its filament dynamics. Actin-
sequestering proteins (figure 1.5, top-left) reduce the pool of free G-actin, limiting its 
assembly, as with thymosin (Dominguez, 2007). Other proteins that interact with G-
actin have the opposite effect. For example, nucleation promoting factors, such as 
Arp2/3, decrease the free-energy required for actin nucleation, reducing the lag-
phase in actin assembly (Goley & Welch, 2006). Also, Profilin-binding to G-actin 
increases the efficiency of F-actin elongation by delivering G-actin to the barbed 
ends of filaments (Firat-Karalar & Welch, 2011).  
 
F-actin binding proteins can affect the efficiency of polymerisation by binding to 
barbed ends of F-actin. Formin caps barbed ends and interacts with profilin to 
Figure 1.5. Regulation of actin (red) by actin-binding proteins 
(blue). Polarity of actin is indicated by pointed ends (-) and 






increase the efficiency of filament growth (Paul & Pollard, 2009). Conversely, 
Gelsolin severs filaments before nucleating fragments, resulting in actin disassembly 
then assembly (Sun et al., 1999). In contrast to capping proteins, certain actin-
binding proteins can bind along the length of F-actin. This prevents other protein 
interactions, resulting in either stabilised filaments, as with Tropomyosin (Ursitti & 
Fowler, 1994), or severed filaments, as can occur with ADF/cofilin 
(Andrianantoandro & Pollard, 2006).  
 
ADF/cofilin is ubiquitously expressed in mammals and is a key regulatory player in 
actin dynamics. Mammalian ADF/cofilin has 3 isoforms - cofilin-1, cofilin-2 and 
actin-depolymerising factor (ADF) - with overlapping but not identical roles 
(Vartiainen et al., 2002). Cofilin-1, also known as non-muscle cofilin, is ubiquitous 
and is crucial for embryonic development (Gurniak et al., 2005). As with all 
ADF/cofilins, its role in actin dynamics is complex, depending on its stoichiometric 
ratio to actin and pH (figure 1.6).  
Figure 1.6. Regulation of actin, (red) dynamics by cofilins, (small blue 
circles). Cofilin concentration is indicated by grey gradient. As the ratio of 
cofilin to actin is increased, the action of cofilin changes from severing, to 
binding, to nucleating. Inset gives two possible outcomes of filament 
severing on actin dynamics, which is dependent on the presence of other 
factors (big blue circles). Black ends indicate where filament was severed. 
Polarity of actin is indicated by pointed ends (-) and barbed, spiky (+) ends. 






Cofilins can bind filamentous or monomeric actin, but have a preference for ADP-
actin (Van Troys et al., 2008). When cofilins bind to F-actin, they introduce a tighter 
helical twist into the filament (McGough et al., 1997). At low concentrations, this 
causes filament severing due to the tension between areas of the filaments that are 
tightly twisted by cofilins and areas that are not (Bobkov et al., 2006). This can result 
in actin filament disassembly if the barbed end is capped, or assembly due to an 
increased number of barbed ends (figure 1.6). Increasing the number of barbed ends 
is enhanced in the presence of branching factors and G-actin-ATP 
(Andrianantoandro & Pollard, 2006). Because cofilins preferentially bind to ADP-
actin, older actin filaments tend to be targeted for this severing (Van Troys et al., 
2008). At higher concentrations cofilins bind along the whole length of filaments. 
This is actually stabilising because there is no torsional tension as the whole filament 
is bound by cofilin (Andrianantoandro & Pollard, 2006). At actin-saturating 
concentrations of cofilins, they bind actin monomers and act as nucleation factors, 
promoting filament assembly (figure 1.6).  
 
Cofilins are also regulated by specific mechanisms and more generally by 
physiological pH. Higher pH enhances actin-severing activity, while lower pH 
enhances actin-binding activity (Pavlov & Muhlrad, 2006). Cofilins are inhibited by 
phosphorylation at serine 3 by LIM-kinase, and activated by dephosphorylation by 
Slingshot (Huang et al., 2006). Additionally, active cofilins are sequestered in the 
inner leaflet of the cytoplasmic membrane by polyphosphoinositide-4,5- 
bisphosphate and are released by the action of phospholipase C (Zhan et al., 2003). 
 
Actin-binding proteins are responsible for local actin regulation and in turn are 
regulated locally by actin-binding regulatory proteins. However, there are 
mechanisms for more global co-ordination of actin dynamics. For example, small 
GTPases of the Rho family (Cdc42, Rac, Rho) regulate actin-binding proteins and 
their regulators in response to extracellular stimuli (figure 1.7, (Hall, 1992; Ridley & 
Hall, 1992)). Figure 1.7 is a very simplified example of a well-established model of 





family activity on actin-binding proteins and their regulators. For example, Rho 
activates formin (mDia), which results in long F-actin filaments (Kovar, 2006). It 
also activates Myosin II via Rho kinase (ROCK, (Somlyo & Somlyo, 2000)), 
allowing stress fibre formation by actin bundling. 
 
 
On top of this regulatory tier, there are activators and inhibitors of Rho-family 
GTPases, which are only active when bound by GTP, not GDP. Guanine nucleotide 
exchange factors (GEFs) replace GDP with GTP, activating the regulators, while 
GTPase activating proteins (GAPs) cause GTP hydrolysis and consequent 
deactivation of these regulators (Hall, 1992). These extra levels of control shown in 
Figure 1.7. Global regulation of actin dynamics by Rho-family GTPases Rac, Rho and 
Cdc42. Actin-binding proteins are blue, GTPases are active when GTP bound (green) 
and inactive when GDP bound (red). Cell phenotype of activation of example Rho-family 
GTPases is indicated on the bottom. These GTPases themselves are activated by 
guanine nucleotide exchange factors (GEFs) and inactivated by GTPase activating 
proteins (GAPs). Wiskott-Aldrich syndrome protein (WASP), p21 activated kinase (PAK), 





figure 1.7 briefly illustrate the complexity of actin dynamics signalling cascades and 
the many levels that it is possible to manipulate. 
 
1.4.3 Bacterial actin regulatory proteins 
Bacteria can hijack elements of the actin cytoskeleton, taking advantage of its ability 
to move and shape cells according to stimuli, and to engulf, divide and traffic 
intracellular and extracellular contents. All these properties can be exploited by 
bacteria where it is advantageous to carve a niche on or inside cells, multiply there 
and spread (Wong et al., 2011). To do this, bacteria manipulate actin regulatory 
cascades at multiple points. 
 
For a bacterial niche on the outside of cells, it is advantageous to manipulate the 
actin cytoskeleton to promote tight binding and regulate bacterial uptake. Both 
EHEC and EPEC Tir proteins cause tight attachment in A/E lesions by activating the 
same pathway in different ways. TirEPEC is clustered by binding to intimin and then 
tyrosine-phosphorylated by host proteins (Phillips et al., 2004). Nck binds to 
phosphorylated TirEPEC and recruits N-WASP (a regulator of actin-nucleation 
proteins), resulting in Arp2/3-dependent nucleation of actin (Garmendia et al., 2004). 
TirEHEC is functional in the absence of Nck. Lacking the key tyrosine residue for Nck 
recruitment, TirEHEC is instead bound by a non-LEE encoded T3S protein, EspFu. 
EspFu clusters N-WASP, activating Arp2/3-dependent actin nucleation (Campellone 
et al., 2004). Activation of Arp2/3 promotes A/E lesion formation, which tightly 
anchors bacteria to the actin cytoskeleton through the host cell membrane.  
 
To regulate bacterial uptake, EHEC and EPEC secrete EspH into cells. EspH inhibits 
many mammalian Rho family-GEFs, preventing host activation of Rho-family 
GTPases (Wong et al., 2012). This inhibition allows bacteria to take control of 
membrane modelling by actin with their own Rho-family GEF mimics (Dong et al., 
2010). Map is a GEF mimic that activates Cdc42, resulting in short-lived filopodia 
formation. This activity is transient because Tir, which additionally mimics Cdc42-
GAPs, antagonises Map activity and Map is quickly targeted to mitochondria (Wong 





bacterial uptake, resulting in a vacuolar A/E lesion (Bulgin et al., 2009). This action 
is contrary to what might be expected of an extracellular pathogen. However, EspT is 
only rarely present in EPEC strains, and the effect this has on EPEC pathogenesis 
remains to be seen (Arbeloa et al., 2009).  
 
Other bacteria routinely manipulate the actin cytoskeleton to deliberately invade host 
cells. This is a rapid but complex process, regulated both in space and time by T3S 
effector proteins. Shigella IpaC, a component of the T3SS translocon pore, directly 
nucleates actin, highlighting that subversion of actin dynamics can happen at the 
earliest opportunity (Kueltzo et al., 2003). In contrast, another Shigella T3S effector, 
IpaA, causes actin depolymerisation by interacting with vinculin-containing actin-
membrane anchors (Bourdet-Sicard et al., 1999). S. Typhimurium also secretes 
effector proteins of opposing function, to allow temporal regulation of actin 
dynamics. SopE, another bacterial protein that mimics Rho-GEFs, activates Cdc42 
and Rac1 (Bulgin et al., 2010). This induces membrane ruffles that are stabilised by 
SipA inhibition of cofilin function (Wong et al., 2012; Zhou et al., 1999). Large 
membrane ruffles are formed, and these engulf bacteria, allowing their entry into 
host cells. However, S. Typhimurium also secretes SptP, which mimics Rho-family 
GAPs and antagonises SopE (Kubori & Galán, 2003). SptP has a longer half-life than 
SopE, allowing the bacteria to dramatically but reversibly remodel host membranes 
for invasion. 
 
However, it is not just T3S effectors that are involved in bacterial manipulation of 
the actin cytoskeleton. Specific membrane-bound proteins expressed at bacterial 
poles can harness actin dynamics to move bacteria through the cytoplasm of host 
cells. Burkholderia psuedomallei BimA, Listeria monocytogenes ActA, Rickettsia 
Sca2 and Shigella IcsA all mediate this actin-based intracellular motility (Haglund & 
Welch, 2011). The first bacterial actin-based motility discovered was that of ActA 
from L. monocytogenes, and was known as actin-rocketing. ActA binds directly to 
Arp2/3 independently of N-WASP, which then nucleates and branches polymerising 
actin filaments behind the bacteria, rocketing it forwards (Welch et al., 1998). Sca2 





cooperation with profilin and fimbrin (Haglund et al., 2010). Shigella IcsA nucleates 
actin less directly than ActA, by binding N-WASP to recruit Arp2/3 (Egile et al., 
1999), resulting in similar actin rockets to Listeria.   
 
This example of three types of actin-based motility highlights the diversity of 
mechanisms that bacteria use to subvert the actin cytoskeleton. To take advantage of 
the same principle, nucleation of actin filaments at one pole to propel them forward, 
these bacteria activate the same process at three different tiers of actin regulation 
(Haglund & Welch, 2011). Figure 1.8 highlights this, in the context of the other 
examples given.  
 
Figure 1.8. Bacterial proteins, 
(outlined in black), subvert actin 
dynamics at multiple regulatory 
levels. Bacterial proteins affect 
GEF activity, mimic GEF and 
GAP proteins, and bind to actin-
binding proteins and their 
regulators with differential 
outcomes in actin dynamics. 
Effects on actin dynamics are 
illustrated in the bottom square, 
but this does not include 
proteins that alter Rho-family 
GTPase activity, as this 
depends on which GTPase is 
affected. Bacterial proteins can 
also bind directly to actin and 
cause actin polymerisation. 
Bacterial proteins that act 
antagonistically with one 
another are indicated by a faint 
grey broken line. Bacterial 
proteins that mediate actin-
based motility are filled black. 
Bacterial proteins that mimic 
host GEFs, GAPs or actin-
binding proteins (ABP) are filled 
with green, red or blue 
respectively. Rho-GTPases (red 
and green squares) are active 
when GTP bound (green) and 
inactive when GDP bound (red). 
Actin-binding proteins (ABP) 
and their direct regulators 





1.5 Bacterial flagella 
As mentioned in section 1.3, H7 flagella are involved in initial adherence of EHEC 
O157:H7 to the bovine terminal rectum (Mahajan et al., 2009). Flagella can be 
arrayed on bacterial cells in a number of ways. They can be singly expressed 
(monotrichous) or multiply expressed (lophotrichous). This can be either at one pole 
(polar), both poles (amphitrichous), laterally, or all over (peritrichous). E. coli and 
Salmonella have one flagellar system that is expressed peritrichously.  
 
1.5.1 Structure of flagella 
In E. coli and Salmonella, a flagellum consists of a long capped extracellular 
filament, attached to a hook via hook-associated adaptor proteins (HAPs) FlgK and 
FlgL (Büttner, 2012). Flagella filament length varies, depending on secretion 
efficiency, growth conditions and mechanical stress, but they are on average between 
5-10 µm long in E. coli (Turner et al., 2012).  The hook is in turn attached to the 
basal body in the cell wall via a rod (figure 1.9). The basal body contains an L-ring in 
the outer membrane, a P-ring in the peptidoglycan layer, an MS-ring in the inner 
membrane and a C-ring in the cytoplasm (Berg, 2003). The rod passes through the L 
and P rings, and connects to a secretin and the MS ring. The secretin is part of a 
flagellar T3SS which is housed in the MS and C rings, and the C-ring portion serves 
as a docking site for secretion substrates (Büttner, 2012). The MS ring is made of 
FliF, and is connected to the motor/stator complex via the C-ring rotor/switch 
complex (Ueno et al., 1992). Figure 1.9 shows a schematic diagram of which 








Flagellin is major component of the flagella filament, and in E. coli is called FliC 
(Reid et al., 1999). Salmonella has two flagellins, FliC and FljB, and while they are 
expressed one at a time, Salmonella can switch between types in a process known as 
phase variation (Kutsukake et al., 2006). Structurally, flagellins fold back on 
themselves, like an elaborate hairpin, with the termini associated with one another. 
The termini are conserved and contain rigid helical D0 and D1 structural domains 
(figure 1.10, (Yonekura et al., 2003)). These domains are within the flagella 
Figure 1.9. The components of the flagellar apparatus in E. coli and Salmonella. 
The blue line indicates that the T3S export system acts as a gateway to a 
uninterrupted channel that leads to the tip of the flagellum. Outer-membrane (OM), 






filament, and are necessary for polymerisation and therefore motility (Andersen-
Nissen et al., 2005; Kuwajima, 1988).  
 
 
The central portion of flagellin is variable, and contains D2 and D3 structural 
domains (Kwang et al., 1996; Reid et al., 1999; Yonekura et al., 2003). These 
domains form the surface of the flagella filament (figure 1.10(C)) and exposed 
regions of flagellin can be post-translationally modified. For example, S. 
Typhimurium FliC and FljB surface-exposed lysine residues are methylated (Tronick 
& Martinez, 1971). Among many examples of flagellin glycosylation, 
Campylobacter jejuni FlaA, Helicobacter pylori FlaA and FlaB, Pseudomonas 
aeruginosa FliC and Listeria monocytogenes FliC are all glycosylated via serine and 
threonine residues (reviewed in Logan, 2006). This can alter the properties of flagella 
filament surfaces, which can be involved in binding. 
 
Figure 1.10. Structure and organisation of flagellin. (A) 
Flagellin peptides have central variable regions (red) and 
terminal conserved regions (blue), which associate with one 
another. (B) Crystal structure of S. Typhimurium FliC 
(PDB:1UCU) with conserved and variable regions indicated 
in blue and red, and a schematic of polymerisation of 
monomers. (C) Schematic of a flagella filament with the 
variable region on the outside and the conserved region on 





1.5.2 Flagella assembly 
The regulation of flagella assembly is complex and hierarchical (figure 1.11). There 
are 3 sets of co-ordinately regulated genes, which are expressed in phases (Kalir et 
al., 2001). flhDC is expressed first, as the master regulator. The flhDC promoter 
integrates environmental stimuli with cross-regulatory inputs, like cAMP, to control 
flhDC expression (Brown et al., 2009; Chilcott & Hughes, 2000). Due to the 
energetic costs of assembling and running flagella systems, and their recognition by 
host immune systems, flhDC expression is tightly regulated (Soutourina & Bertin, 
2003). flhDC expression is influenced by growth phase (RpoS, (Dong & Schellhorn, 
2009)) quorum sensing of bacterial density (QseBC, (Clarke & Sperandio, 2005)), 
pH and temperature (HN-S and CRP, (Soutourina et al., 1999)). Additionally, 
coordination of flagella expression with other surface factors, to avoid steric 
hindrance and allow temporal expression during colonisation, also occurs. For 
example E. coli flagella are inversely regulated with type-1 fimbriae (Lehnen et al., 
2002), and T3SS (Iyoda et al., 2006). 
 
Expression of flhDC is required to produce flagella, because FlhD2C2 drives 
transcription of mid-phase genes (figure 1.11). Mid-phase genes encode proteins for 
the hook/basal body (HBB), HAPs (FlgK, FlgL, FliD), their T3S chaperones, a 
specific flagellar sigma factor (σ28), its anti-sigma factor (FlgM) and a hook length 
regulator, FliK (Brown et al., 2009). The mid-phase genes are expressed in a 
hierarchy that corresponds to HBB assembly, according to the affinity of FlhD2C2 to 
the different promoters (Chilcott & Hughes, 2000). The proteins encoded by mid-
phase genes are required to regulate late-phase gene expression and protein secretion. 
Additionally, σ28 prevents FlhD2C2 auto-inhibition, resulting in more early to mid-
phase transcription if conditions are still stimulatory (Brown et al., 2009). FlgM 
inhibits the σ28-driven expression of late-phase genes, until FlgM is secreted through 
the complete basal body (figure 1.11, (Chilcott & Hughes, 2000)).  
 
Genes under late-phase control encode the HAPs, filament, T3S chaperone, motor 
and chemotaxis proteins (figure 1.11). FlhB, part of the flagellar T3SS, does not 





(Brown et al., 2009). This process is regulated by the secretion rate of the mid-phase 
protein FliK. At ~55 nm, FliK secretion rate through the HBB is slow enough to 
allow it to interact with FlhB (Hughes, 2012). This causes a conformational change 
in FlhB that changes its recognition specificities, allowing the secretion of the late-
phase proteins (Büttner, 2012). 
 
 
HAPs FlgK, FlgL and FliD are secreted first, in that order, because they are also 
under mid-phase regulation and so present before the other late-phase proteins. 
Additionally, there are specific chaperones for FlgK, FlgL, FliD and FliC, which also 
regulate late-phase protein secretion (Chilcott & Hughes, 2000). Secreted FliD drives 
filament formation by increasing the polymerisation efficiency of flagellin. It does 
Figure 1.11. Regulation of flagellar apparatus assembly in E. coli and Salmonella (as 
discussed in the main text). Phases of genes in blue, late phase components in red. 
Substrate-specificity switch (*), Basal body (BB), hook-basal body complex (HBB).  





this by capping the tip of the apparatus, slowing and guiding flagellin secretion. 
Flagellin is secreted in a partially unfolded state, in order to pass through the 30Å 
channel (Yonekura, 2000). FliD gives flagellin a chance to refold and make contacts 
with adjacent FliC, one at a time. With each FliC subunit added, FliD twists to the 
next site ready for a new FliC subunit. This results in FliD twisting in discrete steps 
at the end of the growing filament (Yonekura, 2000). 
 
1.5.3 Flagellar rotation 
Bacterial flagella can rotate, and this torque propels bacteria forwards (Blair, 2009). 
This form of motility is known as swimming and is powered by motor/stator 
complexes. These complexes surround the interface between C and MS rings, and 
are responsible for conducting proton motor force to the rotor/switch complex to 
generate rotation (Büttner, 2012). Each complex is made of four MotA subunits with 
two central MotB subunits and forms two channels (Braun et al., 2004). It is likely 
that the passage of hydrogen ions through these channels changes specific ionic 
interactions between MotB and MotA. MotB is anchored to the peptidoglycan layer 
while MotA is not, causing more pronounced conformational changes in MotA 
subunits (Blair, 2009).  
 
MotA movement is turned into rotation by its electrostatic interactions along the 
charged ridges of the rotor/switch complex (Blair, 2009). The rotor/switch complex 
connects the motor/stators to the MS ring and potentiates the rotation through the 
flagellum via FliG (Brown et al., 2007). Other components of the rotor/switch 
complex can change the direction of rotation in response to stimuli by altering the 
conformation of FliG (Blair, 2009). 
 
1.5.4 Swimming motility 
Flagellar rotation, which occurs like a ship’s propeller, can be used to push bacteria 
forward through liquids. This is known as swimming motility. There are other kinds 
of motility; swarming motility on solid substrates also uses flagella, while gliding 





rigid left-handed helices and their rigidity is important for developing forward 
motion (Macnab & Ornston, 1977). However, flagella filaments have to be flexible 
enough to resist shearing forces, and it is their flexibility that allows peritrichous 
flagella to bundle behind moving bacteria (Arkhipov et al., 2006). In this way 
bacteria can swim in a straight line, which is known as ‘running’.  
 
Bacteria change direction randomly, by ‘tumbling’. Tumbling is induced by 
changing the direction of the flagellar rotation, by altering the conformation of the 
switch complex protein, FliG (Larsen et al., 1974). This causes flagella to flay out 
from their bundle, twisting the bacterium. The altered conformation of the switch 
proteins resets very quickly, returning the direction of flagellar rotation back into 
running mode (Larsen et al., 1974). As a result, the bacterium swims away in a 
straight line, in a new but random direction (Arkhipov et al., 2006). In the absence of 
any chemoattractants or chemorepellents, this switching between running and 
tumbling modes occurs stochastically (Berg, 2003).   
 
Chemotaxis describes the process of cells moving in the direction of an increasing or 
decreasing chemical gradient, depending on whether the chemical is attractive or 
repellent. Bacteria control the direction of swimming by altering the frequency of 
tumbling by phosphorylating chemotaxis proteins like CheY, which can then bind to 
FliM in the motor switch (Wadhams & Armitage, 2004). If bacteria are moving 
along a chemical gradient, then they tumble less frequently. If bacteria are not 
swimming along a chemical gradient, they tumble more frequently until they are.  
 
1.5.5 Homology of flagella to T3SS 
Flagella are so complex that they are often used as an example in both sides of an on-
going debate between evolutionists and creationists. Creationists believe that 
something so irreducibly complex had to have been designed, while evolutionists 
think that for flagellar machines to be so complex, they must have evolved over 
billions of years. The icing on the cake for evolutionists came with technological 





homology between flagellar and translocation T3SSs across a range of bacteria that 
indicated a common ancestral origin (Pallen & Matzke, 2006).  
 
Even without sequence data, the homology between flagella and T3SS is clear at 
many levels (Abby & Rocha, 2012). The superstructure of both macromolecular 
machines is similar, from the pore that runs through their entire length, membrane 
rings housing the substrate docking site and secretion apparatus, to the caps on the 
homo-multimeric filaments projecting from the cell (table 1.2, (Hughes, 2012)). In E. 
coli O157:H7 T3S filaments are made of EspA, which is structurally homologous to 
FliCH7 from flagella filaments (Crepin et al., 2008). Also, the tip complexes of the 
EHEC H7 flagella filament and T3S needle are both pentameric, encoded by the 
structurally homologous proteins FliDH7 and EspD respectively (Büttner, 2012). 
 
 
Table 1.2. Structural homology of T3SS proteins with flagellar components. Table is adapted 











Secretin EscC YscC InvG SsaC MxiD FlgHI 
M ring EscD YscD PrgH SsaD MxiG FliG 
MA core EscRST YscRST SpaPQR SsaRST SpaPQR FliPQR 
M/C core EscV YscV InvA SsaV MxiA FlhA 
IM ring EscJ YscJ PrgK SsaJ MxiJ FliF 
M/C core EscU YscU SpaS SsaU SpaS FlhB 
C ring EscQ YscQ SpaO SsaQ SpaO FliN 
Inner rod EscI YscI PrgJ SsaI SpaM FlgBCFG
Length 
control 
EscP YscP InvJ SsaP Spa32 FliK 
Needle/hook EscF YscF PrgI SsaG MxiH FlgE 
ATPase 
complex 










The similarity between these two systems goes beyond their constituent parts. 
Flagella and T3SSs are also assembled and regulated in a similar manner (Büttner, 
2012). Both are assembled by inserting the inner-membrane ring into the membrane 
first, followed by the outer-membrane ring, the central rod-like structure and finally 
the filament (Suzuki et al., 1978). Both systems show secretion hierarchies and use 
chaperone proteins to correctly fold, prevent degradation of and deliver secretion 
substrates (Büttner, 2012). 
 
Of course, there are some obvious differences between flagella and T3SSs too. 
Flagella filaments are much longer than EspA filaments, and wider, with a larger 
central channel (Crepin et al., 2008). This is likely due to FliC being larger than 
EspA. Also, flagella have a hook, where T3SSs have a needle. Flagella rotate and are 
connected to a motor, while T3SSs are static. The IM ring in T3SSs is more 
complex. T3SSs diverged from flagella and adapted to different tasks some time ago 
(Abby & Rocha, 2012). Given this is the case however, it is striking how much 
overlap between these bacterial machines there still is. 
  
1.5.6 Immune recognition of flagella 
1.5.6.1 Innate immune recognition 
Flagella are a pathogen-associated microbial pattern (PAMP) recognised by pattern 
recognition receptors (PRRs) of the host innate immune system. There are 
extracellular and intracellular PRRs that recognise flagellin. PRRs recognise 
monomeric flagellin and only poorly recognise filamentous flagellin. This is because 
they recognise conserved regions necessary for filament formation and motility, 
normally hidden within the filament (Smith et al., 2003). Toll-like receptor 5 (TLR5) 
is an extracellular PRR, and NLRC4 (Nucleotide oligomerisation domain (NOD)-
leucine-rich repeat (LRR) family containing caspase-recruitment domain (CARD) 
protein 4) is part of an intracellular PRR (Miao et al., 2007). On recognition of 






TLR5 is generally expressed baso-laterally at epithelial sites but apical expression of 
TLR5 occurs in epithelial cells proximal to M cells (Abreu, 2010). Binding of 
flagellin to the LRR region of TLR5 allows TLR5 to dimerise and activate 
downstream NF-kB signalling pathways,  producing pro-interleukin (IL)-1β and pro-
IL-8 (Rumbo et al., 2006). Apically expressed TLR5 is less reactive to flagellin 
(Rhee et al., 2005). Despite this, apically applied FliCH7 flagellin does result in 
basolateral IL-8 secretion (Berin et al., 2002).  
 
IL-8 is a chemokine which recruits monocytes and neutrophils to the site of 
activation and is induced strongly in response to flagella expressed by pathogenic 
bacteria proximal to intestinal epithelial cells (Khan et al., 2008; Samanta et al., 
1989; Sampaio et al., 2009). In addition to IL-8, bacterial flagellin induces 
production of CCL20, which recruits dendritic cells (Sierro et al., 2001). Recruitment 
of monocytes leads them to differentiate into macrophages. Both neutrophils and 
macrophages are phagocytes, engulfing extracellular pathogens before killing them. 
Both macrophages and dendritic cells process the antigens they are exposed to and 
present them to adaptive immune cells. These adaptive cells then mount a specific 
response and generate immunological memory (Harris & Ronchese, 1999).  
 
Some flagellated bacteria have evolved to escape TLR5 recognition and have still 
retained their motility (Anderssen-Nissen 2006). Mutations of conserved TLR5-
recognition sites in flagellin have been co-selected with other compensatory 
mutations that allow appropriate flagellin folding. However, this has only been 
discovered in α and ε proteobacteria species and is not the case for γ-proteobacteria 
such as E. coli and Salmonella, likely due to different selection pressures. With this 
in mind, there is also the possibility that TLR5 signalling can be of benefit to 
attached bacteria. TLR5 signalling can be cyto-protective by preventing apoptosis, 
ensuring colonised cells remain viable (Vijay-Kumar et al., 2006). Of course, this 
has to be weighed against the obvious disadvantage of flagellin recognition before 
bacterial attachment. However, there is even some debate about whether TLR5 





polymorphisms in the signalling domain which may prevent downstream signalling 
(Smith et al., 2012).  
 
Intracellular recognition of flagellin occurs through NLRC4 inflammasome 
formation (Zhao et al., 2011). An inflammasome is a multi-protein complex that 
causes the activation of pro-inflammatory caspases, such as Caspase-1 (Miao et al., 
2006). NLRC4 was previously known as interleukin-1 converting enzyme (ICE)-
protease activating factor (Ipaf) or CARD12. NLRC4 activation of Caspase-1 results 
in cleavage of pro-IL-1β, pro-IL-6, pro-IL-8 into their mature forms (Ayres et al., 
2012). This implies co-operation between TLR5 signalling, which prepares 
inflammatory cytokines, and NLRC4 signalling, which processes these cytokines for 
their release (Miao et al., 2010). This adds another layer of regulation – two 
conserved regions of flagellin are sensed by the host, at different places and in 
sequence, to mount an innate response and help direct adaptive responses (Fontana & 
Vance, 2011). 
 
Neuronal apoptosis inhibitory proteins (Naip) are key candidates for initiating 
NLRC4 inflammasome activation (Vinzing et al., 2008). NLRC4 is also activated in 
response to T3S components from a number of bacteria, including E. coli (Zhao et 
al., 2011). It is likely that specific Naip proteins adapt different targets to NLRC4, as 
with Naip5 for Legionella pneumophila flagellin in macrophages (Lightfield et al., 
2008). However, little is known specifically about intracellular innate detection of E. 
coli flagellin in intestinal epithelial cells. Naip5 did not recognise flagellin from E. 
coli but a flagella expressing opportunistic E. coli caused sepsis due to NLRC4 
inflammasome dysregulation ((Ayres et al., 2012; Wilmanski et al., 2008) 
 
1.5.6.2 Adaptive immune recognition 
There is also an adaptive immune response to flagella, which results in the 
production of neutralising antibodies or ‘immunoglobulins' (Ig) and memory to 
flagella antigens. Antibodies are generated by the activation and differentiation of B 
cells upon recognition of flagella antigens by specific B cell receptors (Nempont & 





H-serotyping; B cell receptors are a membrane bound form of the antibodies that 
they will produce after differentiation into plasma cells. In parallel, the macrophages 
and dendritic cells recruited to the site by innate signalling then present flagellin 
peptides to T cells (Harris & Ronchese, 1999). This activates antigen-specific helper 
T cells, which then facilitate B cell differentiation into plasma and memory B cells. 
B cells start with IgM and IgD receptor expression. As B cells mature in response to 
local cytokines, they make different kinds of antibodies to the same antigen, in a 
process known as isotype-switching (Estes, 1996). These antibodies recognise the 
same antigen, but have different structures and binding avidities.  
 
Systemic vaccination of cattle with purified H7 flagella results in IgA that recognises 
surface epitopes of FliCH7, and IgG that recognises both surface epitopes and 
extensive linear epitopes (McNeilly et al., 2010b). This indicates that there are 
different sub-populations of B cells that are recognising differentially processed 
flagella antigen but it is not known how this occurs. This has important practical 
implications for vaccination of cattle with H7 flagella. Antibodies to linear epitopes 
directed along the full length flagellin have the potential to block TLR5 recognition 
epitopes (Saha et al., 2007).  
 
1.6 Roles of flagella in pathogenesis 
The specific contribution of flagella to bacterial pathogenesis can be controversial. 
Flagella can be shown to enhance or reduce bacterial colonisation, depending on the 
stage of infection tested. At early stages of infection, flagella tend to enhance 
colonisation through chemotaxis (section 1.5.4) and adherence (section 1.6.3). This is 
because the major limiting factor at this point is bacterial contact and attachment to 
favourable colonisation sites. However, once bacteria are attached, deleterious 
interactions with the host immune response can take precedence. In some scenarios 
though, flagella modulate these responses to maintain attachment. Deletion of 
flagella from Salmonella resulted in reduced NF-κB activation but also increased 





2006). Activation of NF-κB was more self-limiting due to modulation of host 
caspase activity. 
 
1.6.1 Immuno-modulation by flagellin secretion 
Flagella filaments can be naturally depolymerised, snapped or sheared, releasing 
flagellin (as discussed in chapter 6). These flagellin monomers are more sensitively 
detected by the innate immune system than polymerised flagellin (section 1.5.6.1). 
Despite the obvious advantages of limiting the exposure of TLR5-binding epitopes, 
some pathogens have been shown to actively secrete flagellin monomers as potent 
immuno-modulators. Internalised S. Typhimurium secretes FliC flagellin via its 
T3SS from the Salmonella-containing vacuole into the cytosol (Miao et al., 2006). It 
is likely that this is made possible due to the common origin of the T3SS apparatus 
and flagella (section 1.5.5). Type-III secretion of flagellin into cells is pro-
inflammatory, resulting in NLRC4 inflammasome activation (Zhao et al., 2011). If 
this inhibits the colonisation of extracellular bacterial competitors, it may be 
advantageous to the bacterium. 
 
Lysophospholipid release by host cells can trigger the production and secretion of 
flagellin by extracellular S. typhi in order to detect it more easily (Subramanian & 
Qadri, 2006). This could be advantageous for bacteria too, as it recruits immune cells 
to the site of infection that are necessary for their dissemination. EPEC is also 
physically capable of secreting FliC through its T3SS (Badea et al., 2009). This 
suggests that E. coli in general may also possess the ability to secrete flagellin, but 
that it is more tightly regulated (Badea et al., 2009). However, T3SS of flagellin 
secretion by wild-type bacteria or flagellin translocation into host cells not yet been 
demonstrated.  
 
1.6.2 Flagellar secretion of T3S effector proteins 
The converse of T3S of flagellin through T3SS needles is that some bacteria can use 
their flagella to secrete type-III effector proteins. C. jejuni lacks a functional 





(Guerry, 2007). CiaB has been found inside the cytoplasm of eukaryotic cells. The 
mechanism of translocation has not been demonstrated, but a fully intact flagellum is 
required for this phenotype (Konkel et al., 2004). Deletion of some of these effectors, 
such as FlaC, reduces invasion of the mutant strain, while FspA is cytotoxic when 
applied to cell lines (Poly et al., 2007; Song et al., 2004). Taken together, this 
indicates that proteins with effector function, that are not known to be part of the 
flagellar apparatus, are being secreted by flagella, perhaps directly into cells.  
 
With the above in mind, it is interesting to note that both phase-types of Salmonella 
flagella have been shown to enhance invasion of porcine intestinal tissue culture 
models by deletion mutagenesis (Elvidge, 2012). Motility was thought to play an 
important role, but when bacteria were centrifuged onto cells there was still a 
flagellin-dependent invasion defect. The mechanism, whether secretory, mechanical 
or immune-modulatory, is still unknown. 
 
1.6.3 Flagellar adherence 
The role of flagella in adherence has received more attention over the years, as 
researchers have realised that there are phenotypes that require flagella other than 
motility. Flagella have been shown to mediate initial adherence to host cells for 
ETEC, EPEC, EHEC, various Salmonella species, Clostridium difficile and P. 
aeruginosa, (Best & Ragione, 2005; Feldman et al., 1998; Girón et al., 2002; 
Mahajan et al., 2009; Tasteyre et al., 2001). Additionally, through initial, reversible 
adherence to both inanimate and live surfaces, flagella play an important role in 
biofilm formation, and final dispersal from mature biofilms to another site (Van 
Houdt & Michiels, 2006).  
 
A number of pathogens use their flagella for host-cell adherence, using a few 
mechanisms. Enteropathogenic E. coli flagella adhere to HeLa and cow intestinal 
cells by the FliC filament shaft, whereas flagellar adherence is primarily mediated by 
FliD caps with P. aeruginosa (Arora et al., 1998; Girón et al., 2002). For C. difficile, 
there is a cooperative effect of FliC and FliD on adherence (Tasteyre et al., 2001). 





secreted independently of the flagellar apparatus, as with EtpA from ETEC (Roy et 
al., 2009b). Interestingly, the EtpA glycoprotein was found to bind the conserved 
terminals of FliC flagellin, shown to be inside the flagella filament (Roy et al., 
2009b; Yonekura et al., 2003). Roy et al. (2009) went on to show that EtpA was only 
able to bind the conserved region of FliC in the absence of FliD filament caps.  
 
This has two implications. Firstly, it suggests that the conserved regions of flagellin 
are occasionally surface-exposed and may be able to contribute to binding in a 
largely intact filament. The exposed conserved regions of FliC may be able to bind to 
host immune receptors such as apical TLR5 to promote adherence without immune 
recognition. Secondly, this demonstrates that adhesins are able to use existing 
structures, such as flagella, as an adaptor or platform to project considerable 
distances from the cell. This would increase the likelihood of their coming into 
contact with cell-associated ligands or facilitate proposed flagellar probing of host 
epithelia during initial attachment.  
 
Host-cell binding by flagella often occurs via gangliosides and mucins, which can 
trigger downstream inflammatory signalling cascades. P. aeruginosa flagella bind 
asialo-GM1, triggering TLR2 and Ca2+-dependent secretion of IL-8 in CHO cells and 
the shuttling of TLR5 to the apical surface of polarised 16HBE cells (Adamo et al., 
2004). Conversely, these flagella are also able to bind to and activate Muc1, which 
results in down-regulation of TLR5 activation and IL-8 induction (Lillehoj et al., 
2002; Ueno et al., 2008). This may be important for P. aeruginosa epithelial 
colonisation, as Muc1-/- mice were also more able to clear P. aeruginosa than WT 
mice after pulmonary infection (Lu et al., 2006). EPEC H6 and EHEC H7 flagella 
are able to bind to mucins as well (Erdem et al., 2007), raising the possibility that 
EHEC O157:H7 could use host mucins as receptors for immuno-modulation as well 
as initial adherence. 
 
1.6.4 H7 flagella adherence  
The role of H7 flagella in adherence to host cells has not always been very clear. 





H6 flagella were not (Mahajan et al., 2009). Additionally, EPEC H6 and H2 flagella 
but not EHEC H7 flagella were involved in bacterial adherence to epithelial 
monolayers (Girón et al., 2002). However, these experiments were conducted on 
HeLa cell lines. Subsequent work has shown that EHEC purified H7 flagella adhere 
to primary cell cultures of the BTR and EPEC H11 flagella do not (Mahajan et al., 
2009). Additionally, BTR adhesion by flagella appeared to be H7-specific in the 
context of bacterial colonisation. Complementation of EHEC O157:H7 fliC- strains 
with fliCH6 did not fully restore wild-type binding. This study did not address the 
mechanism of flagella-based adherence, so it is not yet known whether flagella 
FliDH7 cap-binding, rotation or chemotaxis is required for EHEC adherence in this 
model. 
 
Clues for defining the basis for the phenotypic differences between H6 and H7 
flagella have come from the substrate-specificity experiments of Erdem et al. (2007). 
They showed that H6 but not H7 flagella bind to collagen, while EHEC H7 flagella 
bind more sensitively to certain commercial mucin preparations than H6 flagella. 
This differential mucin binding likely relates to differences in flagella filament 
binding avidity, as there was no difference between H6 and H7 flagellin monomers. 
As H6 and H7 flagella tend to be associated with particular pathotypes, differences in 
flagella binding-specificities may contribute to the host and tissue tropisms of EHEC 
and EPEC (Mundy et al., 2007). 
 
1.7 Vaccination with T3S and flagella together  
H7 flagella are involved in adherence to host cells at the principle site of EHEC 
O157:H7 colonisation and are potent immuno-modulators. On this basis, the use of 
H7 flagellin, FliCH7, as part of an EHEC vaccine in cattle was patented (Gally et al., 
2009). Vaccinating cattle intra-muscularly with purified FliCH7 alone reduced the 
number of animals colonised with E. coli O157:H7 after experimental challenge 
(McNeilly et al., 2008). The mode of action was thought to be by the generation of 
specific IgA and IgG that could block FliCH7 flagella BTRE binding (McNeilly et al., 
2008). However, protection was only partial. Faecal shedding of E. coli O157:H7 





(McNeilly et al., 2008). The mechanism of this observed effect is not fully 
understood but likely relates to how FliCH7 monomers and FliCH7 flagella are 
recognised by the innate immune system. Despite this drawback, the use of purified 
FliCH7 in a variety of multi-component recombinant T3S protein vaccines increases 
their efficacy (McNeilly et al., 2010a).  
 
1.8 Aims 
Control of EHEC O157:H7 by vaccination of cattle with combinations of rationally 
chosen antigens is a cost effective way of reducing human HUS incidence. A 
detailed appreciation of what might happen if a potential vaccine actually inhibits 
these factors is vital for this. The role of many virulence factors in EHEC O157:H7 
colonisation is already understood. The exquisite mechanistic detail at a molecular 
level of key T3S effector protein involvement in BTR adherence has made their 
inclusion in a rational vaccine a natural choice.  
 
The role of H7 flagella as an adhesin in EHEC O157:H7 colonisation at its principal 
site and source of infection and spread, the BTR, has only recently been established. 
Currently, FliCH7 has the potential to be efficacious in such a bovine EHEC vaccine. 
Presumably vaccination with FliCH7 is protective because it results in antibodies that 
block FliCH7 flagella adherence. However, there are still issues with FliCH7 
vaccination. To resolve these, more work is needed to understand why blocking 
FliCH7 flagella with FliCH7 antibodies might have an impact on EHEC colonisation 
and pathogenesis. 
 
The mechanism of H7 flagella adherence in EHEC colonisation is not fully 
understood. It is not known if the role of H7 flagella as an adhesin is solely FliCH7-
dependent, or whether other H7 flagella components such as FliDH7 are also 
involved. Which specific epitopes of the FliCH7 monomer are required for FliCH7 
flagella binding to the BTR is also unknown. Additionally, there are no known 
FliCH7 flagella ligands. A precise knowledge of which interactions are involved in 
BTR colonisation by EHEC O157:H7 is required to better design vaccine 





BTR adherence, or even reveal novel contributions of H7 flagella to EHEC O157:H7 
colonisation. Therefore the study described by this thesis aims to: 
 
 Characterise H7 flagella interaction with BTR. 
 Investigate the role of FliDH7 in BTR binding. 
 Define the BTR binding epitopes in FliCH7. 
 Characterise H7-H7 receptor interactions in the BTR. 
 
It is hoped that achieving these aims will lead to improved rational bovine vaccine 
design and a fuller appreciation for how H7 flagella can enhance EHEC colonisation 
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2.1 Bacterial culture 
Bacterial strains (table 2.1, appendix 1) were stored as saturated cultures in Luria-
Bertani broth (LB) with 25% (v/v) glycerol at -70°C. Strains were revived by 
streaking onto LB agar (Melford) and incubating statically at 37°C for 16 h unless 
they contained temperature sensitive plasmids, in which case they were grown at 28-
30°C. Plates were used fresh for phenotypic assays or stored at 4°C for 
deoxyribonucleic acid (DNA) manipulation. Single colonies from streak-plates were 
grown in LB at 28°C-30°C or 37°C at 200 rpm for 16 h, as stated. Bacteria were sub-
cultured 1:100 into the same media at the same temperature unless otherwise stated. 
Plasmid-containing strains were grown in the presence of antibiotics at the following 
concentrations: ampicillin (amp) 100µg/ml, chloramphenicol (cam) 50µg/ml, 
kanamycin (kan) 50µg/ml. 
 
Table 2.1. Strains used or constructed in this study. 
Strain Relevant features Source 
TOP10 E.coli cloning strain; F- mcrA ∆(mrr-hsdRMS-
mcrBC) (Φ80lacZ ∆ M15 ∆ lacX74 deoR recA1 
araD139 ∆ (ara-leu)7697 galU galK rpsL endA1 
nupG 
Invitrogen 
DH5α E. coli plasmid storage strain (McNeilly et al., 
2010) 
BL21(DE3) E. coli  protein expression for purification strain Novagen 
JT1 E.coli K-12; 11 mutations,  fliC(H48)::Tn10; 
fimA::cat derivative of E. coli C600 
(Bachmann, 1987; 
Westerlund-
Wikström et al., 
1997) 
E2348/69 E.coli 0127:H6; sequenced. Mark Stevens 
SL1344∆fljB S. Typhiumurium ∆fljB, for purification FliC (Arques et al., 2009) 
SL1344∆fliC S. Typhiumurium ∆fliC, for purification FljB (Arques et al., 2009) 
Walla-1 E. coli O157:H7, stx+ (Mahajan et al., 
2009) 
ZAP198 E. coli O157:H7, stx- (McNeilly et al., 
2010) 
TUV93-0 E.coli O157:H7; EDL933 (ATCC 700927) stx- (Campellone et al., 
2007) 
TUV∆fliC TUV93-0 intermediate strain clone 10; 
fliC::sacB::kanr 
This study 
TUVfliC- TUV93-0 fliC- clone 1 This study 
TUVfliC-H7 TUV∆fliC10 cis complement fliC CDSE from 
TUV93-0, clone 13 
This study 
TUVfliCH7F TUV∆fliC10 cis complement fliC CDSF from 
TUV930, inserted with F site, clone 1. 
This study 
TUVfliCH6F TUV∆fliC10 cis complement fliC CDSF from 
E2348/69, inserted with F site, clone 1. 
This study 






2.2 Motility enrichment 
Freshly revived colonies were stab inoculated into motility agar plates (1% (w/v) 
tryptone (BD Biosciences), 0.5% (w/v) NaCl, 0.3% (w/v) granulated agar (Melford)) 
and incubated at 28-30°C for 16 h. Agar plugs from leading edge of the motility 
halos were taken using 10 µl inoculation loops, and these was used to inoculate LB 
broth. This was incubated at 28-30°C 200 rpm for 16 h and then sub-cultured in the 
desired media. 
 
2.3 DNA manipulation 
General molecular biology methods were adapted from Molecular Cloning: A 
Laboratory Manual (Russell & Sambrook, 2001), unless indicated otherwise. 
Table 2.2. Plasmids used or constructed in this study. Plasmids in the top portion of the table 
were used for strain construction. Plasmids in the lower portion were used for protein 
expression or purification. Plasmids constructed in this study are validated in appendix 1. 
Plasmid Relevant features Source 
pIB307 Chlr, TºCs replication (28ºC), single copy number (Blomfield et al., 
1991) 
pIBXH7tuv pIB307; H7downD flank; sacB :kan
r ; H7upB flank This study 
pIBXSKtuv pIB307; H7downD flank; H7upB flank This study 
pIBXH7KI pIB307; H7downE flank; H7 CDS(E); H7upB flank This study 
pIBXH7KIF pIB307; H7downF flank; H7 CDS(F); H7upB flank This study 
pIBXH6KIF pIB307; H7downF flank; H6 CDS(F); H7upB flank This study 
pIBXFliD pIB307; FliDdown flank; sacB :kanr ; FliDup flank This study 
pIBXSKFliD pIB307; FliDdown flank; FliDup flank This study 
pWSK29 lac operon, low copy number (<10) ampr  (Kushner, 1991) 
pWSKH7tuv pWSK29; amp
r; SalI-BamHI insertion of fliCH7 (from 
TUV93-0); clone 33 
This study 
pFliCH6 pGEM; amp
r; BamHI-BamHI insertion fliCH6  (from 
E2348/69)  
(Mahajan et al., 
2009) 
pWSKH6 pWSK29; BamHI-BamHI insertion of fliCH6 from 




ampr; L-arabinose-inducible expression; C-terminal 
6x(His) tag 
Invitrogen 
pBADFliDH7 pBAD/Myc-His A; NcoI-SacI insertion of fliDH7 (from 
TUV93-0). For purification of FliDH7 
This study 
pET22(b)+ ampr; IPTG-inducible expression; C-terminal 6x(His) 
tag 
Novagen 
pFLrH7 pET22(b)+ with BamHI-HindIII insertion of full-length 
fliCH7 (from ZAP198). For purification of FLrH71-585 
(McNeilly et al., 
2010) 
pVrH7 pET22(b)+ with BamHI-HindIII insertion of variable 
domain of fliCH7 (from ZAP198). For purification of 
VrH7180-496 
(McNeilly et al., 
2010) 
p5’rH7 pET22(b)+ with BamHI-HindIII insertion of N-terminal 
of fliCH7 (from ZAP198). For purification of NTrH71-179 








Table 2.3. Primers used in this study. Restriction sites are underlined. Temperature in bold 
indicates annealing temperature used for specific primer pair. Amplification conditions are 
detailed in section 2.3.4. 




























































































































































specific O157F CGGACATCCATGTGATATGG 
(Paton & Paton, 
1998) 
 
55°C O157R TTGCCTATGTACAGCTAATCC 
(Paton & Paton, 
1998) 
pIB307 
insert PIBF CCTGTCCTACGAGTTGCATG 




(Flockhart et al., 
2012) 
pWSK29  pWSKF CAGTCACGACGTTGTAAAAC This study 
insert 
55°C pWSKR CGTATGTTGTGTGGAATTGT 
This study 
pBAD  pBADF AGATTAGCGGATCCTACCTG This study 
insert 
56°C pBADR TATCAGACCGCTTCTGCGTTC 
This study 
 
2.3.1 Agarose electrophoresis 
DNA was loaded into 1% (w/v) agarose (Melford) in Tris-Borate-EDTA (TBE; 
90mM Tris-borate, 1mM EDTA) gels containing Safeview (NBS Biologicals) in the 
presence of loading buffer (Bluejuice, Invitrogen) and 1kb or 100bp size markers 
(Promega, Invitrogen and Fermentas). Agarose gels were electrophoresed at 80-100 
V for 20-45 min in TBE and imaged using a Bio-Rad 1000 UV gel-documentation 
system. 
 
2.3.2 Plasmid preparation 
Plasmids were extracted using Wizard SV plus Plasmid Mini-prep kit (Promega), 
GeneJet Plasmid Mini-prep Kit (Fermentas Life Sciences) or EZ-10 Plasmid Mini-
prep kit (NBS Biologicals) according to their instructions with a few exceptions. 5-
10 times more bacteria than suggested were used. All centrifugation was undertaken 
at 29000 x g. Cell lysates were clarified by centrifugation for 10 min rather than 5 





sterile distilled water for 5 min and eluted by 2 min centrifugation. Where low or 
single-copy plasmids were used, multiple preparations were often eluted in a lower 
volume and pooled. Plasmid DNA was stored at -20°C. 
 
2.3.3 Genomic DNA extraction 
For use in cloning, genomic DNA was extracted using the Charge-switch gDNA 
mini-kit (Invitrogen) according to their instructions. Briefly, saturated bacterial 
cultures were centrifuged at 8900 x g for 5 min, pellets were re-suspended in 
proprietary re-suspension buffer with RNAse A. Bacteria were lysed with 1 mg/ml 
lysozyme at 37°C for 10 min followed by lysis buffer and ~200 µg/ml proteinase K 
for 1 h at 80°C. ChargeSwitch magnetic beads were added to this sample, mixed and 
proprietary binding buffer added. This lowered the pH so that DNA bound to beads. 
The beads were separated using magnetism, the buffer was removed. Beads were 
washed twice with proprietary washing buffer using magnetism to retain beads. DNA 
was then eluted by increasing the pH in elution buffer (10 mM Tris-HCl, pH 8.5).  
 
For screening of strains by polymerase chain reaction (PCR, section 2.3.4), DNA 
was extracted from colonies by suspending them with distilled water and incubating 
them at 98°C for 5 min to make a colony lysate which was used in the PCR reaction. 
Alternatively, the colony was suspended in the PCR reaction after re-streaking. 
 
2.3.4 Polymerase chain reactions (PCR) 
For high fidelity amplification of DNA for use in cloning, Phusion DNA polymerase 
(Finnzymes) was used. Reaction mixtures followed manufacturers’ instructions 
(which typically contained proprietary HF buffer, 200µM dNTPs (New England 
Biolabs), 1µM of each primer (Invitrogen), 0.5 µl genomic DNA and 1 U DNA 
polymerase). PCR reactions were undertaken in a Thermo-Hybaid PCR Express 
thermocycler (Thermo Fischer Scientific), with the following program: 98°C for 30 s 





min. PCR reactions were cleaned or gel purified then cleaned using a Wizard SV gel 
and PCR clean-up kit (Promega) according to their instructions. PCR products were 
gel purified if a single size product could not be obtained. In these cases, the whole 
PCR reaction was electrophoresed (section 2.3.1) and the band of the desired size 
was excised and purified using a Wizard SV gel and PCR clean-up kit.  
 
For amplification of DNA for screening, Quick-Load 2x Taq DNA polymerase (New 
England Biolabs) was used. Reaction mixtures contained Quick-Load Taq master 
mix, 1µM of each primer and 1 µl colony lysate or 0.5 µl genomic DNA. PCR 
reactions were undertaken in a thermocycler as above, with the following program: 
95°C for 5 min, then 35 cycles of (95°C for 15 s, annealing T°C for 30 s, 68°C 1 
min/kb), 68°C for 5 min.  
 
2.3.5 Restriction digests 
Plasmid or PCR amplified DNA was digested using specified restriction 
endonucleases purchased from New England Biolabs or Roche according to their 
instructions. Restriction digests typically contained a compatible proprietary buffer, 
10 µg/ml bovine serum albumin (BSA), DNA diluted 3:2 and 20 U of each 
restriction enzyme. These reactions were incubated for 1-2 h at 37°C. Where 
appropriate, to prevent self-ligation, digested plasmids were dephosphorylated by 
shrimp alkaline phosphatase (Promega) at 37ºC for 30 min. Restriction digests were 
cleaned up using a Wizard SV gel and PCR clean-up kit (Promega) according to their 
instructions. 
                                                                                                          
2.3.6 Ligations 
DNA was ligated using the T4 DNA ligase (Promega) according to their instructions. 
Briefly, DNA to be ligated of varying ratios of plasmid:insert, were added to 8 U of 
ligase, and incubated at 16ºC for 16 h. Ligation mixtures were used directly in 






2.3.7 Preparation of chemically competent bacteria 
Saturated cultures of bacteria were sub-cultured 1:100 in LB until the culture reached 
an optical density at 600nm (OD600) of 0.6-0.8. The culture was incubated on ice for 
0.5-1 h then centrifuged at 8900 x g at 4°C for 30 min. The pelleted cells were re-
suspended in transformation buffer 1 (30mM potassium acetate, 10mM CaCl2, 
100mM KCl, 500mM MnCl2, 15% (v/v) glycerol). This was then centrifuged at 8900 
x g at 4°C for 15 min and re-suspended in transformation buffer 2 (100mM 4-
Morpholinepropanesulfonic acid (MOPS), 75mM CaCl2, 10mM KCl, 15% (v/v) 
glycerol). Cells were then either used fresh or stored at -70°C in single-use aliquots. 
 
2.3.8 Chemical transformation 
Plasmids (or ligation reactions) and chemically competent cells were incubated on 
ice for 5 min. Plasmid DNA was added to 1:20 to chemically competent cells 
(section 2.3.7), and incubated on ice for 2 min. This was then heat-shocked at 42°C 
for 35 s, cooled on ice for 1 min then 4:1 LB was added. The cells were then 
recovered for 1 h at 37°C or 2 h at 28°C at 100 rpm as indicated and plated onto LB 
agar containing appropriate antibiotics. Plates were incubated at the same 
temperature for 16 or 36 h respectively. Single transformants were re-streaked and 
mixed into a screening PCR reaction mixture (section 2.3.4) or sub-cultured into LB 
with antibiotics for 16 h for restriction digest confirmation (section 2.3.5). 
 
2.3.9 Preparation of electro-competent bacteria 
Saturated cultures of bacteria were sub-cultured 1:100 in LB until the culture reached 
an OD600 of 0.6-0.8. The culture was incubated on ice for 0.5-1 h then centrifuged at 
8900 x g at 4°C for 30 min. The pelleted cells were re-suspended in 10% (v/v) ice-
cold glycerol. This mixture was centrifuged a further 4 times as previously but re-
suspended in successive half volumes of 10% (v/v) ice cold glycerol. These cells 







Plasmids (or ligation reactions, section 2.3.6) and electro-competent cells (section 
2.3.9) were incubated on ice for 5 min. Plasmid DNA was added to 1:40 to electro-
competent cells and incubated on ice for 1 min. This mixture was then pulsed with 
2.5 kV for 0.1 s over 2 mm. LB was immediately added 9:1 and cells were incubated 
for 1 h at 37°C or 2 h at 28°C at 100 rpm. This was plated onto LB agar containing 
appropriate antibiotics. Plates were incubated at 37°C for 16 h or 28°C for 36 h. 
Single transformants were used fresh where transformation was performed with a 
validated plasmid.  
 
2.3.11 Sequencing 
After delivery of samples according to their instructions, di-deoxy-termination 
sequencing was carried out at The GenePool (UK) using ABI 3730 Sanger with 
BigDye reagents.  
 
2.3.12 Allelic exchange 
Allelic exchange was performed using the method published by (Blomfield et al., 
1991). This method involved the exchange of a counter-selectable sacB-kanr cassette 
with the gene of interest. DNA that was homologous to the flanking regions of fliCH7 
or fliDH7 from TUV93-0 was cloned into pIB307, on either side of the sacB-kan
r 
cassette, to allow homologous recombination with TUV93-0. pIB307 is a low copy 
number camr plasmid, which is temperature sensitive (table 2.2). Growth at 42ºC in 
cam caused integration of pIB307 into the chromosome at regions of homology, to 
allow allelic exchange. Then growth at 28ºC in kan cured the strain of the exchange 
plasmid and the original allele (figure 2.1). For example, this was done with TUV93-
0, to replace fliCH7 with a sacB-kan
r cassette, to make TUV∆fliC (figure 2.3, 
appendix 1). This intermediate strain was then used in a second round of exchange 





2.3, appendix 1). The main difference was that in exchanging with the sacB-kanr 
cassette, unsuccessful resolution was selected against with sucrose, toxic to strains 
containing sacB (figure 2.1). After allelic exchange, all strains were confirmed to be 









1st ROUND: INTERMEDIATE STRAIN 




Figure 2.1. Allelic exchange strategy as described in Blomfield et al 1991. 
The 1st round involves allelic exchange of a gene with the sacB-kanr cassette 
to create an intermediate mutant strain. This is then used to create a knock-

















































FliDup: 608bp FliDdown: 600bp 
fliDH7 fliCH7 




FliDdownF.BamHI / FliDdownR.XbaI 
SacI XbaI
pIBXFliD: ~9.2 kb pIBXSKFliD: ~5.4 kb
sacB-kanr Cassette: 3.8kb 
fliS fliT 
Figure 2.2. Cloning strategy for construction of exchange vectors to make fliDH7 mutants 
in TUV93-0. TUV∆fliD was made using pIBXFliD, which was like pIBXSKFliD but with a 
sacB-kanr cassette between FliDup and H7down. TUVfliD- was made from TUV∆fliD 





2.3.12.1 TUV∆fliC and TUV∆fliD 
pIBXFliDtuv and pIBXH7tuv (figures 2.2 and 2.3, table 2.2, appendix 1) were 
transformed into electro-competent TUV93-0 and incubated at 28ºC on LB agar with 
cam (CLB) for 48 h. Five transformants were used for allelic exchange of fliCH7 or 
fliDH7 with sacB-kan
r to create intermediate strains (see figure 2.1). These were 
streak-plated onto CLB agar and incubated for 16 h at 42ºC. Single colonies were 
then re-streaked onto CLB agar and incubated for 8 or 16 h at 42ºC a further three 
times. The five lineages were pooled in LB broth with kanamycin (KLB) and 
incubated for 16 h at 28ºC 200 rpm. The broth was sub-cultured 1:1000 into KLB 
and incubated for 8 or 16 h at 28ºC 200 rpm a further three times, after which 8 serial 
1:10 dilutions in PBS were made. Dilutions 10-5-10-8 were plated onto KLB agar 
plates and incubated at 28ºC for 48 h. Colonies were plated onto KLB (presence of 
sacB-Kanr), CLB (absence of pIB307) and LB agar and incubated at 28ºC for 24 h. 
Colonies with the correct resistance profile (kanr, cams) were screened for the 
presence of sacB, the absence of fliDH7 coding sequence (CDS) or fliCH7 (CDS)E and 
the size of the region by PCR (table 2.3). Non-motile clones with the correct PCR 
profile was classified as intermediate strains TUVΔfliC10 and TUVΔfliD1 (appendix 
1).  
 
2.3.12.2 TUVfliD-, TUVfliC-, TUVfliC-H7, TUVfliCH7F and TUVfliCH6F 
TUVΔfliD1 was used for allelic exchange of sacB-kanr with pIBXSKFliD to make a 
clean fliDH7 deletion. TUVΔfliC10 was similarly used for allelic exchange of sacB-
kanr with pIBXSKtuv to make a clean fliCH7 deletion, or with pIBH7KI, pIBH7KIF 
or pIBH6KIF to complement the mutation with fliCH7 or fliCH6 (figure 2.2 and 2.3). 
The above exchange vectors were transformed into electro-competent TUVΔfliD1 or 
TUVΔfliC10, plated onto CLB agar and incubated for 48 h at 28ºC. The allelic 
exchange was performed as in section 2.3.12.1 with eight transformants, using CLB 
agar for four 42ºC passages and LB broth for four 28ºC passages. Dilutions 10-5-10-8 
were plated onto 6% (w/v) sucrose LB agar plates and incubated at 28ºC for 48 h. 
Sucroser colonies were patch-plated onto KLB (absence of sacB-kanr), CLB (absence 






Colonies with the correct resistance profile (sucroser, kans, cams) were screened for 
the absence of sacB, the absence or presence of fliDH7 CDS or fliCH7 (CDS)E and the 
size of the region by PCR (table 2.3). Clones with the correct PCR profile and 
motility phenotype were stained with H-type specific polyclonal anti-sera to 
determine flagella expression, and classified as TUVfliD-1, TUVfliC-1, TUVfliC-H7, 
TUVfliCH7F1 or TUVfliCH6F1 accordingly (appendix 1).  
 
2.3.13 Expression plasmids 
2.3.13.1 pWSKH6 
fliCH6, the fliCH6 CDS and native promoter from E2348/69, (~200bp upstream of the 
ATG), were sub-cloned from pFliCH6 to pWSK29 as a BamHI fragment. Direction of 
insertion was screened by sequencing. As the functional importance of directionality 
was unknown, two clones with fliCH6 in opposite directions were assessed for their 
ability to complement fliC mutants JT1 and TUVfliC- in motility assays.  
 
2.3.13.2 pWSKH7tuv and pBADFliDH7 
Primers were designed to amplify the corresponding fliCH7 CDS and promoter region 
or fliDH7 CDS (table 2.3) from TUV93-0 genomic DNA. Digested PCR products 
(SalI-BamHI and NcoI-SacI respectively) were then cloned into pWSK29 or 
pBAD/Myc-His A (table 2.2). The presence of inserts was confirmed by restriction 
digest (section 2.3.5), sequencing (section 2.3.11) and complementation of fliC 
mutants JT1 and TUV93-0 or fliD mutant TUVfliD- in motility assays (section 2.9.2). 
 
2.4 Bioinformatics 
Cloning strategies and primers were designed using Vector NTI v.10 (Invitrogen). 
Primers were checked for specificity using NCBI nblast against relevant genome 





design as TUV93-0 is a stx- derivative of EDL933. Sequences were viewed using 
Chromas 2.33 (Techneleysium Pty Ltd) and identity confirmed using nblast (NCBI). 
All presentation of crystallographic protein structures was performed using UCSF 
Chimera (Pettersen et al., 2004). 
Table 2.4. Sequences used in sequence and structural alignments. Accession numbers refer 
to current version of used sequence, but corresponding sequences were accessed 03/2012. 
Protein & H-type Strain & O-type Uniprot Accession Number 
FliCH6; H6 E2348/69; O126 B7USU2 
FliCH7; H7 EDL933; O157 Q7DBI0 
FliCH11; H11 DEC/10D; O26 Q5ECK7 
FliCH21; H21 serogroup O113:H21 Q0GJI9 
FliCH48; H48 MG1655; OR P04949 
FliCP1; Hi (phase-1) LT2; O4 P06179 
FliDH6; H6 E2348/69; O126 B7USU3 
FliDH7; H7 EDL933(TUV93-0 stx
+); O157 P58297 
FliDH11; H11 11368; O26 C8TTK5 
FliDH21; H21 serogroup O113:H21 Q0GJI8 
FliDH48; H48 MG1655; OR P24216 
 
2.4.1 RNA modelling 
BamHI site insertion effects on fliC mRNA secondary structure were modelled using 
RNAdraw (v1.1b2). Sequences of fliCH6 (from E2348/69) and fliCH7 (from EDL933) 
with 100bp upstream of the ATG site were aligned using NCBI blast. Again EDL933 
was used as it is a sequenced strain and TUV93-0 is a stx- derivative of EDL933. 
Upstream sequence that was found to be conserved was used as model mRNA. 
Modelling different sized portions of sequence made no difference to the predicted 
conformation of the RBS and start site. 2-3 bp changes were made in the conserved 
fliC mRNA sequence to introduce the BamHI sites for TUVfliC-H7, TUVfliCH7F and 
TUVfliCH6F. These theoretical mRNAs were modelled using default parameters at 
28°C and 37°C (figure 2.4). 
 
Models of wild-type sequence predicted an open RBS and transcriptional start site 
(figure 2.4(B)). Changing 3bp to introduce the BamHI site as in TUVfliC-H7, the RBS 
and start site were predicted to be inside a stem loop structure (figure 2.4(C)). This 
was not overcome by modelling the structure at a lower temperature. This helped 





upstream region of the model mRNA were predicted to be tolerated. Figure 2.4(D) 
shows the location (F) where 2 bp could be tolerated to introduce a BamHI site in 
this model, and this was used to design new fliCH6F and fliCH7F knock-ins. 
 
GCGGAAAAAA GATCGGCTTT AGACAATGCA GTATTGGCGG TCTGGAAAGT CGTCAGCGCG CTTTTCAGCG 
TACCGTAGGC GCTAAGTTTA GCGGTAAACG ACGATTGCTG ATTTGAAATG GGGGTTAGCG TCGCTTTTTG 
CGCGGCGGTG AGGCTATCAA GGATTGAACT TAAATCCAGA CCTGACCCGA CTCCCAGCGA TGAAATACTT 
GCCATGCGAT TTCCTTTTAT CATTCGACAC GTAAAACGAA TACCGGGGTT ATCGGCCTGA ATTGCGCAAA 
GTTTACGTTT AATTGTTTTT TTTAATAGCG GGAATAAGGG GCAGAGAAAA GAGTATTTCG GCGACTAACA 
AAAAATGGCT GTTTGTGAAA AAAATTCTAA AGGTTGTTTT ACGACAGACG ATAACAGGTT TGACGGCGAT 
TGAGCCGACG GGTGGAAACC CAATACGTAA TCAACGACTT GCAATATAGG ATAACGAATC ATGGCACAAG 
TCATTAATAC CAACAGCCTC TCGCTGATCA CTCAAAATAA TATCAACAAG AACCAGTCTG CGCTGTCGAG 
TTCTATCGAG CGTCTGTCTT CTGGCTTGCG TATTAACAGC GCGAAGGATG ACGCCGCAGG TCAGGCGATT 






Figure 2.4. Modelling BamHI site insertion 
effects on fliCH7 mRNA secondary 
structure. (A) Conserved upstream 
sequence used as model mRNA; identical 
in EDL933 and E2348/69 (grey), <5bp 
variation (unhighlighted). RBS and start site 
(green). Models show model mRNA and 
enlarged boxed promoter regions at 37ºC 
unless indicated, and thickness of pairing 
indicates probability. (B) EDL933 WT. (C) 
BamHI insertion in TUVfliC-H7 (purple in 







2.4.2 Multiple sequence alignments 
FliC and FliD amino-acid sequences (table 2.4) were aligned using MUSCLE, a 
multi-sequence alignment program shown to be more accurate than other 
conventional methods (Edgar, 2004). The E2348/69 and DEC/10D FliC sequences 
were corrected by predicted translation of DNA sequence files as the sequences were 
incorrectly annotated and didn’t include all of the expressed protein sequences. 
Structural alignments were carried out using FFAS03 via PDB0408 (Jaroszewski et 
al., 2005). Only one crystallographic structural template for flagellin exists, for S.  
Typhimurium SJW1655 (PDB#:1ucu), so the three FliC of different H-types were 
structurally aligned individually to this. These were merged manually, imposing gaps 
against all other proteins where one protein was predicted an insertion compared to 
the template structure.  
 
Alignment quality was judged by three criteria. Firstly, as the DNA sequence of the 
terminals is highly conserved (data not shown; (Reid et al., 1999)), the alignment 
was judged by whether or not both terminals were aligned for all proteins. Secondly, 
the region of FliCH7 known to confer H7-serospecificity (N352-P374; (Kwang et al., 
1996)) was expected to be part of an insertion sequence. In addition to this, numbers 
and type of insertions in defined secondary structure for PDB 1ucu were compared. 
Secondary structure elements are usually more highly conserved than turns and coils, 
therefore insertions in the former are more likely to indicate a poor quality 
alignment.  
 
2.4.3 Mass-spectrometry fragment PTM analysis 
All programs used were accessed on-line through the Expasy bioinformatics resource 
portal. FliCH6 and FliCH7 sequences were input into NetOGlyc and NetNGlyc to 
predict possible O-linked and N-linked glycosylation.  This was used as a guideline 






Mass spectrometry was undertaken on the two sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) species of acid depolymerised 
FliCH7 flagella, and sheared FliCH7 flagella (section 2.5.2 and 2.5.5 respectively). 
Peptide-mass fingerprinting using MASCOT was used to assign peptide identities 
within each sample (section 2.5.7). Identified peptides gave a sequence coverage that 
ranged between 61.5-71.8% of FliCH7. Unassigned mass:charge (m/z) values were 
put through GlycMod, FindMod and FindPept programs to predict possible post-
translational modifications. 
 
2.5 Protein manipulation 
Table 2.5. Proteins used in this study. 
Protein Source Storage/handling 
95% pure human 
platelet actin (β/γ)  
Cytoskeleton Inc. Lyophilised 4°C Solution 
snap-frozen in single-use 
aliquots and stored -70°C. 
99% pure human 
platelet actin (β/γ) 
Cytoskeleton Inc. Lyophilised 4°C Solution 
snap-frozen in single-use 
aliquots and stored -70°C. 
99% pure rabbit 
skeletal actin- Pyrene 
(β/α) 
Cytoskeleton Inc. Lyophilised 4°C Solution 
snap-frozen in single-use 
aliquots and stored -70°C. 
Cofilin-1 human 
recombinant  
Cytoskeleton Inc. Lyophilised 4°C Solution -
70°C or        -20°C 
temporarily 
Arp2/3 complex from 
bovine brain  
Cytoskeleton Inc. Lyophilised 4°C Solution 
snap-frozen in single-use 









Sigma Lyophilised 4°C 
FliCH6  Flagella purified from TUVfliCH6F by 
shearing or acid depolymerisation  
-20°C. 
FliCH7  Flagella purified from TUVfliCH7  by 
shearing or acid depolymerisation  
-20°C. 
FliCP1  Flagella purified from SL1344∆fljB 
by shearing 
-20°C. 





Purified from DH5a::pVrH7his 









Purified from DH5a::pFLrH7his 





Purified from DH5a::p5’rH7his 





Purified from TOP10::pBADfliDhis 




Table 2.6. Antibodies used in this study. 
Primary Antibody Details Company Dilution Used 
α-H6  polyclonal rabbit 
IgG 
Mast Assure 1:1000 
α-H7  Polyclonal rabbit 
IgG 
Mast Assure 1:1000 




Mast Assure 1:100 





α-O157  Polyclonal rabbit 
IgG 
Mast Assure 1:100 
α-O157  Monoclonal 
mouse IgG3 
AbD SeroTec 1:1000 
α-C-terminal 6x(His) Monoclonal 
mouse IgG1 
Invitrogen 1:5000 
Pre-immune serum Polyclonal rabbit 
serum 
SNBTS 1:100 
α-FliD bleed 1  Polyclonal rabbit 
serum 
SNBTS as indicated 
α-FliD bleed 2  Polyclonal rabbit 
serum 
SNBTS as indicated 
α-FliD bleed 3  Polyclonal rabbit 
serum 
SNBTS as indicated 
pre-T3S+H7 vaccination 
bovine serum  
Polyclonal bovine 
serum 
Tom McNeilly 1:100 
post-T3S+H7 vaccination 
bovine serum  
Polyclonal bovine 
serum 
Tom McNeilly 1:100 
pre-E. coli O157:H7 challenge 
bovine serum  
Polyclonal bovine 
serum 
Tom McNeilly 1:100 
post- E. coli O157:H7 
challenge bovine serum  
Polyclonal bovine 
serum 




α-galectin-4 polyclonal goat 
IgG 
R&D 1:1000 
Secondary Antibodies Details Company Dilution Used 
α-rabbit IgG-HRP  Polyclonal goat 
IgG 
R&D Systems 1:1000 
α-rabbit IgG-FITC  Polyclonal goat 
IgG 
Sigma 1:1000 





IgG or 1:5000 (α-his) 
α-bovine IgG-HRP  Polyclonal mouse 
IgG 
AbD SeroTec 1:1000 
α-goat IgG-HRP  Polyclonal rabbit 
IgG 
R&D Systems 1:1000 
Staining Details Company Dilution Used 
DAPI  Various 1:1000 
WGA-texas red  Invitrogen 1:1000 
Phalloidin-texas red  Invitrogen 1:250 
Phalloidin-AlexaFluor588  Molecular Probes 1:1000 
Phalloidin-AlexaFluor647  Invitrogen 1:250 
 
2.5.1 Protein concentration estimation 
Cell lysates were tested by A280 and micro bicinchoninic acid assay (mBCA) 
methods. Purified proteins were tested by mBCA, A280 and densitometry from 
protein stained SDS-PAGE gels. Densitometry was useful in testing flagella 
preparations as flagellin does not generally contain many aromatic residues, causing 
inaccurate estimation with other methods. With A280, an absorbance of 1.0 = 1.0 




Using the method established by (Wiechelman et al., 1988), protein standards or 
samples were dispensed in duplicate into 96-well plates and diluted 1:10 in working 
BCA reagent (Novagen; contains bicinchroninic acid, sodium bicarbonate, sodium 
carbonate and sodium tartrate pH 11.25, with 0.08% (v/v) cupric sulphate). Samples 
were incubated at 37°C for 15-30 min. A590 was measured using a Synergy HT plate-
reader (BioTek). 
 
2.5.1.2 Bradford assay 
Using the method established by (Bradford, 1976), protein standards or samples were 
diluted 1:100 in Bradford reagent (AppliChem) and incubated at room temperature 








Using SDS-PAGE, protein standards and samples were run through 4-12% 
polyacrylamide gels. Gels were stained using the Imperial protein stain (Thermo 
Fischer), destained and imaged by scanning. They were then analysed by 
densitometry in GeneTools software (Syngene). 
 
2.5.2 SDS-PAGE 
Samples were diluted in Laemmli sample buffer (Laemmli, 1970), then incubated at 
95-100°C for 5 min unless indicated. The samples were then loaded into a 4-12, 15 
or 20% (v/v) polyacrylamide, 1% (w/v) SDS gels as indicated. 0.75, 1 and 1.5 mm 
polyacrylamide gels were run in 25mM Tris, 192mM glycine, 0.1% (w/v) SDS. 4-
12% gels were run at 120 V for 90-120 min, 4-15% and 4-20% gels were run at 
120V for 120-150 min.   
 
2.5.2.1 Protein staining 
SDS-PAGE gels were stained for proteins using coomassie G250, Imperial Protein 
Stain (Thermo Fischer) or by silver staining at RT. Coomassie staining was carried 
out by incubating gels in G250 solution, rocking for 16 h then de-staining in distilled 
water, with rocking for 6 h. Imperial protein staining was done as with coomassie 
staining for high sensitivity, or for rapid detection, gels were incubated in the stain 
for 1-2 h rocking, and de-stained as above for 2 h.  
 
Silver staining was done using SDS-PAGE (section 2.5.2). Gels were incubated with 
rocking for 1h in fixing solution (30% (v/v) ethanol, 10% (v/v) acetic acid). Gels 
were then incubated with rocking for 1 h in sensitising solution (500mM sodium 
acetate trihydrate, 30% (v/v) ethanol, 4% (v/v) of 5% (w/v) sodium thiosulphate, and 
0.12% (v/v) glutaraldehyde). After sensitisation, gels were washed 4 times in H2O at 





solution (0.25% (w/v) silver nitrate, 0.04% (v/v) formaldehyde). Gels were washed 
with H2O twice at exactly 1 min intervals, developed in 2.5% (w/v) sodium 
carbonate, 0.01% (v/v) formaldehyde until bands were stained and stopped with 
50mM EDTA. Gels were imaged using a gel-documentation system or a scanner. 
 
2.5.3 Western-blotting 
Proteins in SDS-PAGE gels (section 2.5.2) were Western-blotted onto nitrocellulose 
(Amersham, GE Healthcare) using the standard Bio-Rad wet and semi-dry methods. 
The wet method was carried out on ice in Towbin buffer (25mM Tris, 192mM 
glycine, 20% (v/v) methanol pH 8.3), at 60V for 1.5 h or 10V for 16 h. The semi-dry 
method was carried out at RT in Schaeffer-Nielsen buffer (48mM Tris, 39mM 
glycine, 20% (v/v) methanol, 0.04% (v/v) SDS, pH 9.2), and transferred with 15V 
for 30-60 min, depending on the gel thickness (mm).  
 
Blots were blocked in Carbofree (VectorLabs) or 5% (w/v) skimmed milk powder 
(Sigma, Marvel), 0.1% (v/v) Tween20 (Sigma) in Dulbecco A PBS (PBST) at RT for 
at least 2 h or 4°C for at least 16 h. Blots were washed three times between steps in 
0.1% (v/v) PBST for 15 min intervals at RT, with rocking. Primary antibodies were 
added at the desired concentration (table 2.6), either straight into the blocking buffer, 
or after washing as above, then adding it to 1% (w/v) skimmed milk powder, 0.1% 
(v/v) PBST. Primary antibodies were incubated with blots for at least 1 h at RT, 
rocking, and then the blots were washed as above. Horseradish peroxidase (HRP)-
conjugated secondary antibodies were added to 1% (w/v) skimmed milk powder, 
0.1% (v/v) PBST at the desired concentration (table 2.6) and incubated with blots for 
at least 1 h RT, rocking, and then the blots were washed as above. 
 
Blots were developed using chemi-luminescence (with either enhanced chemi-
luminescence (ECL) solution A (2.5mM luminol (Fluka), 400µM p-Coumaric acid 
(Sigma) in 100mM Tris-HCl pH 8.5) and ECL solution B (0.2% (v/v) H2O2 in 





Fischer. Blots were either exposed onto chemi-luminescence film (Amersham, GE 
Healthcare) or captured on the G:box (Syngene) using GeneSnap (Syngene). If blots 
were exposed to film, they were incubated in the ECL reagents for 5 min at RT, 
rocking. They were then sealed, exposed to film, and developed (Kodak). If blots 
were captured on the G:Box, they were placed on an acetate sheet and covered with a 
thin layer of ECL reagent in the G:box. The G:box settings used were a focus of 62 
at a distance of 575mm, at the highest quality.  
 
2.5.3.1 Far Western-blotting  
Far Western blots were performed like Western blots, but with an extra detection 
step. Instead of detecting proteins on nitrocellulose membranes directly with 
antibodies, blotted membranes were probed with protein solutions, and their binding 
to the blotted membranes was detected with specific antibodies. This made it 
possible to use this method to screen for protein:protein interactions.  
 
80 µg BTRE freeze-thawed cell lysates 5 µg 95% pure human platelet actin or 1 µg 
purified receptor candidates were Western-blotted onto nitrocellulose membranes 
and blocked according to section 2.5.3. These membranes were washed three times 
in 0.1% (v/v) PBST at RT, rocking, at 15 minute intervals. Membranes were then 
probed with 1 µg/ml PBS of FliCH7 flagella or recombinant FliDH7 for 3 h at RT, 
rocking and washed as above. FliCH7 flagella or recombinant FliDH7 were labelled 
using α-H7 rabbit IgG and a-his mouse IgG, and detected with appropriate horse 
radish peroxidase (HRP)-conjugated antibodies as detailed in section 2.5.3 and table 
2.6.  
 
To assess the involvement of glycosylation in protein interactions detected, 
Carbofree (VectorLabs) blocked membranes were treated with PNGase-F or O-
glycosidase prior to protein binding. 25 mU (IUB) PNGase-F (New England 
Biolabs) or 2.5 mU (Roche) O-Glycosidase F (Roche) in enzyme buffer (50mM 





7.5) were incubated with membranes at 37°C for 16 h. Membranes were then washed 
three times in 0.1% (v/v) PBST at RT, rocking, at 15 minute intervals before protein 
binding was performed. 
 
2.5.4 DIG-labelled glycan detection 
Proteins were Western-blotted onto nitrocellulose membranes (section 2.5.3) and a 
digoxigenin-3-0-succinyl-ϵ-aminocaproic acid (DIG)-labelling Glycan Detection kit 
(Roche) was used according to manufacturer’s instructions. This method was 
described in (Haselbeck & Hosel, 1990). Briefly, blotted proteins were washed twice 
in PBS then oxidised by incubation with 10mM sodium metaperiodate in 100mM 
sodium acetate pH 5.5 for 20 min at RT, rocking. Membranes were then washed 
three times in PBS at RT rocking, with 10 minute intervals. Membranes were then 
DIG-labelled by incubating them with DIG-hydrazide diluted 1:5000 in 100mM 
sodium acetate pH 5.5 for 1 h at RT, rocking. Membranes were washed three times 
in tris-buffered saline (TBS) at RT, rocking, at 10 min intervals then blocked with 
the blocking reagent supplied with the kit for 1 h at RT, rocking. After washing as 
above, membranes were incubated with α-DIG FAb-alkaline phosphatase diluted 
1:1000 in TBS for 1 h at RT, rocking. Membranes were washed as above once more 
then stained with NBT/X-phosphate (4-nitro blue tetrazolium chloride/5-bromo-4-
chloro-3-indolyl-phosphate) diluted 1:500 in staining buffer (100mM Tris, 50mM 
MgCl2, 100mM NaCl, pH 9.5) until bands appeared. The staining reactions were 
then stopped by rinsing membranes with H2O and imaged on a gel-documentation 
system (G:box, Syngene). 
 
2.5.5 Purification of bacterial flagella  
2.5.5.1 Acid depolymerisation  
Fresh colonies were motility-enriched and grown in LB broth at 30°C 200 rpm to an 
OD600 of 1-1.5. Cultures were then centrifuged at 10000 x g for 15 min at 4°C. The 





culture volume for 16 h at 4°C. Re-suspended pellets were adjusted to pH 2.0 with 
1M HCl and incubated for 30 min rocking at RT to depolymerise flagella. They were 
then centrifuged at 5000 x g for 30 min at 4°C, pelleting the bacteria. The 
supernatants were separated and adjusted to pH 7.0 with 1M NaOH to re-polymerise 
flagella. Flagella were precipitated with 2.67M ammonium sulphate at 4°C for 16 h. 
They were centrifuged at 15000 x g for 15 min at 4°C and supernatants kept aside for 
SDS-PAGE analysis. The pellets were re-suspended in PBS, 1:500 of the initial 
culture volume. These preparations were then dialysed 1:1000 against sterile PBS 
four times in succession at 4°C (for 8 h then 16 h, twice) and analysed by SDS-
PAGE and mBCA (section 2.5.1 and 2.5.2) for purity and concentration. 
 
2.5.5.2 Shearing  
Fresh colonies were motility-enriched and grown in LB broth at 30°C 200 rpm to an 
OD600 of 0.8-1.2. These cultures were then centrifuged at 4100 x g at 4°C for 30 min 
to pellet cells. The supernatants were discarded and pellets were re-suspended in PBS 
1:5 of the initial culture volume for 16 h at 4°C. Re-suspended pellets were diluted 
1:2 with cold PBS and sheared at top speed for 2 min on ice using an IKA T-10 
homogeniser (Ultra-Turrax). Culture supernatants were then centrifuged at 4100 x g 
at 4°C for 15 min and transferred to fresh tubes multiple times, until there were no 
visible pellets. To completely clear the supernatants of bacterial cells, they were then 
centrifuged at 16000 x g 4°C for 10 min. The top 80% of supernatants were 
transferred into fresh tubes and centrifuged at 20500 x g at 4°C for 1.5 h to pellet 
flagella. Pellets were re-suspended in PBS 1:500 to initial culture volume. Re-
suspension by pipetting or vortexing was carried out for 2 min, incubated on ice for 
10 min, then re-suspended for another 2 min. Samples were stored at 4°C until 
protein concentration (section 2.5.1) and purity (section 2.5.2) were assessed. 






2.5.6 Purification of His-tagged proteins 
Plasmids containing desired 6x(His) tagged proteins were electroporated into electro-
competent E. coli BL21(DE3), except for FliDH7, where TOP10 was used. Fresh 
ampr transformants were used to inoculate LB broth with amp (ALB), which were 
incubated at 37°C 200 rpm for 16 h. These were sub-cultured 1:100 into ALB, 
incubated at 37°C 200 rpm to an OD600 of 0.6. Cultures were then induced with a 
final concentration of 1mM isopropyl β-D-1-thiogalactopyranoside (IPTG, Promega) 
and incubated in the same conditions for a further 3-4 h. Cultures were centrifuged at 
4100 x g 30 min to pellet bacteria. Cell pellets were stored for 16 h at -20°C.  
 
Pellets were then thawed on ice for 30 min and re-suspended in lysis buffer (50mM 
NaH2PO4, 300mM NaCl, 10mM imidazole, pH8.0) 1:500 to initial culture volume. 1 
mg/ml lysozyme (Sigma) was added and preparations were incubated on ice for 30 
min. Lysates were then sonicated on ice using 6 200 W 10 s bursts with 10 s 
intervals. Lysates were drawn in and out of narrow-gauge needles 5 times and 
centrifuged at 10000 x g at 4°C for 30 min for lysate clarification. Lysate 
supernatants were used for further protein purification. 
 
Ni-NTA resin (Novagen) was washed 3 times with lysis buffer by gentle 
centrifugation (100 x g for 1 min) to create 50% slurries. 50% slurries were added 
1:4 to clarified lysate supernatants in capped columns. These were then incubated for 
30 min RT rocking. The columns were then fixed in place, un-capped and allowed to 
flow through. Resins were washed twice with 4:1 volumes of wash buffer (50mM 
NaH2P04, 300mM NaCl, 20mM imidazole, pH 8.0). Proteins were then eluted from 
the column resin 1:1 with elution buffer 4 times (50mM NaH2P04, 300mM NaCl, 
250mM imidazole, pH 8.0), in four fractions. 
 
Fractions were analysed by SDS-PAGE and Western-blotting with α-his mouse IgG 





and purity. High yield fractions of acceptable purity were assayed for protein 
concentration and aliquoted for storage.  
 
2.5.7 Mass spectrometry 
Mass-spectrometry, tandem mass-spectrometry and peptide mass fingerprinting were 
undertaken by Kevin Mclean at the Moredun Research Institute Proteomics Facility. 
Protein bands from Imperial protein stained SDS-PAGE gels were excised and 
delivered to Kevin Mclean for trypsinisation, enrichment, clean-up and mass 
spectrometry according to their protocols. Spectra were then input into MASCOT 
peptide mass fingerprinting software (Matrix Science) to generate protein identities. 
 
2.5.7.1 Accurate MW determination by mass-spectrometry 
FliCH7 was analysed by online HPLC-MS by Andy Gill in the facilities of 
Proteomics and Metabolomics at the Roslin Institute. A sample of sheared FliCH7 
flagella was diluted to ~1 pmole/µl in 0.1 % (v/v) formic acid and ~20 pmole was 
applied to a microbore HPLC column (Dionex Acclaim C18, 4.6 mm i.d., 150mm 
length, 5 μm beads, 120 Å pore size) pre-equilibrated with 0.1 % (v/v) formic acid by 
use of a Ultimate HPLC system (Dionex). Bound components were eluted with a 
gradient of 0.1 % (v/v) formic acid in acetonitrile into the electrsopray source of an 
amaZon ETD ion trap mass spectrometer (Bruker Daltonics, Germany). The mass 
spectrometer acquired full scan mass spectra with final spectra being an average of 8 
trap fills of a maximum averaging time of 200 ms. Signals corresponding to intact 
H7 protein were summed, the raw data was smoothed and background subtracted and 
then de-convoluted by use of the Burker proprietary algorithm. 
 
2.5.8 FliDH7 antibodies 
All serum was collected and stored in 50% (v/v) Alsever’s solution. Rabbits were 
screened for exposure to FliDH7 by probing FliDH7 Western blots with their blood 





recombinant FliDH7 at 1 mg/ml in 25% (v/v) Freund’s complete adjuvant in PBS, by 
four small injections – 2 intra-muscularly in hind-legs, 2 sub-cutaneously over each 
scapula. Further booster doses of FliDH7 were given with 25% (v/v) Freund’s 
incomplete adjuvant as above, at 28-day intervals. Before each dose of recombinant 
FliDH7, serum was collected (pre-immune serum (PI), bleed 1, 2 and 3). Sera from 
the rabbit were monitored throughout by testing it for recognition of recombinant 
FliDH7 by Western blotting and enzyme-linked immuno-sorbent assay (ELISA). 
ELISAs were done by coating 1 µg of recombinant FliDH7 in 100mM bicarbonate 
buffer pH 9.6 for 16 h at 4°C and blocking it with 3% (w/v) BSA (fraction V, Sigma) 
in 0.1% (v/v) PBST for 2 h RT, rocking. Rabbit sera were added at different dilutions 
in 3% (w/v) BSA, washed in 0.1% (v/v) PBST, and detected with a-rabbit IgG-HRP 
diluted in 3% (w/v) BSA and ECL reagents as in section 2.9.1.1. Rabbits were 
exsanguinated and serum was stored at -70°C. 
 
2.6 Primary culture of BTR epithelial cells 
2.6.1 Isolation of BTRE 
This method was performed by Edith Paxton for the majority of cells. Abbattoir-
derived bovine rectal canals were collected. These were cut longitudinally and 
washed in H2O. The terminal rectal canals were isolated as the ~5 cm of tissue 
proximal to the recto-anal junction. The underlying bulk of connective tissue was cut 
away and terminal rectums were thoroughly mixed in washing media (Hank’s 
Balanced Salt Solution (HBSS), Sigma) containing 25 µg/ml Gentamicin (Sigma), 5 
µg/ml Fungizone (Invitrogen), 100 U/ml penicillin and 30 µg/ml streptomycin 
(Invitrogen)) and incubated for 30 min at RT. Epithelial mucus was then removed 
from tissue by lightly scraping epithelia with sterile glass slides. The epithelial layers 
were then isolated from the sub-mucosa by firmly scraping the tissue with sterile 
glass slides. Epithelia were collected in this way and shaken vigorously in HBSS to 
disrupt tissue. These were then centrifuged at 300 x g for 2 min at RT, carefully 






Digestion medium (Dulbecco’s Minimum Essential Medium (DMEM, Sigma), 1% 
(v/v) foetal bovine serum (FBS, Sigma), 25 µg/ml Gentamicin (Sigma), 100 U/ml 
penicillin and 30 µg/ml streptomycin) was added to cell pellets (<10 ml), then 75 
U/ml Collagenase (Sigma) and 20 µg/ml Dispase I (Roche) were added. These were 
mixed vigorously and incubated at 37°C 200 rpm for 1 h 20 min. 
 
Digested tissues were centrifuged at 300 x g for 2 min at RT. Pellets were re-
suspended in HBSS and this process was repeated until the top of supernatants were 
free of crypts. At this stage, 1:5 less HBSS was added with each re-suspension until 
all of the supernatants were clear. Pellets were then washed with HBSS and re-
suspended in primary cell culture medium (DMEM, 2% (v/v) FBS, 2mM L-
glutamine (Invitrogen), 25 µg/ml gentamicin (Sigma), 100U/ml penicillin 
(Invitrogen), 30 µg/ml streptomycin (Invitrogen), 10 ng/ml epidermal growth factor 
(Sigma), 0.25 U Insulin (Sigma)) to a concentration of ~5000 crypts/ml.  
 
2.6.2 Primary BTRE growth 
500-700 crypts/well were seeded in primary cell culture medium on Collagen 
(Nutacon) coated plates. Primary cell cultures were incubated at 37°C, 5% CO2, 80% 
humidity for 1-2 days, then half of the media was replaced with feeding medium (as 
primary cell culture medium but 5% (v/v) FBS). Media was then completely replaced 
every 2 days until cells were confluent.  
 
2.6.3 Primary BTRE cell lysate preparation 
Confluent cells were harvested for freeze-thawed cell lysates by washing them twice 
in PBS then incubating them with TripLE Express (Gibco) at 37°C 5% CO2 80% 
humidity for 10 min. The TripLE Express on cells was then diluted 1:2 with PBS, 
cells were scraped off, collected and centrifuged at 300 x g at RT for 2 min. They 
were then washed by re-suspending and centrifuging as above in PBS or HBSS, 





cycles of snap-freezing in ethanol and dry-ice and thawing at RT. These lysates were 
clarified by centrifugation at 18000 x g for 10 min at 4°C to remove cellular debris. 
For cell lysates prepared using Triton X-100, cells were washed twice in PBS then 
incubated with lysis buffer (3% (v/v) Triton X-100 (Sigma), 20mM Tris, 150mM 
NaCl, 1mM EDTA) for 5 min RT. Cells were then scraped off and mixed by 
pipetting. 
 
2.7 Wide-field immunofluorescence microscopy  
Samples were visualized using a Leica DM-LB epi-fluorescence microscope (Leica 
Microsystems), photographed using a Hamamatsu ORCA-ER B/W CCD digital 
camera (Hamamatsu Photonics K.K.) and analysed using OpenLab 4.0 (Improvision; 
UK). A minimum of three fields of view were sampled per duplicate. 
 
2.7.1 Imaging of flagella expression in bacterial cultures 
Fresh colonies of TUV93-0 and its derivatives were grown in LB broth at 30°C 200 
rpm for 16 h. These saturated cultures were fixed by diluting them 1:10 in 4% (w/v) 
paraformaldehyde (PFA) on ice for 30 min, and were stored at 4°C. Samples were 
heat-fixed at 37ºC to multispot glass slides (C.A.Henley Essex Ltd) in duplicate. 
These were stained using H-type specific polyclonal rabbit IgG (table 2.6, diluted 
with 1% BSA in PBS) at RT for 30 min in a dark, slow-rocking humidified chamber. 
After washing the slides three times in PBS, they were incubated with anti-rabbit 
fluorescein isothiocynate (FITC)-conjugated goat IgG (diluted 1:1000 with 1% (w/v) 
BSA in PBS) for a further 30 min at RT. Slides were washed again in PBS and dried 
at 37ºC before mounting with DAKO (a fluorescent mounting medium, Sigma). 
Slides were left for a minimum of 2 days before viewing and were stored at 4ºC in 






2.7.2 A/E lesion formation 
This was undertaken by Xuefang Xu as in (Xu et al., 2012). Confluent embryonic 
bovine lung (EBL) cells grown in glass 4-well chamber slides were washed 
and incubated with minimal essential medium (MEM) with the Hydroxyethyl-
Piperazine Ethanesulafonic Acid (HEPES) modification 1 h prior to infection with 
TUV93-0. 2 x 106 bacteria were incubated with EBL cells at an MOI of 10 at 37°C 
5% CO2 80% humidity for 3 h. Cells were washed twice with PBS, fixed in 2.5% 
(w/v) PFA in PBS for 20 min at RT, then permeabilised for 5 min with 0.1% (v/v) 
Triton X-100 in PBS at RT. Cells were washed three times in PBS and α-O157 rabbit 
IgG (Mast Assure) diluted 1:50 in 1% (w/v) BSA (PBS) were added for 35 min. 
Slides were then washed  three times in PBS, and incubated with anti-mouse IgG-
AlexaFluor568 (Molecular Probes) diluted 1:1000 in 1% (w/v) BSA (PBS) for 30 min 
in the dark. The cells were then washed three times in PBS and stained with 1 
µg/ml phalloidin-FITC (fluoroscein isothiocyanate, Sigma) in PBS for 30 min in the 
dark. Slides were then washed twice with PBS and mounted with DAKO mounting 
medium. The slides were imaged by fluorescent microscopy after at least 16 h to 
allow the mountant to set. 
 
2.8 Confocal microscopy 
2.8.1 Bacterial infection 
Semi-confluent primary BTRE cells (section 2.6.2) grown in 4 well chamber slides 
were washed twice with PBS then incubated for with MEM-HEPES 1-2 h prior to 
infection with TUV93-0. Fresh colonies of TUV93-0 were grown in LB broth at 
30°C 200 rpm for 16 h then were centrifuged at 4100 x g for 5 min at RT and the 
pellet was re-suspended in MEM-HEPES to an OD600 of 0.3-0.4. 1 x 10
7 bacteria 
were added to each well and cells were incubated for 1 h at 37°C 5% CO2 80% 






2.8.2 Bacterial staining 
Cells were washed with PBS three times then fixed with 2% (w/v) PFA in PBS for 
>5 min. If wheat-germ agglutin (WGA)-Texas red (Invitrogen) was added, it was at 
this point prior to permeabilisation, diluted 1:1000 in PBS for 30 min, kept dark. 
Cells were permeabilised with 0.1% (v/v) Triton X-100 in PBS for 2 min then 
washed three times with PBS. Cells were then labelled with α-H7 rabbit IgG diluted 
1:1000 in PBS for 16 h at 4°C, washed three times in PBS, then labelled with α-
O157 rabbit IgG diluted 1:100 in PBS for 1 h at RT. After washing three times in 
PBS, α-rabbit IgG-FITC was added, diluted 1:100 in PBS, for 1 h RT in the dark 
onwards if not already kept in the dark. Cells were then washed three times in PBS. 
 
2.8.3 BTRE staining 
If wheat-germ agglutinin-Texas red had been used, phalloidin-AlexaFluor647 was 
used to label actin. If not, then Texas red conjugated phalloidin was used instead. In 
either case, the phalloidin was added, diluted 1:250 in PBS, for 1 h at RT, and cells 
were then washed three times with PBS. If 4,6-diamidino-2-phenylindole (DAPI) 
was used, it was added, diluted 1:1000 in PBS for 30 min at RT. Slides labelled with 
wheat-germ agglutin were mounted using VectorShield (VectorLabs) mountant, the 
rest were mounted using ProLong Gold (Invitrogen) mountant. Slides were stored for 
at least 5 days to set before imaging. 
 
2.8.4 Confocal imaging 
Imaging was undertaken at the Roslin Institute Bioimaging Facility on a Zeiss 
LSM5-Pascal confocal microscope with 488 nm, 543 nm HeNe lasers and an 633 nm 
argon laser (Lasos GmBH), using Axiovert software, or performed by Trudie 
Gillespie at the IMPACT facility in the Centre for Integrative Physiology at the 
University of Edinburgh. At the IMPACT facility, slides were imaged using a Zeiss 
LSM510 confocal system with a 488 nm Argon Kryton laser, 514 nm HeNe laser, a 








2.9.1 Enzyme-linked immuno-sorbent assays (ELISAs) 
2.9.1.1 Mucin II ELISA 
96-well MaxiSorb ELISA plates (Nunc) were coated with 100 µg/well of porcine 
gastric mucin fraction II (Sigma) in 100mM bicarbonate buffer pH 9.6 at 4°C for 16 
h. TUV93-0 that had been fixed with 4% (w/v) PFA (section 2.8.2) was coated onto 
the plate as a positive control. Coating was removed and wells were blocked with 1% 
(w/v) BSA at 37°C for 1 h. Wells were washed with 0.1% (v/v) PBST three times.  
 
Strains were grown at 28°C in LB broth 200 rpm for 16 h. Saturated cultures were 
centrifuged at 8900 x g and cell pellets were re-suspended in PBS to an OD600 of 1.0. 
Strains were added to wells in 1:2 serial dilutions, incubated at 37°C for 1 h, and 
washed three times with 0.1% (v/v) PBST. 
 
Bound bacteria were labelled with α-O157 rabbit IgG, diluted 1:100 in PBS, for 1 h 
at 37°C, and were then washed three times with 0.1% (v/v) PBST. HRP-conjugated 
α-rabbit IgG antibodies were diluted 1:1000 in PBS and incubated in wells for 1 h at 
37°C before washing again as above. Bacteria were detected using OPD-fast 
(Sigma); after 15 min at RT, the reaction was stopped using 1M H2SO4 and A492 was 
read in a Fluostar Optima plate reader.  
 
2.9.1.2 Far ELISAs 
96-well MaxiSorb ELISA plates (Nunc) were coated with 1 µg/well of galectin-4, 
cofilin-1 or 95% pure human platelet actin in 100mM bicarbonate buffer pH 9.6 at 
4°C for 16 h. 1 µg/well of purified flagella proteins were coated onto the plate for 
positive and negative detection controls. Coating was removed and wells were 





(v/v) PBST three times then 1000, 500, 100 or 0 ng/well of purified flagella proteins 
in PBS were added to wells for 3 h at RT, rocking, then washed again.  
 
Bound flagella proteins were labelled with specific antibodies (table 2.6), diluted in 
0.1% (v/v) PBST for 1 h at RT, rocking, before washing three times in 0.1% (v/v) 
PBST. These rabbit and mouse IgG were then detected with specific HRP-
conjugated secondary antibodies (table 2.6), diluted in 0.1% (v/v) PBST, for 1 h at 
RT, rocking. After washing as above, bound protein was detected using SuperSignal 
West Pico ECL reagents (Thermo-Fischer) in the G:box using GeneSnap (Syngene), 
as with Western blots (section 2.5.3).  
 
Binding results were then quantified in GeneTools (Syngene) by densitometry of the 
inverted chemi-luminescence image using a spot radius of 25. Data from three 
independent experiments were normalised using the formula Relative binding = 100 
x [(Test-0P)/( PC-0P)], where 0P = 0 ng flagella protein, PC = positive detection 
control. Statistical analysis was carried out in Minitab 16. Data residuals were 
assessed for normality using a Kolmogorov-Smirnov test (p>0.05). A general linear 
model was used to assess the statistical significance of results, where the response 
was relative binding, and the model included experiment as a confounding factor and 
receptor candidate (galectin-4, cofilin-1 and actin) and protein concentration (1000, 
500, 100 ng/well) as factors. Post-hoc Tukey pairwise comparisons of the interaction 
between protein concentration and receptor candidate terms were then performed on 
the data, with a p-value of <0.05 being taken as significant. 
 
2.9.1.3 Cell-based ELISAs  
Cell-based ELISAs were used to detect protein binding to BTRE cells or to assess α-
FliD-inhibition of E. coli O157:H7 binding to BTRE cells. In each case, BTRE 
primary cell culture was performed as described in section 2.6.2, then 1-2 h before 
protein or strain co-incubation, cells were washed twice with PBS then incubated 






2.9.1.4 Protein-binding cell-based ELISAs 
Primary BTRE cells were incubated with 10 µg/well protein (sheared FliCH7 flagella, 
recombinant FliDH7, VrH7180-496) for 3 h at 37°C 5% CO2 80% humidity. Cells were 
washed three times in PBS and fixed with 2% (w/v) PFA for 20 min at RT with 0.1% 
(v/v) Triton X-100, except for experiments with sheared FliCH7 flagella. Endogenous 
peroxidase activity was quenched with 1% (v/v) H2O2 in methanol at RT for 20 min, 
except for experiments with sheared FliCH7 flagella. After washing cells three times 
with PBS, they were blocked with 3% (w/v) BSA (fraction V, Sigma) in PBS at 4°C 
for at least 16 h.  
 
After blocking buffer was removed, α-6x(His) mouse IgG (Invitrogen) was added 
1:5000 to 3% (w/v) BSA and incubated with cells for 1 h at RT, except with FliCH7 
flagella, where α-H7 rabbit IgG was used at a 1:1000 dilution. Cells were washed 
three times in PBS then α-mouse IgG-HRP (BD) was added 1:5000 to 3% (w/v) BSA 
and incubated and washed as above, except with FliCH7 flagella, where α-rabbit IgG-
HRP was used at a 1:1000 dilution. 
 
Binding was detected using SuperSignal West Pico ECL reagents (Thermo-Fischer) 
in a G:Box (Syngene) with a 62 focus at 575mm in GeneSnap (SynGene). 
Densitometry was performed on inverted images in GeneTools (SynGene) using a 65 
spot radius. Cells were then washed three times in PBS and 0.1% (v/v) crystal violet 
stain was added to measure BTRE cell coverage, except with FliCH7 flagella. This 
was incubated at 4°C for 30-45 min then washed three times in PBS. 20% (v/v) 
acetone in ethanol was added, incubated for 30 min at RT, rocking, and A590 was 
read in a Synergy HT plate reader (BioTek). 
 
Binding data from 2 experiments with 3-5 technical replicates was assessed for 





formula BTRE binding = (Rt/CVt)- (Rno1y/CVno1y) where R = raw pixel volume, CV 
= crystal violet value, t = test, No1y = no primary antibody control. With FliCH7 
flagella there were no CV values, but otherwise analysis was the same. Molecular 
binding efficiencies were calculated using the formula Molecular binding efficiency 
= Binding index/(protein concentration in nM x 1000), where Binding index = 
(BTRE binding at 10 µg/ml)/(BTRE binding at 0 µg/ml). This gives BTRE 
binding/nmol of protein. 
 
2.9.1.5 Antibody inhibition cell-based ELISAs 
Freshly revived TUV93-0 was grown in LB broth at 30°C 200 rpm for 16 h. TUV93-
0 was then sub-cultured 1:50 in LB broth at 30°C 200 rpm until it reached an OD600 
of 0.3. Cultures were centrifuged at 8900 x g for 5 min and pellets re-suspended in 
MEM-HEPES (Sigma). Pre-immune, α-H7 and α-FliD rabbit antisera (table 2.6) 
were mixed 1:10 with separate bacterial cultures and incubated at RT statically for 30 
min. 1 x 107 bacteria were added to cells and incubated for 1 h at 37°C 5%CO2 80% 
humidity. BTRE cells were then washed three times in PBS, fixed with 2% (w/v) 
PFA for 15 min at RT then permeabilised with 0.1% (v/v) Triton X-100 for <1min. 
Cells were washed three times in PBS, peroxide treated, washed and blocked as in 
section 2.9.1.3.  
 
After blocking buffer was removed, α-O157 mouse IgG (AbDSeroTec) was added 
1:1000 to 3% (w/v) BSA and incubated with cells for 1 h at RT. Cells were washed 
three times in PBS then α-mouse IgG-HRP (BD) was added 1:1000 to 3% (w/v) BSA 
and incubated and washed three times in PBS. Binding was detected, densitometry 
and crystal violet staining was performed as in section 2.9.1.4. Binding data from 
two experiments with 5 technical replicates was assessed for quality and normalised 






2.9.2 Motility assays 
Motility assays were used to phenotypically validate the construction of fliC 
expression vectors and mutants. Fresh streak plates or electro-transformants were 
stab inoculated once into dried semi-solid agar plates (1% (w/v) tryptone, 0.5% (w/v) 
NaCl, 0.3% (w/v) granulated agar). Antibiotics were added prior to plate-pouring 
where appropriate. Inoculated plates were incubated at 28ºC for 16 or 24 h, as 
indicated. Assays were carried out with 4 replicates where possible and repeated at 
least once for confirmation. Motility assays are very variable, even with wild-type 
flagellated strains. As such, motility was regarded as complemented where motility 
halos of mutants were within limits of typical wild-type variation. 
 
2.9.2.1 Antibody inhibition of motility  
Colonies from freshly revived TUV93-0 were stab inoculated into motility agar 
containing 1:1000 dilutions of pre-immune rabbit serum, α-H7 and α-FliD bleed 1, α-
FliD bleed 3, α-H7+ α-FliD bleed 1 or α-H7+α-FliD bleed 3 (sera was added when 
agar was cooling). Plates were incubated at 30°C for 24 h and motility was 
quantified by scanning plates and measuring relative halo radius in GeneTools 
(SynGene). Where halos were not circular, halo radius was considered to be the 
radius of the largest circle that could fit within the halo. Motility inhibition was 
assessed as a percentage of motility in the presence of pre-immune serum. Analysis 
was performed on data from two independent experiments with 3 technical replicates 
(except with bleed 3, which only had 3 technical replicates).  
 
2.9.3 Co-immunoprecipitation of FliCH7 flagella with BTRE cell lysates 
Pierce protein A/G agarose 50% slurry (Thermo Scientific) was used according to 
manufacturer’s instructions. Briefly, slurries were washed twice by centrifugation at 
10000 x g for 1 min and re-suspension in equal volume of TBS. Resin was 
centrifuged as above then re-suspended in 250 µg of BTRE cell lysate (Triton X-100 
method, section 2.6.3) for 2 h at 4°C, rocking. Beads were then centrifuged as above 






Sheared FliCH7 flagella or an equivalent volume of TBS were added to pre-cleared 
cell lysates for 16 h at 4°C rocking. Fresh Pierce protein A/G agarose beads were 
washed as above and α-H7 was added, diluted 1:4 in TBS, for 1 h at 4°C, rocking. 
This α-H7/A/G agarose was then washed as above and added to pre-cleared cell 
lysates +/- FliCH7 flagella for 2 h at 4°C, rocking. The beads were washed again and 
2xSDS-PAGE sample buffer added for 5 min at 100°C. The eluted proteins were 
separated from the A/G beads by centrifugation as above. Supernatants were 
analysed by 12% SDS-PAGE and coomassie staining. 
 
2.9.4 CnBr-Sepharose pull-downs 
2.9.4.1 Bead preparation 
Cyanogen bromide (CnBr) activated sepharose 4B lyophilised beads (GE Healthcare) 
were used according to manufacturer’s instructions. They were dissolved to 2% 
(w/v) bead re-suspension buffer (1mM HCl, pH 3.0) and centrifuged at 3600 x g for 
5min at RT. The beads were re-suspended as above in bead re-suspension buffer 
three more times. The fourth time, the beads were re-suspended as a 50% slurry in 
re-suspension buffer and stored at 4°C. 
 
2.9.4.2 Pull-downs 
Slurries were touch-spun down and re-suspended in coupling buffer (100mM 
NaHCO3, 500mM NaCl, pH 8.3). 50 µg protein (flagella proteins or receptor 
candidates) was added 2:1 to CnBr beads for 16 h at 4°C, rocking, except galectin-4, 
where only 1:3 was added. Excess protein was washed off beads by five cycles of 
centrifugation at 17900 x g for 30 s and re-suspension of beads in the same volume 
of coupling buffer. The above was done with receptor candidates, except at 100 x g 
for 10 s. The beads were centrifuged as above once more, but re-suspended in 
blocking buffer (100mM Tris-HCl, 500mM NaCl, pH 8.0) and incubated for 2 h 





with alternate cycles of re-suspension in coupling buffer or wash buffer (100mM 
acetic acid, 100mM sodium acetate, 500mM NaCl, pH 4.0). On the final 
centrifugation, beads were re-suspended in 180 µg BTRE freeze-thawed cell lysate in 
HBSS (section 2.6.3) or 5-10 µg sheared flagella in PBS. These were incubated for 
16 h at 4°C, rocking. 
  
2.9.4.3 Elution and analysis 
CnBr beads were centrifuged at 17900 x g for 30 s if incubated with cell lysates or at 
100 x g for 10 s if incubated with sheared flagella. Beads were then washed by three 
cycles of centrifugation as above and re-suspension in 0.1% (v/v) PBST. Beads were 
centrifuged a final time and eluted as in co-immunoprecipitation (section 2.9.3), then 
analysed by 12% SDS-PAGE and imperial protein staining. For pull-downs with 
BTRE cell lysates, bands only apparent in the presence of flagella proteins and 
equivalent cell lysate bands were excised and identified by mass spectrometry 
(section 2.5.7). For pull-downs with receptor candidates, Western blots (section 
2.5.3) for all constituents were performed. 
 
2.9.5 Flagella co-sedimentation assays 
2.9.5.1 Purified flagella 
1:1 molar ratios of sheared FliCH7 flagella and cofilin-1 were incubated in interaction 
buffer (10mM Tris-HCl, 50mM NaCl, 1mM dithiothretol (DTT), pH 6.8 or 8.0) for 
30 min at RT static.  Reactions were diluted 1:3 in interaction buffer and ultra-
centrifuged at 172600 x g for 1.5 h at 4°C. Supernatants were kept aside for SDS-
PAGE analysis. Pellets were re-suspended in an equal volume of interaction buffer. 
Equal volumes of pellet and supernatant samples were added to 5xSDS-PAGE 
sample buffer and were analysed by SDS-PAGE. Results were quantified using 
densitometry in GeneTools and normalised by the formula Protein recovery = 
(Rf/Rtot) x 100 where Rf = raw pixel volume of fraction and Rtot = total raw pixel 






2.9.5.2 Bacteria-associated flagella 
Freshly revived TUV93-0 and TUVfliC- were inoculated into LB broth and incubated 
at 30°C 200 rpm for 16 h. Saturated cultures were centrifuged at 8900 x g for 5 min 
at RT and cell pellets were re-suspended in interaction buffer (section 2.9.5.1). 1 
nmol of cofilin-1 was added to each strain for 1 h at RT statically, and then samples 
were centrifuged at 17900 x g for 2 min. As pellets were very delicate, a fixed 
volume from the top two thirds of the supernatant were taken as the supernatant 
fraction, the middle bit discarded, and the pellet re-suspended in an equal volume of 
interaction buffer. Fractions were then prepared for SDS-PAGE and Western-
blotting for FliCH7 and cofilin-1. Results were quantified as in section 2.9.5.1. 
 
2.9.6 Size exclusion chromatography 
Samples were applied to an HPLC column (Sigma TSK G4000SWXL, 4.6 mm i.d., 
300mm length, 8 μm beads, 450 Å pore size) pre-equilibrated with 100mM Tris-HCl, 








Columns were calibrated with molecular weight standards (Blue Dextran 2.5 MDa, 
Thyroglobulin 670 kDa, BSA 66 kDa, Ribonuclease A 13.5 kDa, ATP 0.5 Da, figure 
2.5).  
 
For FliCH7 flagella-cofilin-1 interactions, proteins were mixed at 1:0, 1:1 and 1:4 
molar ratios in 10mM Tris-HCl, 50mM NaCl, 1mM DTT pH 8.0, immediately 
before first application to column. Each ratio was run ten times at 30 min intervals, 
and A220 over ml was recorded. Data was analysed by calculating the area under 
curve (AUC) for each run, for large filaments (4.5-6.75 ml  >2 MDa- ~1.4 MDa), 
small filaments (6.75-9 ml  ~1.4 MDa- ~300 kDa) and ‘monomers’ (9-11.25 ml < 
~300 kDa) with the formula AUC = [(A1+A2)/2] x (T2-T1), where A = absorbance at 
220 nm and T = time. Data were normalised by using a percentage of the sum of 
large filaments, small filaments and monomer AUCs. Differences in % AUC for the 
above groups between different molar ratios of cofilin-1 to FliCH7 flagella were 
analysed for statistical significance using a Kruskal-Wallis test in Minitab 16. 
 
2.9.7 Actin polymerisation assays 
2.9.7.1 G-actin preparation 
G-actin was prepared by re-suspending lyophilised pyrene conjugated-rabbit skeletal 
muscle actin (Cytoskeleton) in G-buffer (10mM Tris, 200µM CaCl2, 200µM 
adenosine triphosphate (ATP), 1mM DTT, pH 7.5) for 1 h on ice in the dark to 
depolymerise. This was then ultra-centrifuged at 100000 x g for 2 h at 4°C to pellet 
nucleated actin. The top 80% of the supernatant was kept on ice in the dark for 
further use.  
 
2.9.7.2 Test protein preparation 
Test proteins were all dialysed into 50mM Tris-HCl pH 7.5 using U-tube 
concentrators according to manufacturer’s instructions (Novagen). Molar 





(densitometry was used to adjust these values for FliCH6 and FliCH7 flagella) with 
BSA standards.  
 
2.9.7.3 Actin polymerisation 
To normalise the polymerisation capability of G-actin preparations, a gain value was 
applied to all wells (calculated using pyrene-actin +/- 0.25x polymerisation buffer 
(12.5mM KCl, 500µM MgCl2, 250µM ATP) read after 1 h incubation at RT in the 
dark). Assays were carried out in black opaque 96-well plates. Cofilin-1 or sheared 
flagella were added to wells, followed by 1µM actin, and then polymerisation was 
initiated with 0.25x polymerisation buffer. Samples were excited at 365nm, and 
emission data was measured 407nm for 1 h, at 30 s intervals.  
 
Maximum velocity of reactions (Vmax) were calculated with the formula Vmax = (A2-
A1)/(T2-T1), where A = absorbance at 407nm and T = time. Differences due to 
addition of flagella with different concentrations of cofilin-1 were assessed for 
statistical significance using a general linear model in Minitab 16. In this model, 
Vmax was the response, experiment was a confounding factor, and flagella type 
(FliCH6, FliCH7, FliCP1, FljBP2) and cofilin-1 concentration (250uM, 500uM) as 
factors. Tukey pairwise comparisons of flagella type were carried out with p-values 
of <0.05 being taken as significant. 
 
2.9.8 Actin depolymerisation assays 
Lyophilised 99% pure human platelet actin was re-suspended in G-buffer and pyrene 
conjugated-rabbit skeletal muscle was added to it at a ~1:10 dilution. 0.25x 
polymerisation buffer was added for 1 h at RT to prepare F-actin. ~5µM F-actin was 
added to wells in black opaque 96-well plates. Samples were excited at 365nm, and 
emission data was measured 407nm for 1 h at 1 min intervals. After 3 min ~1µM 
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3 : H7 Flagella binding interaction with 





















3.1 H7 flagella adherence 
As shown in the paper by Mahajan and colleagues (Mahajan et al., 2009), H7 flagella 
play a role in initial colonisation of E. coli O157:H7 at the BTR. They proposed that 
H7 flagella do this by binding to rectal epithelial cells. However, the Mahajan study 
raised many questions. For instance, what is the nature of this adhesion? What parts 
of the flagella and flagellin are involved in binding? Is it a protein-protein 
interaction, or do flagella interact with sugars or lipids? Does the binding involve 
specific or non-specific receptors? Or is this binding a more physical phenomenon, 
involving hydrophobic or physical forces? This body of work follows on directly 
from that study. An initial aim of the work was to develop, if possible, a simplified 
binding assay and use this to investigate the molecular basis of the interaction.  
 
The role of H7 flagella in initial adhesion is unlikely to be restricted to FliCH7. While 
FliCH7 is the main structural component, other proteins form extracellular parts of the 
flagella filament. The flagella hook and its adaptors are made up of 3 proteins 
(Büttner, 2012). Flagella assemble distally in a clear hierarchy, the final stage being 
the assembly of FliC into the filament, a process directed by the FliD tip pentamer 
(section 1.5.2, (Yonekura, 2000)). fliC mutants therefore still have extracellular 
flagella basal bodies, with hooks and tips. This may be one reason that the 
differences in adhesion between wild-type E. coli O157:H7 and its fliCH7 mutant 
(Mahajan et al., 2009) were subtle. Complementation of the fliCH7 mutant with fliCH6 
by Mahajan et al. did not fully restore wild-type levels of binding to bovine terminal 
rectum epithelial cells (BTRE), indicating that FliCH6 flagella has a reduced adhesive 
capacity compared to FliCH7 flagella. However, along the same lines as with the 
fliCH7 mutant, the variation with the fliCH6 complement and the fliCH7 was such that 
there was still some overlap between FliCH6 and FliCH7 flagella-associated bacterial 
binding levels. These results therefore indicate that there may be adhesins other than 







3.2 Vaccination with FliCH7 flagella 
Intra-muscular vaccination of cattle with purified FliCH7 flagella was partially 
protective against E. coli O157:H7 challenge (McNeilly et al., 2008). In this study, 
fewer cattle were colonised following oral challenge after vaccination compared to 
non-vaccinated controls. Specific FliCH7 flagella-neutralising IgA and IgG were 
thought to block initial BTRE binding of EHEC (McNeilly et al., 2008). However, in 
the vaccinated cattle that were colonised by E. coli O157:H7, total faecal shedding 
was not reduced. Instead, after an initial delay, there was a prolonged period of E. 
coli O157:H7 shedding (McNeilly et al., 2008). This partial protection was still 
shown to be the case when FliCH7 flagella were used as part of a multi-component 
recombinant vaccine (McNeilly et al., 2010a). 
 
The prolonged shedding in colonised animals was thought to be due to IgG, but not 
IgA, that recognised FliCH7 TLR5-binding epitopes, blocking TLR5 activation 
(McNeilly et al., 2010b). H7-specific IgA and IgG would block FliCH7 flagella 
binding and prevent or delay initial colonisation of E. coli O157:H7. However, if E. 
coli O157:H7 were still able to colonise cattle, H7-specific IgG could then block its 
detection by the innate immune system. This would increase the time taken for the 
bovine host to clear E. coli O157:H7 and therefore prolong bacterial shedding.  
 
FliCH7 flagella still have the potential to increase the efficacy of vaccines against E. 
coli O157:H7. This is because including FliCH7 flagella in bovine vaccines results in 
antibodies that block flagella binding. Theoretically, if a vaccine component could be 
designed that retains the ability to elicit antibodies that block FliCH7 flagella binding, 
but does not raise antibodies that also block innate immune recognition, it should be 
protective. 
 
3.3 FliDH7 adherence 
The role of FliDH7 in H7 flagella-based adhesion was not ruled out by Mahajan et al. 
in their 2009 paper. FliDH7 is likely to play a role as it is right at the tip of the flagella 
filament, and therefore has the largest ‘reach’ from the bacterial cell. FliD has been 





Scharfman & Arora, 2001) and Clostridium difficile (Tasteyre et al., 2001). Some of 
these results must be interpreted with caution though. Reduced binding by fliD 
mutant strains could either be due to their lack of FliD, or the resulting inability to 
produce fully-formed flagella filaments.  However, there is evidence in the 2009 
article by Mahajan et al. that in some cases flagella tips are adhering to the BTRE 




It is not known if FliDH7 is immunogenic in cattle. It is also unknown whether there 
is any innate recognition of FliDH7, or if vaccination with purified FliDH7 would 
(A) (B) 
(C) 
Figure 3.1. Confocal micrographs of E. coli O157:H7 adhering to a BTRE cell with the 
tips of H7 flagella after 1 h post infection. (A) E. coli O157:H7 adhering to a BTRE cell 
with the tips of H7 flagella (arrow) in 1 XY slice. (B) Flagella adherence to a BTRE cell 
via its tip (arrow) in a series of XZ slices. (C) Projection of the standard deviation of 
values in the XZ slices shown in (B) shows the tip of the H7 flagella adhering to the 
BTRE cell (arrow). Actin is stained in red (Phalloidin-TRITC) and bacteria and flagella 
are stained in green (α-O157 and α-H7 rabbit IgG, followed by α-rabbit IgG-FITC goat 
IgG). These images were constructed from the raw data, obtained by Arvind Mahajan, 





result in FliDH7-neutralising antibodies. If FliDH7 was involved in initial binding (and 
therefore E. coli O157:H7 colonisation), but not recognised by TLR5, it would be a 
promising candidate to include as part of a multi-component vaccine. 
 
3.4 Aims 
 To repeat previous observations of FliCH7 flagella interacting with the BTRE. 
 To investigate the potential role of FliDH7 in BTRE binding. 




3.5.1 H7 Flagella interactions with the BTRE 
 
Confocal microscopy was undertaken to observe the interaction of H7 flagella with 
primary cultures of BTRE first-hand. Observations at 1 h post-infection for the most 
part showed flagella adhering along the majority of the filament. Figure 3.2 shows 
two bacteria and their flagella (green) adhering to the BTRE membrane (red). This is 
an example of two of the three major types of flagella-based adherence that were 
observed. The flagellum of the bacterium shown in the YZ projection appears to be 
binding via lateral adhesion. That is to say, it is adhering along its length, flat on one 
face, with its bends occurring laterally in the XY plane. The flagellum of the 
bacterium shown in the XZ projection appears to be binding via perpendicular 
adhesion. That is to say it is adhering to the membrane at discrete points along its 
length, as its kinks occur in the XZ plane, perpendicular to the membrane (in the XY 
plane).  
 
A point to note is that in this primary epithelial culture system the wheat-germ 
agglutinin labelling is fairly non-specific, staining internal membranes as well as 
external membranes, despite the lack of permeabilisation. However, the external 





XZ and YZ stacks (arrow, figure 3.2). Flagellum staining in the XZ projection is 
partially occluded where the flagellum crosses this line. 
 
 
The third major type of flagella-based adherence is penetrative. Figure 3.3 shows the 
first z-stack in which this was captured. In this micrograph, the bacterium and its 
flagellum are stained green and actin is stained blue. The XY montage of z-slices 
starts from above the cell, where the bacterium is, and goes downwards into the cell. 
The flagellum appears to be right inside an area of actin staining, coincident in at 
least 3 z-slices. A YZ projection shows the bacterium in the edge of or outside a cell, 





Figure 3.2. Confocal micrograph projections of E. coli O157:H7 
interacting with BTRE membranes (methods 2.8). All projections are 
of maximum values, XZ and YZ projections are of areas indicated. 
Membranes are red (Wheatgerm-agglutinin-Texas Red) and bacteria 
are green (α-O157 and α-H7 rabbit IgG followed by α-rabbit IgG-
FITC). Arrow indicates concentration of membrane staining. Images 
are representative of 2 independent experiments, with 5-10 fields of 
view captured. Images were captured using a Zeiss LSM5 pascal at 
the Roslin Institute in the University of Edinburgh, and presented in 







To further investigate penetrative adherence by H7 flagella, additional samples were 
taken to Trudi Gillespie at the IMPACT facility in the Centre for Integrative 
Physiology, University of Edinburgh (figure 3.4 and 3.5, methods 2.8.4).  The impact 
facility has an upright Zeiss LSM510 confocal system coupled to a 
Titanium:Sapphire multi-photon laser, from which it is possible to get very clear 
high-resolution confocal micrographs. This is particularly important when imaging 
flagella, as they are only ~20 nm thick (Büttner, 2012). Whilst not occurring with 
every flagellated bacterium, and despite probably being a dynamic process, clear 




Figure 3.3. Confocal stack of E. coli 
O157:H7 flagella interaction with 
BTRE primary cell culture, 1 h post-
infection. The XY view is shown in a 
montage of the 6 uppermost z slices, 
top downwards. The YZ projection is 
of the complete z stack. Actin is blue 
(Phalloidin-AlexaFluor647) and 
bacteria are green (α-O157 and α-H7 
rabbit IgG followed by α-rabbit IgG-
FITC). Images are representative of 
2 independent experiments with 5-10 
fields of view captured. Images were 
captured using a Zeiss LSM pascal 
and presented in ImageJ. Scale bar 






Fluorophore-labelled phalloidin is much smaller than an antibody pair would be in 
indirect immunofluorescence, and it has a very high affinity for F-actin, so the area 
of staining is very specific (Faulstich et al., 1983, 1988).  As this staining is so 
specific and the actin cytoskeleton is only present inside eukaryotic cells, any 
coincidence of flagellum staining with actin suggests that the flagellum is inside the 











Figure 3.4. Co-incidence of E. coli O157:H7 flagella with actin in primary BTRE cells 
after 1 h. (A) A confocal z-stack with insets B (B) and C (C). Insets show an XY and 
corresponding XZ image. (D) Close up images of inset XZ images, where H7 flagella 
appear to be co-incident with actin. Actin is red (Phalloidin-Alexa Fluor 647) and bacteria 
are green (α-O157 and α-H7 rabbit IgG followed by α-rabbit IgG-FITC). Images are 
representative of 2 independent experiments with 5-10 fields of view captured. Images 
were captured using a Zeiss LSM510 at the IMPACT facility in the University of 





actin staining (insets B and C, (B)-(D)). Figure 3.4(D) shows magnified XZ 
projections of both examples where flagella appear to be inside BTRE cells. Figure 
3.5 shows what appears to be a bacterial flagellum coincident with cortical actin. 
This can be seen in montages of z-slices of the XY plane (figure 3.5(B)) or y-slices 





Figure 3.5. E. coli O157:H7 and flagella interaction with actin cortex of 
primary cell cultures from the BTRE after 1 h of infection (section 2.8). (A) 
Projection of a confocal z-stack. (B) Montage of XY z-slices, reading from 
left downwards. (C) Montage of XZ y-slices. Actin is red (Phalloidin-Alexa 
Fluor 647) and bacteria are green (α-O157 and α-H7 rabbit IgG followed 
by α-rabbit IgG-FITC). Images are representative of 2 independent 
experiments with 5-10 fields of view captured. Images were captured 
using a Zeiss LSM pascal at the IMPACT facility in the University of 






Observing H7 flagella penetrate into host cells led to a re-assessment of micrographs 
previously captured by another PhD student, Xuefang Xu (figure 3.6). Multiple 
O157+ slightly curved filaments appear to be inside actin-rich A/E lesions. Xuefang 
Xu acquired these images at 3 h post-infection of embryonic bovine lung (EBL) cells 
using a Leica DMLB widefield fluorescence microscope. Images are therefore two-
dimensional, so it is impossible to say that these filaments are definitely inside the 
A/E lesions. However, the O157 staining appears to occlude actin staining, indicating 
the filaments are where actin is expected to be.  
 
Bearing in mind host cell penetration by H7 flagella, figure 3.6 raises an interesting 
possibility. Perhaps the O157+ filaments are flagella. It is possible that the polyclonal 
O157 anti-serum is recognising another filamentous protein, such as EspA. However, 
the filaments are morphologically similar to flagella and the polyclonal O157 anti-
serum recognises FliCH7 epitopes independently of the O157 antigen (figure 3.7). 
Figure 3.7 shows α-O157 recognition of ~ 2µg denatured FliCH7 flagella purified 
from strains +/- O157 LPS and native FliCH7 flagella on E. coli O157:H7. If these 
filaments were FliCH7 flagella, this suggests that, having already penetrated host cell 


















Figure 3.6. O157+ filaments are present within A/E lesions of embryonic bovine 
lung cells. (A) Whole-widefield micrograph with merged channels of intimately 
attached E. coli O157 micro-colonies (methods 2.7.2). (B) and (C) Magnified 
images of micro-colonies indicated in (A). These images contain insets of one 
example where O157 positive filaments occlude actin pedestal staining. 
Widefield fluorescent microscopy was undertaken on E. coli O157:H7 micro-
colonies on embryonic bovine lung cells, 3 h post-infection. The O157 strain 
(TUV93-0) used was labelled with a-O157 rabbit IgG (Mast Assure) and 
AlexaFluor568-conjugated a-rabbit IgG (Sigma). Actin was stained using FITC-
conjugated phalloidin (Sigma). Images are representative of 1 experiment with 6 
6 fields of view captured but similar results have been obtained in another 2 
independent experiments by confocal microscopy. Micrographs were imaged 
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Figure 3.7. Detection of FliCH7 flagella with O157 and H7 antibodies. (A) 
Detection of flagella purified from strains +/- O157 LPS by Western-
blotting. Flagella were purified by shearing (S, methods 2.5.5) or acid 
depolymerisation (NS, methods 2.5.5) and added neat to 2x Laemmli 
sample buffer for SDS-PAGE; proteins to the right of the dashed line 
were Western-blotted. The O157- LPS (K-12) strain used was a fliC 
negative strain, JT1, containing pWSK29 (-), pWSKH6 (FliCH6, H6, 
~5µg) or pWSKH7 (FliCH7, H7, ~2µg, table 2.1 and 2.2). The O157
+ LPS 
strain used was TUV93-0. Molecular weight markers (M) are annotated 
on the left. (B) Detection of flagella on E. coli O157:H7 by 











3.5.2 Role of FliDH7 in flagella BTRE binding 
To assess the role of FliDH7 in H7 flagella binding to the BTRE, different 
components of the H7 flagella filament were cloned and purified. The fliDH7 
expression plasmid pBADFliDH7, which was used to purify recombinant His-tagged 
FliDH7, partially complemented TUVfliD
- strain (figure 3.8, methods section 2.9.2). 
This indicates that the His-tag does not interfere with FliDH7 function. Figure 3.9 
shows the flagella components that were purified. FliCH7 from sheared-off H7 
flagella (FliCH7, methods 2.5.5), recombinant His-tagged FliCH7 (FLrH71-585), its 
variable region (VrH7180-496), its amino-terminal of FliCH7 (NTrH71-179) and FliDH7, 
are all of expected size and are recognised by α-H7 or α-His anti-serum as 
appropriate. The regions of FliCH7 chosen for recombinant protein purification were 
based on a previously published scheme (McNeilly et al., 2010b), where phenotypic 
differences of FLrH71-585, VrH7180-496 or NTrH71-179 with FliCH7 may indicate 
involvement of post-translational modifications, non-H7-specific regions and H7-




































Figure 3.8. Complementation 
of TUVfliD
-
 motility with fliD
H7
. 
Plasmids indicated on the left 
were electroporated (methods 
2.3.10) into the strain 
indicated. These were stab-
inoculated into semi-solid agar 
(methods 2.9.2) + 50µg/ml 
amp and incubated at 28°C for 
24 h then imaged. Images are 
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Figure 3.9. Western-blots of purified native FliCH7, recombinant H7 fragments and 
FliDH7 (methods 2.5.3 and 2.5.6). (A) Imperial protein stained SDS-PAGE gel of 
native sheared FliCH7 (60kDa), FLrH71-585 (61kDa), VrH7180-496 (38kDa), NTrH71-179 
(20kDa) and their respective α-H7 and α-His Western-blots. (B) Coomassie 
stained SDS-PAGE gel of recombinant FliD
H7
 (48kDa) and it’s respective α-His 
Western-blot. Expected sizes are shown in brackets. 
Figure 3.10. Binding of H7 
flagellar proteins to primary 
BTRE cells. Purified FliCH7 
flagella and recombinant 
constituents were tested for 
their ability to adhere to the 
BTRE by far cell-based 
ELISAs (methods 2.9.1). 
Proteins were labelled by α-H7 
rabbit IgG (Mast Assure, for 
sheared H7 flagella) or α-His 






), then α-rabbit or 
mouse IgG-HRP respectively.  
Binding was detected by 
chemiluminescence and 








Purified flagella components were tested for their ability to bind to primary cultures 
of BTRE by far cell-based ELISA (methods 2.9.1). Figure 3.10 shows that after 
addition of 10 µg/ml of FliCH7, VrH7180-496 or FliDH7 to primary BTRE cell cultures 
for 3 hours, these proteins were all detectable above background levels (0 µg/ml, a 
negative control of media alone). However, background levels were variable, 
between and within experiments. For example, there was overlap between FliDH7 
binding and VrH7180-496 background levels. Additionally, the background levels in 
FliCH7 experiments were more than protein binding in VrH7180-496 experiments. This 
was likely due to plate to plate variation of BTRE primary cell cultures and the 
different types of antibodies used respectively.  
 
Molecular binding efficiency indices were calculated to take into account differences 
in antibody detection and normalise binding according to the molar concentration of 
protein used, as the proteins vary in size (38-60kDa). The molecular binding 
efficiency indices were 19.69 for FliCH7, 18.26 for VrH7180-496 and 16.22 for FliDH7. 
Sheared FliCH7 flagella therefore appeared to bind the BTRE more effectively than 
its recombinant constituent parts. The data shown are of two direct repeats, but many 
more very similar experiments, testing the effect of cell permeabilisation and 
peroxidase treatment on protein binding detection (methods 2.9.1), were undertaken 
with equivalent results. The specificity of this binding has not yet been demonstrated, 
as all proteins tested appeared to adhere to the BTRE cell cultures. However, these 
results suggest that sheared FliCH7 flagella, VrH7180-496 and FliDH7 are all physically 
capable of binding to primary cultures of BTRE. 
 
To see if FliDH7 is specifically involved in binding to the BTRE during E. coli 
O157:H7 colonisation, FliDH7 antiserum was raised for use in binding inhibition 
assays (section 2.5.8). Recombinant FliDH7 was used as a 3-dose vaccine by the 
Scottish National Blood Transfusion Service at the Pentlands Science Park. They 
then supplied rabbit sera taken pre-vaccination (pre-immune), one month after the 
first dose (bleed 1 or B1), the second dose (bleed 2 or B2) and the third dose (bleed 3 







These sera were validated by testing their ability to bind to linear epitopes (figure 
3.11(A)) and conformational epitopes (figure 3.11(B)) of recombinant FliDH7. Pre-
immune serum did not recognise denatured FliDH7 at a dilution of 1:100, whereas 
bleed 1 did at a dilution of 1:1000 by western blot. As bleed 1 recognised linear 
epitopes of FliDH7 adequately, it was assumed that subsequent bleeds would also do 
PI 
Figure 3.11. Validation of α-FliDH7. 
(A) Western-blots of recombinant 
FliDH7 probed with the α-rabbit IgG-
HRP (R&D) alone (No 1y), pre-
immune rabbit serum (PI) or bleed 1 
of α-FliDH7 (B1) at the titres 
indicated. (B) Indirect ELISAs of 
sera from the 3 bleeds with 
recombinant FliDH7. Representative 
wells are shown at the top; below 
this the mean density of triplicates is 
plotted. Bleed 1 values are less 
comparable as they are imaged in 
an independent experiment 


















so. At a dilution of 1:10 000, bleeds 1-3 recognised conformational FliDH7 epitopes, 
whereas pre-immune serum did not, even at a dilution of 1:100, as shown by this 
ELISA. Pre-immune serum was therefore used as a control for any effects due to 
additional serum components in FliDH7 antiserum in subsequent assays. 
 
FliDH7 anti-sera were then tested for their ability to inhibit E. coli O157:H7 motility. 
As can be seen in figure 3.12, motility of TUV93-0 after treatment with serum raised 
against recombinant FliDH7 is less than with pre-immune serum. Additionally this 
motility inhibition is probably at least equivalent to that by commercial α-H7 rabbit 
IgG (methods 2.9.2). This data suggests that serum raised against recombinant 
FliDH7 recognises native FliDH7.  
 
Figure 3.12 also suggests that bleed 1 and 3 sera may have different characteristics. 
Bleed 3 serum appears to have a greater inhibitory effect than bleed 1 serum. 
However, in combination with α-H7 antibodies, the opposite is the case. This may be 
artefactual, having restricted analysis of bleed 3 to technical replicates in the absence 
of biological replicates. However, it is in line with the generation of an adaptive 
antibody response. Bleed 3 serum is likely to contain mainly IgG, that would bind to 
FliDH7 with higher affinity than the IgG and IgM in bleed 1 serum (Estes, 1996), and 
this could explain why bleed 3 is more effective than bleed 1 alone. Yet despite the 
high proportion of lower affinity IgM in bleed 1 serum, it is more effective in 
motility inhibition in combination with α-H7 rabbit IgG than bleed 3 serum is. 
Perhaps this is because IgM has more binding sites than IgG. The higher avidity of 
IgM may allow it to cross-link monomers in pentameric FliDH7 caps. The 
combination of high affinity IgG from α-H7 antibodies with a higher proportion of 
high avidity IgM from bleed 1 serum may be more effective than just having lots of 
specific IgG, as in the case of α-H7 antibodies in combination with bleed 3 serum. 
With this in mind, bleed 3 was used for antibody inhibition studies, to make it more 








Pre-incubation of E. coli O157:H7 with FliDH7 bleed 3 serum and α-H7 antibodies 
reduced BTRE binding, when compared to pre-immune serum controls (figure 3.13). 
This reduction was not dramatic, but neither was the previously published inhibition 
by α-H7 (Mahajan et al., 2009). As α-FliDH7 bleed 1 does not recognise denatured 
FliCH7 (figure 3.14(A)), there is little reason to assume that the FliDH7 bleed 3 serum 
is not specific for FliDH7. These results from 2 independent experiments of 5 
technical replicates indicate that the antibodies which bound to FliDH7 inhibited its 
function, and this reduced E. coli O157:H7 binding to the BTRE. However, these 
Figure 3.12. FliDH7 antibody inhibition of E. coli O157:H7 motility. (A) Motility 
halos of TUV93-0 incubated with the sera indicated. Images are representative 
of triplicates. (B) Motility as a percentage of the halo radius of TUV93-0 
incubated with pre-immune rabbit serum (PI). Bleed 1 (B1) and bleed 3 (B3) 
FliDH7 sera were tested, with α-H7 as a control. TUV93-0 was stab-inoculated 
into semi-solid agar (section 2.9.2.1) containing a 1:1000 dilution of the rabbit 
sera indicated and incubated at 30°C for 22 h before imaging and radius 
measurement. 







results do not discriminate between the FliDH7 binding to the BTRE directly and 
downstream effects of FliDH7 inhibition on FliCH7 filament formation. However, as 
purified FliDH7 is capable of BTRE binding, these results do suggest that FliDH7 is 













Figure 3.13. α-FliDH7 inhibition of E. coli O157:H7 binding. Motility-
enriched (section 2.2) TUV93-0 were incubated with a 1:10 dilution of 
the anti-serum/antibodies indicated, then used to infect confluent 
primary BTRE cells for 1h at 37°C 5% CO2 85% humidity. Cells were 
washed and bacteria were labelled using α-O157 mouse IgG (AbD 
SeroTec) followed by α-mouse IgG-HRP (R&D). Binding was quantified 








Protein No 1y α-H7 1:1000 PI 1:100 α-D B1 1:5000 








































Figure 3.14. α-H7 antibodies recognise linear epitopes of FliDH7. (A) Western-blots of 
sheared FliCH7 flagella (H7) and recombinant FliDH7 (D) probed with secondary antibody 
alone (α-rabbit IgG-HRP, No 1y), α-H7 rabbit IgG (mast assure), pre-immune rabbit serum 
(PI) and α-FliD bleed 1 serum (α-D B1) at the dilutions indicated, according to methods 
2.5.3. (B) Representative wells from an indirect FliDH7 ELISA (methods 2.9.1) detected by 
α-FliDH7 bleed 1 (B1), α-H7 (mast assure), pre-immune rabbit serum (PI) and α-His 







3.5.3 Implications of FliDH7 binding on potential E. coli O157:H7 vaccine 
If FliDH7 was involved in binding to the BTRE, it would be worth investigating 
whether there is an antibody response towards it during E. coli O157:H7 challenge of 
cattle, and how current vaccine strategies affect this. For instance, does the bovine 
host normally recognise FliDH7? Does vaccination with the immuno-dominant FliCH7 
epitope skew antibody responses away from or towards a FliDH7-neutralising effect? 
Sera from a vaccine trial conducted by Tom McNeilly at Moredun Research Institute 
(McNeilly et al., 2010a) were used to start to address these questions.  
 
Sera obtained from Tom McNeilly represent two groups of seven calves from a 
larger four group trial that tested different vaccine preparations. One group of calves 
was intra-muscularly vaccinated with purified Tir, Intimin, EspA and FliCH7 flagella 
before E. coli O157:H7 experimental challenge. The other group was the study 
control group, which was not vaccinated before the same experimental challenge. 
Figure 3.15 shows Western-blots of recombinant FliDH7 that were probed with sera 
taken pre- and post-challenge or pre- and post-vaccination. IgG in these sera was 
then detected with HRP-conjugated α-bovine IgG (AbD SeroTec). Experimental 
challenge does not appear to result in FliD-specific IgG (figure 3.15(A)). However, 
vaccination with purified T3S proteins and H7 flagella does result in FliDH7-specific 
IgG (figure 3.15(B)). The same approach was applied for IgA, but H7-specific IgA 
was barely detectable despite known high H7-specific IgA titres, indicating that 
detection conditions were not optimal. 
 
To see if raising FliD-specific IgG as a consequence of FliCH7 flagella vaccination is 
species-specific, similar Western-blots were probed with H7 polyclonal rabbit 
antibodies from Mast Assure (figure 3.14(A)). This commercial α-H7 also contained 
IgG that recognised denatured recombinant FliDH7, showing that this phenomenon 
was not bovine-specific. Interestingly, this recognition was confined to denatured 
linear epitopes of FliDH7, not the native epitopes tested by ELISA (figure 3.14(B)). 
The bovine sera have not yet been tested for IgG-based FliDH7 recognition by 








Previous studies used microscopy and mutagenesis to assess the role of FliCH7 










Figure 3.15. Recognition of recombinant FliDH7 by bovine IgG from 
EHEC challenged calves. (A) Western-blots of FliDH7 (D), FliCH7 (H7) 
and BSA (B) probed with bovine serum pre- and post-challenge with 
E. coli O157:H7 and a secondary antibody control (α-bovine IgG-
HRP (company), No 1y). (B) Western-blots of FliDH7 (D), FliCH7 (H7) 
and BSA (B) probed with bovine serum pre- and post-vaccination 
with purified H7, with a secondary antibody alone control as 
previously. 
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FliDH7 in H7 flagella adhesion, microscopy is not specific enough as discussed 
below, due to the variation in adherence mechanisms. Additionally, mutagenesis 
cannot separate the specific binding capacities of FliDH7 from its regulatory and 
structural role in FliCH7 filament formation. Testing the BTRE binding inhibition of 
E. coli O157:H7 by purified flagella is also not specific enough, as the flagella 
preparations are likely to contain FliCH7, FliDH7 and other hook proteins. With this in 
mind, the BTRE binding capacity of individual flagellar components was assessed.  
 
The intention was to test the specific quantitative binding of purified flagella, 
recombinant FliDH7, FliCH7 and its different domains (VrH7180-496, NTrH71-179, 
CTrH7497-585 as published by (McNeilly et al., 2010b)) to the BTRE. VrH7180-496 does 
not contain any FliDH7 and recombinant FliDH7 does not contain any FliCH7. Binding 
of VrH7180-496 and recombinant FliDH7 would therefore confirm specific adherence of 
FliCH7 or FliDH7 respectively. The results in this chapter show that both recombinant 
FliDH7 and VrH7180-496 from H7 flagella can bind BTRE cells. Unfortunately the 
specificity of this is unknown. Based on previous data, the expectation was that 
purified FliCH7 flagella would bind, as a positive control, and the NTrH71-179 and 
CTrH7497-585 domains of FLrH71-585 would not bind, and serve as negative controls. 
However, there were setbacks in purifying FLrH71-585, NTrH71-179 and CTrH7497-585 
domains, partly due to receiving incorrect constructs. Given the time it would have 
taken to make and purify protein from correct constructs, a decision was made to 
qualitatively assess the binding capacity of the proteins already purified. However, 
the other FliCH7 domains have since been purified and could be used in further 
binding studies with more biological replicates. In any case, both FliCH7 and FliDH7 
were able to bind to the BTRE. If this is specific binding, both molecules are 
potential EHEC vaccine candidates, as neither are likely to contain TLR5 epitopes 
that hamper full protection with purified flagella. 
 
It was hoped that the specific role of FliDH7 in E. coli O157:H7 binding would 
become clearer with α-FliDH7 inhibition binding studies. Adding FliDH7 antiserum 
reduced E. coli O157:H7 BTRE binding to a level comparable with whole flagella 





an inhibition of FliCH7 filament formation, flagellar motility or FliDH7 binding. A 
combination of fluorescence microscopy and scanning electron microscopy could be 
used to resolve this. 
 
No FliDH7-specific serum IgG was detected after experimental challenge with E. coli 
O157:H7 in the animal tested. Either FliDH7 does not illicit specific antibodies or 
there may be a more local mucosal IgG or IgA response. Testing sera and mucosal 
scrapings from the BTRE by ELISA in more animals would indicate which 
alternative is the case, quantify any responses and show how common they are. 
Interestingly, vaccination with H7 flagella (predominantly FliCH7) did raise FliDH7-
specific IgG, at least in the one calf and rabbit tested. It is possible that FliDH7 was 
inadvertently present in the purified FliCH7 flagella preparations used for vaccination. 
If this was the case, and FliDH7 is involved in BTRE binding, it is already being used 
to prevent E. coli O157:H7 colonisation. This raises the question of how efficacious 
the Tir, Intimin and EspA vaccine would be with FliDH7, in the absence of FliCH7. 
 
Having looked closely at the adherence of whole flagella to BTRE primary cell 
cultures, it was apparent that broadly speaking there were three types of adherence. 
These were lateral, perpendicular and penetrative adhesion, named as such for the 
direction of flagella curving relative to the host cell membrane. The mechanisms 
involved were not apparent by simple observation. This was due to the amount of 
variation; flagella were not all adhering at their tips or penetrating like a needle into 
host cells. From this it was not any more clear which parts of the flagella are 
involved, nor whether adhesion is based on the force of the flagella motor (MotAB), 
hydrophobicity, or involves particular receptors. Additionally, it was not possible due 
to technical and time restraints to image bacterial flagella penetrating eukaryotic cell 
membranes very successfully. The gold standard for this would be transmission 
electron microscopy. However, the logistics of attempting to image sections that 
capture and dissect the length of a 20 nm thick flagella filament from bacterial 






Flagella are evolutionarily related to T3SS (Abby & Rocha, 2012) and contain a T3S 
export apparatus in the basal body to secrete flagellar components (Büttner, 2012). 
Like a T3SS, flagella have a central channel spanning the entire structure, with a cap 
at the distal end (Samatey, 2009). Also like E. coli O157:H7 T3SS needles which are 
capped by pore-forming proteins EspBD, FliCH7 flagella are capped by FliDH7. It is 
not known if FliD can be pore-forming, or whether it generically dissociates from 
FliC, as it does in entero-toxigenic E. coli (Roy et al., 2009). Additionally, secretion 
of effector proteins through flagella into culture supernatants has been demonstrated, 
at least with Campylobacter secretion of Cia proteins (Konkel et al., 2004). Taking 
this together with the penetration of H7 flagella into host cells, the idea of T3S of 
effector proteins through H7 flagella starts to gain credibility.  
 
Penetration into host cells greatly increases the number of potential flagella 
interactants. In essence, the known interface between the host and H7 flagella is 
extended by this finding. FliC and FliD could be acting as effector proteins in their 
own right, independent of the T3S translocon, potentially affecting a number of host 
cell processes and its immune recognition. If this were the case, this further justifies 
defining the H7 binding epitope for use as part of a multi-component vaccine against 
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4.1 FliCH7 BTRE-binding epitopes 
Given that H7 flagella may be playing a more complex role in adherence than previously 
thought, it’s inclusion in a multi-component vaccine against E. coli O157:H7 in cattle is 
further justified. However, vaccination with FliCH7 flagella is not always protective, due 
to the TLR5-neutralising antibodies it generates. Also, the role of FliDH7 in flagella 
binding remains unclear. Therefore a closer examination of H7 flagella-based adhesion 
was necessary to tease apart H7 flagella binding epitopes and TLR5 recognition 
epitopes. This was done by comparing FliC sequences that are unlikely to contain BTRE 
binding epitopes with FliCH7, with the hope that this would shed some light on which 
FliCH7 sequences could be required for BTRE binding.  
 
To narrow down which binding epitopes are specific to FliCH7, assumptions were made 
based on existing binding data. This binding data showed that FliCH7 protein adhered to 
BTRE primary cell cultures, the assumption being that this was specific because FliCH11 
and FliCH21 did not (Mahajan et al., 2009). fliCH6 did not fully complement wild-type 
O157:H7 BTRE cell binding in an isogenic fliCH7
- strain (Mahajan et al., 2009). 
Therefore it was assumed that FliCH6, FliCH11 and FliCH21 do not contain BTRE binding 
epitopes. In addition, FliCH48 is from a non-pathogenic, lab-adapted strain of E. coli K-
12. This strain was thought unlikely to be able to colonise the BTRE, so the FliCH48 
sequence was also included for comparative analysis.  
 
As well as variation between FliC of different serotypes, diversity within the H7 allele of 
fliC has been reported (Reid et al., 1999; Wang et al., 2000) and this was also taken into 
account. However, there was not as much sequence divergence as might be expected, 
even at a nucleotide level, considering its wide distribution across E. coli of different 
serotypes. In a study by Wang et al. (2000), there were only 1 or 2 nucleotide differences 
between the ancestral O55:H7 strains and O157:H7 strains that they sequenced. They 
reported a total variation of 0.06 to 3.12% (Wang et al., 2000). FliCH7 from ZAP198 and 






4.1.1 Structural epitopes 
Multiple protein sequence alignments do not take into account, in their making, the 
structural context of particular amino acids, nor do they provide this at the end. For 
example, insertions are less likely to occur in structurally constrained regions, such as α-
helices and β-sheets, than in flexible and disordered loops (Kelley & Sternberg, 2009). 
Amino acid substitutions are also more likely to occur in surface exposed regions 
because there is less structural constraint for side chains and with pathogen extracellular 
proteins, generally a greater selective pressure due to their interactions with the host 
immune system (Hilleman, 2002). 
 
A multiple structural alignment with the same FliC sequences was undertaken because it 
uses a structural template to impose higher gap penalties in structurally ordered regions. 
This results in an alignment that has a smaller total of larger insertions in loop regions, 
and their likely location in the protein. Currently the only solved structure of FliC is 
from S. Typhimurium (FliCP1, PDB entry 1UCU, (Yonekura et al., 2003)). Sequence 
threading of FliCH7 through the 1UCU structure was useful to see if binding epitopes 
could be mapped, or whether a specific FliCH7 structure would be needed to define 
structural epitopes. 
 
4.2 FliDH7 BTRE-binding epitopes 
As shown in the previous chapter, FliDH7 plays a role in H7 flagella-based adherence 
and specific adhesion was not ruled out. With this in mind, multiple FliD protein 
sequence alignments were carried out using the same methods, strains and reasoning as 
with FliC. Except that to date there is no solved structure for FliD, so a structural 
template sequence was not included. 
 
4.3 Post-translational epitopes 
To fully characterise the H7 flagella binding epitope, the possibility that FliCH7 is post-





post-translational modification of flagellins in Gram negative bacteria (see Logan, 2006 
for a review). Helicobacter pylori and Campylobacter jejuni flagellin subunits are 
glycosylated by chromosomally expressed glycosylation islands (Schirm et al., 2003; 







Figure 4.1. ε-methyl-lysines (orange) are located on the outside surface of FliCP1 from S. 
Typhimurium. A) Rotational views of the whole FliC monomer show ε-methyl-lysines are 
located exclusively in the D2/D3 domains. B) Top, bottom and side views of the D2/D3 domain 
show that ε-methyl-lysines are not uniformly distributed, but are located more on the bottom 
than the top and one side more than the other. C) Methylated lysines, indicated approximately 
by orange line, are only the outside of the structural assembly of the filament (developed from 
Yonekura et al. 2003). Surface models were constructed using PDB entry 1UCU in USCF 





S. Typhimurium flagellins are highly methylated by FliB (Tronick & Martinez, 1971). 
FliB specifically methylates surface exposed lysine residues on both FliCP1 and FljBP2 
D2/D3 domains (Stocker & McDonough, 1961), as shown in figure 4.1 with FliCP1. 
Methylation by FliB does not affect motility and its functional significance has not been 
determined (Burnens et al., 1997). Attempts to understand the function of flagella 
methylation were made before it was discovered that flagella can act as adhesins. E. coli 
O157:H7 has multiple horizontally-acquired genomic regions that encode proteins of 
unknown function (Perna et al., 2001), including a number of proteins with predicted 
glycosylation or methylation activity. Therefore there is the potential for post 
translational modification of FliCH7 in E. coli O157:H7.  
 
4.4 Aims  
 To compare phenotypically relevant FliC and FliD protein sequences to identify 
H7-specific regions. 
 To establish a structural context for FliCH7 specific epitopes.  
 To determine if FliCH7 undergoes post-translational modification. 
 
4.5 Results 
4.5.1 FliC variation  
A multiple sequence alignment (methods 1.4.2) of FliCH7, FliCH6, FliCH48, FliCH11, 
FliCH21 and S. Typhimurium FliCP1 showed that the amino (N) and carboxy (C) termini 
are both highly conserved, and the central region is very variable (figure 4.2 and table 
4.1). This is highlighted in table 4.1; total sequence identity and similarity of the termini 
is approximately double that of the central region. This is in line with previous 
discussion about flagellins (section 1.5.1.1 and (Hakalehto et al., 1997; Smith et al., 
2003)). Therefore, as the flagellins with different BTRE binding epitopes have highly 
conserved termini, BTRE-specific binding epitopes are most likely to be present in the 






Table 4.1. Sequence identity and similarity of FliCH6, FliCH48, FliCH11, FliCH21 and S. Typhimurium 
FliCP1 to FliCH7 using the GONNET scoring matrix. 
FliC % Identity % Similarity % Identity of 
variable region  
% Similarity of 
variable region  
H6 53.6 62.7 20.0 34.7 
H11 43.4 55.2 12.2 24.5 
H21 42.5 55.7 13.5 26.6 
H48 52.2 60.9 17.8 29.9 
P1 40.7 55.5 12.6 26.2 
 
Figure 4.2 and table 4.1 also show that FliCH6 is the most closely related sequence to 
FliCH7, followed by FliCH48. FliCH11 and FliCH21 appear to be closely related to one 
another, but distinct from FliCH6, FliCH7 and FliCH48 (figure 4.2). Because FliCH6 is 
more similar to FliCH7 while still retaining phenotypic binding differences, FliCH11 and 
FliCH21 were omitted from further alignments. FliCP1 is the least identical sequence to 
FliCH7 (table 4.1) and this trend is apparent when looking at the whole sequence or just 
the variable region.  
 
 
Figure 4.2. Multiple sequence alignment of FliC from flagella with different BTRE adherence 
phenotypes (see table 4.1 and next page). Sequences from UniprotKB, see table 2.4 for details. 
Adherent (+), not adherent (-), not tested (NT). FliCH7 (H7, +), FliCH6 (H6, +/-), FliCH48 (H48, NT), 
FliCH11 (H11, -), and FliCH21 (H21, -), with S. Typhimurium FliCP1 (P1, NT). Residues are shaded 
if >60% similar. Residues are coloured according to property (green = small/hydrophobic, red = 
acidic, turquoise = aromatic, dark blue = basic, light blue = hydroxyl/amine). Alignments were 



















































































D0  D1a  D1b  
D2a  D3  D2b  
H7 sero-specificity 
Figure 4.3. Multiple structural alignment of FliCH6 (H6), FliCH7 (H7) and FliCH48 
(H48) with S. Typhimurium SJW103 FliCP1 (P1, PDB entry 1UCU). Pairwise 
alignments were carried out using the FFAS03 server, manually collated and 
presented in BioEdit. Structural domains are coloured as indicated (see bottom 






The structural alignment of FliCH6, FliCH7 and FliCH48 with S. Typhimurium FliCP1 is 
shown in figure 4.3. Table 4.2 details the specific structural domain boundaries for each 
FliC allele, predicted by the multiple structural alignment in figure 4.3. This alignment 
predicts far fewer insertions than in figure 4.2, but the insertions are still in the central 
portion of the sequence. Figure 4.3 shows that FliCH6 has a predicted 51aa insertion in 
the D3 domain (270-321aa), and FliCH7 has a predicted 88aa insertion and FliCH48 has a 
predicted 2aa insertion, both in the carboxy-terminal D2a domain, (302-390aa and 331-
2aa respectively). The FliCH7 insertion contains an experimentally validated H7-specific 
linear epitope (Kwang et al., 1996). This insertion is structurally unique, as no structural 
templates were found when searching FFAS03 databases with this 88aa sequence. 
Figure 4.4 illustrates where FliCH6 and FliCH7 insertions are in relation to the structural 
template, FliCP1 (PDB entry 1UCU, (Yonekura et al., 2003)). This gives a clear idea of 
where H7-specific BTRE binding epitopes are likely to be in the FliCH7 monomer.  
 
 
Table 4.2. Structural domain boundaries for FliCH48, FliCH6 and FliCH7 based on the multiple 
structural alignment in figure 4.3. Boundaries are shown for N-terminal and C-terminal portions 
of structural domains. 
DOM H48 H6 H7 
N C N C N C 
D0 M1-D44 G453-G498 M1-D44 Q503-G548 M1-D44 Q540-G585 
D1a A45-T103 K406-A452 A45-T103 S456-A502 A45-T103 A493-A539 
D1b N104-K176 - N104-N176 - N104-N176 - 
D2a N177-F190 P285-G338 G177-D190 V337-V387 G177-D190 N285-K424 
D2b - A339-G405 - G389-E455 - S425-S492 







Apart from the main location in the monomer, the structural models of FliCH6 and FliCH7 
do not give any structural information about the specific insertions. These models tell us 
that the sero-specific insertions are not in the same place, and where their similarity with 
FliCP1 ends, but not their structural conformation. This information is particularly 
important if the insertions are likely to contain the binding epitopes. Therefore the 
known crystal structure for FliC is not similar enough to FliCH7 to be useful in structural 
epitope discovery and modelling.  
H6 site of 
insertion 
51aa










Figure 4.4. Structural organisation of FliC and position of predicted H6 and H7 insertion sites. 
(A) Electron cryomicroscopy structure of S. Typhimurium FliCP1 from an (PDB entry 1UCU, 
(Yonekura et al., 2003)) is coloured in UCSF Chimera according to structural domains as 
shown in figure 4.3. (B) Position of predicted H6 and H7 insertion sites in known structure for 
FliCP1 based on multiple structural alignment in figure 4.3. Amino acids either side of insertion 





4.5.3 FliD variation 
Figure 4.5. Multiple sequence alignment of FliD proteins from flagella with different BTRE 
adherence phenotypes. Sequences from UniprotKB, from strains detailed in table 2.4. 
Residues are shaded if ≥60% similar. Residues are coloured according to property as in figure 






The FliD protein sequences were more conserved than the FliC sequences from the same 
strains (table 4.1, figure 4.5 and figure 4.6(A)). As with FliC, FliD from these strains 
formed the same two distinct groups of homology, (H6 with H7 and H48, and H11 with 
H21). FliDH6 and FliDH48 share 98-99% identity with FliDH7, but FliDH11 and FliDH21 
only share ~50% identity with FliDH7, (71.5% similarity, see figure 4.6(A)). FliDH11 and 
FliDH21 are 98.9% identical and 99.8% similar with one another when using the same 
scoring matrix. Unlike with FliC, the variation between these two groups occurs along 
the whole length of the protein sequence (see figure 4.5). 
 
 
Figure 4.6(B) puts the above sequence comparisons into context with the BTRE binding 
phenotype. H7 flagella bind to BTRE epithelial cells. Both FliC and FliD from H11 and 
H21 are less than 50% identical to the corresponding H7 sequences, but neither flagella 
bind to BTRE epithelial cells. Complementation of fliCH7
- with fliCH6 leads to variably 
reduced bacterial binding compared to wild-type bacteria because these fliC sequences 
are only ~50% identical. However, in this experiment the FliD was FliDH7, not FliDH6, 
100 100 ++ 
98.5 53.6 +/- 
99.1 52.2 ? 
50.1 43.4 - 








binding (A) (B) 
Figure 4.6. Summary of FliD sequence and 
phenotype comparison. (A) Sequence identity 
and similarity of FliDH6, FliDH48, FliDH11 and 
FliDH21 to FliDH7 using the GONNET scoring 
matrix. (B) Summary of FliC and FliD 
sequence identity to FliCH7 and FliDH7 (%) and 
flagella binding phenotype. Grey boxes <75% 
identity, blue boxes >75% identity. 









resulting in chimeric flagella. If FliDH7 is involved in this binding, this might account for 
the subtlety of differences observed.  
4.5.4 Post-translational modification of FliCH7 
Investigating possible post-translational modifications of FliCH7 became a priority when 
different purification methods gave different protein band patterns by SDS-PAGE 
(figure 4.7). All purification of FliCH6 and FliCH7 flagella was carried out using isogenic 
chromosomal fliC knock-ins (TUVfliCH6F1 and TUVfliCH7F1, methods 2.3.12).  Aside 
from the proteins themselves, any low level contaminants and genetic content required 




Purification of flagella by shearing is a relatively mild method, carried out entirely in 
PBS and yields one ~58 kDa H7+ band or one ~56 kDa H6+ band by Western-blotting, 
FliCH7 or FliCH6 respectively (figure 4.7). Purification by acid depolymerisation is a 
harsher method; flagella filaments are depolymerised by reducing pH and the purified 
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Figure 4.7. Differential migration 
during SDS-PAGE by FliCH6 and 
FliCH7 purified by shearing (S) 
and acid depolymerisation (NS) 
of TUVfliCH6F1 and TUVfliCH7F1 
strains. Samples were incubated 
at 95ºC for the time indicated, 
prior to loading. Western blotting 
with specific antibodies is shown 
below. Molecular weights 
indicated on the left (M). Bands 
A, B and C were excised for 
mass spectrometry (methods 





purification resulted in faint smearing of protein bands when visualised with coomassie 
staining; as shown for 3 H7+ bands and 2 H6+ bands in figure 4.7. Both acid-
depolymerised FliCH6 and FliCH7 samples have a band with a reduced electrophoretic 
mobility by SDS-PAGE. This may be because this species has a higher apparent 
molecular weight or an altered surface charge as a result of the acid treatment. Therefore 
this differential size shift may be evidence of post-translational modification of FliC in 
an O157 strain background. 
 
On the basis that flagellin can be glycosylated (Logan, 2006), the FliCH7 sequence was 
searched for N-linked and O-linked glycosylation motifs (see figure 4.8(A)). 8/9 ≥60% 
probability glycosylation sites were in the H7-specific insertion, as determined by 
structural alignments (figure 4.3). All 5 predicted O-linked glycosylation sites were 
within the H7-sero-specificity region, which also contained a motif with 65-70% 
likelihood for N-linked glycosylation (figure 4.8(A)). 
 
Comparative analysis of the identified mass:charge peaks (m/z) from the different 
species of FliCH7 excised only showed differential cleavages by trypsin. However, 
unidentified larger masses of particular sizes can indicate the presence of a post-
translational modification. Also, unrepresented peptides in the sample coverage can be a 
result of post-translational modification preventing sample ionisation during the matrix-
assisted laser de-ionisation (MALDI) procedure, or the presence of only a larger 
(modified) peptide species. As there were no apparent unassigned larger or missing 
peptide masses unique to sample B, unassigned m/z common to all samples were 











Figure 4.8. Predicted sites of post-translational modification in the FliCH7 D2/D3 
domain. (A) % likelihood of correctly predicted N and O linked glycosylation sites in 
FliCH7 using NetNGlyc and NetOGlyc programs from expasy bioinformatics 
resource portal. (B) Potential PTMs indicated by analysis of MS peptide fragments. 
MASCOT was used to assign peptide identities for each sample; sequence 
coverage of D2/D3 domain from all samples is indicated by grey line. Total 
coverage frequency = units/5. Unassigned m/z were put through FindMod and 
GlycMod programs from expasy bioinformatics resource portal; frequency of total 
putative glycosylation, methylation and acetylation modifications are indicated by 








Figure 4.8(B) summarises this analysis of unidentified m/z and unrepresented peptides. 
Of the two N-linked glycosylation sites not ruled out by this research, the second site 
corresponds to an unrepresented region and a 60-65% probability prediction. This result 
is suggestive of glycosylation. However, glycosylation of sheared and acid-
depolymerised FliCH6 and FliCH7 in an O157:H7 background was not detected by 
sodium metaperiodate labelling (see figure 4.9).  
 
 
There were no putative post-translational modifications in the FliCH7 sero-specificity 
region (352-374, see figure 4.8(B), (Kwang et al., 1996)). However, there was an m/z 
that could correspond to methylation or acetylation of a peptide in close proximity to the 
sero-specificity region. This peptide was otherwise unrepresented in the spectra. 
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Figure 4.9. Detection of glycosylation of FliCH6 and FliCH7 with DIG-labelled sodium 
metaperiodate (methods 2.5.4). Samples were run on an 12-4% SDS-PAGE gel (left), 
western blotted onto nitrocellulose, and detected using a DIG-glycan detection kit 
(right, Roche). Creatinase from E. coli (-). Transferrin (+). Sheared flagella preparation 





at 59,823.6 Da, which is very similar to the predicted value minus the initiator 
methionine (59,822.3 Da) ruling this out under these conditions (figure 4.10). 
 
4.6 Discussion  
The principle aim of the above investigations was to gain a better understanding of what 
is specific about FliCH7 and FliDH7 that allows H7 flagella to bind to the BTRE. Both 
sets of phenotypically relevant FliC and FliD sequences showed similar groupings of 
homology. H6 and H48 sequences were most similar to H7, with H11 and H21 being 
similar to one another but distinct from H7. The areas of variation in FliC and FliD were 
different; FliD variation occurred along the full length of the protein, while FliC 
variation only took place in the central region. Therefore H7-specific FliD binding 
epitopes could be at discrete points throughout the protein sequence. However, as the 
Figure 4.10. Mass spectrum and (inset) deconvoluted mass spectrum of sheared FliCH7 from 
TUV93-0. FliCH7 was analysed by online HPLC-MS by dedicated personnel in the facilities of 
Proteomics and Metabolomics at the Roslin Institute (methods 2.5.7). The measured mass of 
59,823.6 Da is in good agreement with the theoretical mass predicted from the sequence of 


























termini are highly conserved, H7-specific FliC binding epitopes could only be in the 
central domain of the sequence.  
 
A multiple structural alignment of the H7-homologous FliC, using FliCP1 from S. 
Typhimurium as a template, predicted discrete H6- and H7-specific insertions. The H7-
specific insertion maps to the H7-sero-specificity region as determined by (Kwang et al., 
1996). This gives some confidence in the quality of the alignment and the prediction that 
302-390aa in FliCH7 contains the specific BTRE binding epitopes. However, the known 
structure of FliC or any other structures are not similar enough to FliCH7 for accurate 
structural prediction of the binding epitopes.  
 
The multiple structural alignment undertaken in this study has subsequently been used 
by the group in further Biotechnology and Biological Sciences Research Council 
(BBSRC)-funded research into uses of FliCH7 flagella as a vaccine technology. This 
work is specifically looking at the mucosal adjuvancy of FliCH7 flagella by introducing 
different antigenic epitopes into FliCH7. This alignment has been useful as a guide for 
what changes the flagellin structure might tolerate, in addition to empirical data 
reviewed by Westerlund-Wikström (Westerlund-Wikström, 2000), and for knowing 
where specific regions are for mutagenesis. 
 
To see if BTRE-specific binding epitopes in FliCH7 were post-translationally modified, 
FliCH7 was analysed using sequence and mass spectrometry. If post-translational 
modifications were to be part of a BTRE-specific binding epitope they would likely 
occur in the FliCH7-specific insertion between 302-390aa. The most likely predictions of 
glycosylation did not occur within this region and there was no experimental evidence to 
confirm them. Methylation was predicted to occur within this region but was not 
detectable by any discrepancy in molecular weight under these conditions. Perhaps this 
is because glycosylation and methylation prediction software was developed using 
eukaryotic parameters.  Differential migration of different FliCH7 preparations by SDS-





depolymerisation but not shearing. As acid-depolymerisation is a harsher method than 
shearing, this explanation is not unreasonable. Taken together, these results suggest that 
FliCH7 is not post-translationally modified under these conditions.  
 
As FliCH7 does not appear to be post-translationally modified, the type of binding 
interaction is limited to being protein-based on the FliCH7 flagella side, unless O157 LPS 
is associated with FliCH7. This simplifies BTRE binding epitope discovery and 
engineering of recombinant epitopes for use in vaccines. Having predicted a region that 
may contain specific BTRE binding epitopes, experimental validation was necessary to 
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5.1 Definition of FliCH7 binding epitopes by mutagenesis 
The overarching aim of this study is to produce an improved H7-based vaccine 
component that raises neutralising antibodies against FliCH7 flagella BTRE-binding 
epitopes but not TLR5-activation epitopes. To do this, it is useful to know the 
location of BTRE-specific binding epitopes in FliCH7. The previous chapter detailed 
the predictions made about where they might be. However, looking at the effect of 
defined fliC mutations on EHEC binding phenotypes is required to confirm these 
predictions.  
 
A cloning strategy that allows E. coli O157:H7 to express chimeric flagella at wild-
type levels would be ideal for testing defined fliCH7 mutations. This is because 
mutants complemented with fliC expression plasmids can over-express flagella. 
Flagella over-expression leads to bundling and clumping of bacteria and 
consequently altered binding. This can even be the case with low copy number 
plasmids containing the wild-type promoter region. Therefore the preferred method 
was to introduce different alleles into the fliCH7 locus. To start with, introduction of 
different fliC H-antigen types would be attempted to test and confirm the allelic 
exchange methodology (section 2.3.12). With this in mind, a fliCH7 knock-out was 
made, and used to make chromosomal complements with different fliC. 
 
The main difficulty with making a chromosomal fliCH7 complement that expresses 
flagella at wild-type levels is that the regions involved are highly conserved. The 
small changes necessary to introduce restriction sites can disrupt the mRNA structure 
and reduce fliCH7 flagella expression. Figure 5.1 shows the effect that changing 3 bp 
in the fliCH7 promoter region has had on flagella expression; flagella are short and 
bacteria are less motile, despite the fliCH7 sequence being the same in all other 
respects. However, a strategy was developed that was successful in introducing 





1). This strategy is now being used by the group to introduce more subtle changes in 
fliCH7. These strains will then be used to test key FliCH7 residues involved in binding 
and host receptor recognition, in a project funded by the BBSRC. 
 
 
Having created fliC chimeras, it was possible to directly compare the fliCH6 and 
fliCH7 binding epitopes in phenotypic assays. FliCH6 and FliCH7 specific binding 
assays published by (Erdem et al., 2007) were used as a starting point. They reported 
that FliCH6 and FliCH7 flagella filaments and monomers bind to mucin I and mucin II 
crude preparations from Sigma (not to be confused with binding to specific mucins 
MucI and MucII). FliCH7 flagella binding to mucin II was detectable by dot-blot at 
lower levels of mucin II compared to FliCH6 flagella filaments. This was not the case 
with FliCH6 and FliCH7 monomers, implying that FliCH7 flagella filaments had a 














37ºC 16hr α-H7 
Figure 5.1. Flagella expression of wild-type E. coli O157:H7 
(TUV93-0) compared to initial fliCH7 complement (TUVfliC
-
H7). This 
was assayed by motility in semi-solid agar (left, methods 2.9.2) 





was used as the basis for an ELISA, where mucin II was used to coat plates, and 
strain binding was detected using α-O157 antibodies.  
 
The results from a pilot mucin II binding α-O157 ELISA are shown in figure 5.2. 
More TUV93-0 and TUVfliCH7F binding was detected compared to TUVfliC
- and 
TUVfliCH6F. This suggests that there is a measurable difference and perhaps some 
specificity between FliCH6 and FliCH7 binding to mucin II in this ELISA. However, 
this experiment has only been attempted once, without verifying flagella expression 




There are a number of advantages to putting different functional fliC alleles into the 
same strain background. Firstly, this allows the direct comparison of the contribution 
of different fliC alleles to E. coli O157 BTRE colonisation, without over-expression 
and antibiotic issues associated with plasmid-based complementation. Secondly, it 
allows the use of whole bacteria as a binding substrate in simplified binding assays, 
as the strains are otherwise isogenic. Also, having such strains is a good source of 
different flagella that is relatively easy to purify and can be compared with the 
confidence that additional ‘contaminating’ components are similar, for example in 
TLR5 stimulation assays.  For binding assays, levels of other proteins such as FliDH7, 





Figure 5.2. Role of FliCH7 
flagella in E. coli O157 
strains binding to crude 
mucin II by ELISA 
(methods 2.9.12). TUV93-
0 is an E. coli O157:H7 
strain, TUVfliC- is its 
isogenic fliCH7 mutant. 
TUVfliCH6F and TUVfliCH7F 
are isogenic chromosomal 
fliC complements of 







required is the fliC allele coding sequence between two BamHI sites. This means that 
this system could be used for very detailed mutagenesis, and the results can be 
examined at a protein and whole bacteria level. 
 
Despite these advantages, this approach is not practical without a binding assay that 
can discriminate between FliCH6 and FliCH7 binding epitopes. Mucin II may act as a 
specific binding substrate for FliCH7 flagella, but this binding assay had its issues. 
Commercial mucin preparations are highly variable and homogenous re-suspension 
is difficult to achieve. Also, without quantifying flagella expression in the strains 
tested, no definite conclusions from binding differences could be made. 
 
A measurably clear and specific assay was needed to map FliCH7 binding epitopes. 
With this and the above issues in mind, it became clear that a change in approach 
was required. FliCH7 flagella are known to bind to the BTRE. The BTRE is therefore 
a source of potential FliCH7 receptors. Using purified FliCH7 receptors as substrates 
in binding assays would reduce the variability associated with crude preparations. 
 
5.2 Aims  
 To generate candidate FliCH7 and FliDH7 binding partners from the BTRE.  
 To confirm in vitro binding interactions of candidates with FliCH7 flagella 
and investigate how generic this is. 
 To develop a binding assay to map H7-specific BTRE-binding epitopes in 
FliCH7 and FliDH7. 
 
5.3 Results 
5.3.1 Generation of FliCH7 flagella receptor candidates from the BTRE 
To generate some candidates for BTRE FliCH7 flagella receptors, far-co-
immunoprecipitation of BTRE cell lysates with sheared FliCH7 flagella was carried 





linked to α-H7/FliCH7 compared to the same beads without FliCH7 by SDS-PAGE. 
This is probably because the antibody recognition site in FliCH7 is likely to be in the 
same region as BTRE binding epitopes. FliCH7 would therefore be unable to bind 
BTRE proteins because the binding sites would be occupied by α-H7 unless they 






To avoid this, FliCH7 flagella were instead linked to cyanogen-bromide (CnBr) 
activated sepharose beads. Cross-linking occurs at free amine groups and so cross-
linking to the beads occurs more randomly, allowing FliCH7 flagella and the binding 
epitopes to be presented in a variety of ways. In this case though, the cross-linking 




Figure 5.3. SDS-PAGE analysis of samples from co-
immunoprecipitation of α-H7 and sheared FliCH7 flagella 
with BTRE cell lysates (A/G-FliCH7, methods 2.5.2 and 
2.9.3). Pre-cleared protein A/G beads with α-H7 alone were 
used as a negative control (A/G). IgG heavy chain (IgG HC), 





specific band was detectable at high contrast after imaging the protein-stained 12% 
SDS-PAGE gel (Figure 5.4). This band was excised from the gel and analysed by 
mass-spectrometry at Moredun Research Institute. This identified the cell-lysate 




To confirm this finding, far-Western blots were carried out with purified human 
platelet actin (Cytoskeleton Inc., figure 5.5). Actin from platelets is a mixture of β 
and γ cytoskeletal isotypes, which are highly conserved between cows and humans. 
Probing Western-blots of this actin with sheared FliCH6 and FliCH7 flagella and 
recombinant FliDH7 showed that none of these bound to actin in this setting, but to 
gelsolin instead. This may be due to a binding interaction that is conformation 
  
Figure 5.4. SDS-PAGE analysis of pull-down with BTRE cell lysates 
(CL, methods 2.9.4) with sheared FliCH6 or FliCH7 flagella or 
recombinant FliDH7 linked CnBr beads. Pre-cleared empty beads were 
used as a negative control. Arrows indicate protein bands that were 
excised and the one identified as β-Actin (ACTB1) by mass 





specific, so undetectable where actin is denatured. However, it could also be because 
actin was pulled down indirectly. FliCH7 flagella could have bound an actin binding 
protein that pulled down actin with it, as indicated by the gelsolin binding. Actin is a 
large component of the cytoskeleton and would therefore be far more detectable 
because of its sheer quantity in the cell lysate.  
 
To generate more receptor candidates, far-Western blots of BTRE cell lysates were 
carried out and probed with sheared FliCH7 flagella (figure 5.6(B)) and recombinant 
FliDH7 (figure 5.6(C)). This resulted in similar non-specific binding patterns, but 
both also had a high intensity band between 17-24 kDa. As there were a lot of 
proteins at that size (figure 5.6(A)), the experiment was repeated using 20% SDS-
PAGE gels instead of 12%. This reduced the number of proteins present in one band, 
and therefore the number of potential false-positive identifications. It also gave a 
more accurate indication of molecular weight due to the higher resolution of smaller 
proteins. Figure 5.7 shows that doing this split the high intensity band into at least 2 
strong bands for FliCH7 flagella. These bands are present for FliDH7 too, but at a 
Figure 5.5. Far-Western blots of FliCH6 and FliCH7 flagella and recombinant 
FliD
H7
 (DH7) with βγ actin (Act, methods 2.5.3.1). FliCH6 and FliCH7 flagella 














were detected with α-H7, both followed by α-rabbit IgG-
HRP. FliDH7 was detected with α-His followed by α-mouse IgG-HRP. Bands 
indicated by arrows were excised and identified by peptide-mass fingerprinting 





lower intensity. Removal of N-linked sugars by PNGase-F or O-linked sugars by O-
Glycosidase appeared to make these bands more intense and sharp, particularly for 
FliDH7. This was also the case with lysates from tunicamycin treated cells (data not 
shown). Together, this indicates that FliCH7 flagella and FliDH7 are interacting with 




Figure 5.6. Far-Western blots of 
BTRE cell lysates with sheared 
FliCH7 (H7) flagella and 
recombinant FliDH7 (DH7). (A) 12% 
SDS-PAGE gel of BTRE cell 
lysates (CL) and positive controls 
(+C). (B) Far-Western blots of 
BTRE cell lysates probed with 
sheared FliC
H7
 flagella, detected 
with α-H7 (left) and without α-H7 
(right). (C) Far-Western blots of 
BTRE cell lysates probed with 
recombinant FliDH7 with α-His (left) 
and without α-His (right). See 







Figure 5.7. Far-Western blots of BTRE cell lysates (CL) using 20% SDS-PAGE gels to 
further resolve low molecular weight bands, +/- N and O-linked sugars. (A) Far-Western 
blots probed with sheared FliC
H7
 flagella (H7) with no protein and no α-H7 controls, with 
PNGase-F (PNGF, New England Biolabs) and O-Glycosidase (O-Glyc, New England 
Biolabs) treatment to remove N-linked or O-linked glycans in-situ as indicated. (B) Far-
Western blots probed with recombinant FliD
H7 
(DH7), as with (A). Indicated bands were 
excised from 2 different cell lysates and identified as ADP-ribosylation factor 1 (ADF1), 
cofilin-1(CFL1), arp2/3 complex subunit 4 (ARPC4) and galectin-4, nucleoside diphosphate 
kinase B (NDKB) by tandem mass spectrometry peptide mass fingerprinting at Moredun 





The two strongest bands in figure 5.7 (indicated by arrows) were carefully overlaid 
and identified on the SDS-PAGE gel, excised and analysed by tandem-mass 
spectrometry at Moredun Research Institute (section 2.5.7). This was done more than 
once, with at least two different cell lysates to reduce error in band excision. The 
upper band was identified as containing cofilin-1 (CFL1), ADP-ribosyltransferase 1 
(ADF1) and arp2/3 complex subunit 4 (ARPC4). The lower band contained galectin-
4 and nucleoside di-phosphate kinase B (NDKB). From these experiments a list of 
potential BTRE receptors has been generated: gelsolin, cofilin-1, ARPC4, galectin-4 
and nucleoside di-phosphate kinase B. These are all actin-binding proteins. 
 
5.3.2 Confirmation of FliCH7 flagella BTRE receptors 
 
Figure 5.8. Far-Western blots 
of purified receptor candidates 
cofilin-1 (CFL, 18.5 kDa), 
galectin-4 (GAL, 34 kDa + 1% 
BSA, 69.3 kDa), gelsolin (GSN 
85.7 kDa) and arp2/3 complex 
(Arp, bottom box) with FliCH7 
flagella (H7). These blots were 
probed with sheared FliC
H7
 
flagella and no protein and no 
α-H7 controls are shown. 
Arrows indicate positive 
bands. The possibility of a 
very weak band is indicated by 






The first step was to see if these candidates were the proteins being bound to in 
figure 5.6 and 5.7. To do this, far-Westerns with available purified proteins were 
undertaken. ADF1 was unavailable at the time and NDKB was also not purchased as 
there were many isotypes with alternative splice-forms which would have been 
impractical to test. 
 
As seen in figure 5.8, FliCH7 flagella bound to recombinant human cofilin-1 and 
recombinant human galectin-4. There may be a very faint band for ARPC4, but it 
was not included in further tests in the light of more promising candidates. FliDH7 
was not shown to bind to any of these purified candidates by far-Western blot (figure 
5.9). This indicates that FliDH7 binding in figure 5.7 was non-specific.  
 
Figure 5.10 shows Western-blots confirming the presence of cofilin-1 at ~18 kDa 
and galectin-4 at ~17 kDa in the cell lysates. This is important as the full-length 
galectin-4 is 36 kDa, but it was detected at ~17 kDa, probably due to degradation 
during lysate preparation or storage. Galectin-4 was first discovered as a 17 kDa C-
terminal fragment in rat intestine extracts (Leffler et al., 1989), the N-terminal 
having been lost by degradation due to sample handling. It is therefore likely that 
Figure 5.9. Far-Western blots of purified receptor candidates cofilin-1 (CFL, 18.5 kDa), 










FliCH7 flagella bound cofilin-1 in the upper band and galectin-4 in the lower band in 





Pull-downs and ELISAs were carried out with purified cofilin-1 and galectin-4 to see 
if their interaction with FliCH7 flagella was genuine. Actin was used as a negative 
control. The cross-linking efficiencies of purified candidate proteins to the CnBr-
Figure 5.10. Western-blots of 
BTRE cell lysates (CL) to 
confirm the presence of cofilin-1 
with α-cofilin-1 (α-CFL) and 
galectin-4 with α-galectin-4 (α-
GAL, arrows). 





) with cofilin-1 (CFL), βγ-Actin (ACT) and galectin-4 (GAL) 
linked CnBr beads.  Empty beads and actin-linked beads were used as 
negative controls. Coating efficiency of the candidate receptors with the 






activated sepharose beads were variable (figure 5.11, lower panel), with actin most 
efficient and detectable by protein staining, and cofilin-1 barely detectable by 
Western-blot with specific antibodies. Galectin-4 was not detectable by protein 
staining, but was easily detectable as 2 species by Western-blot (36 kDa, and 17 kDa 
shown). However, even with cofilin-1 barely detectable on the beads, the amount of 
FliCH7 flagella and FliDH7 that was recovered is quite remarkable. This is particularly 
the case as FliDH7 did not appear to bind to denatured cofilin-1. As this experiment 
was not quantitative, ELISAs were performed to better test the binding interactions 
of these proteins with one another. 
 
ELISAs confirmed that FliCH7 flagella specifically bind to cofilin-1. FliCH7 flagella 
bound to galectin-4 at lower levels and bound to actin at much lower levels still 
(figure 5.12(A)). FliDH7 also bound to cofilin-1, at seemingly lower levels, and 
galectin-4 comparably, but not at all to actin (figure 5.12(C)). This indicates that 
FliDH7 interacts with native cofilin-1 and galectin-4.  
 
It is difficult to make precise quantitative comparisons between flagella proteins 
tested given that different antibody pairings were used. Data were normalised to the 
positive and negative detection controls (methods 2.9.1). Quantification by 
densitometry is not so accurate that the discrepancies still present after normalisation 
would make much difference to the analysis. With this caveat in mind though, 
statistical analysis was only carried out between candidate proteins binding to the 
same flagella protein, and all other comparisons are qualitative. 
 
Flagella from other entero-pathogenic bacteria were tested, to see how generic these 
binding interactions might be, or whether they were FliCH7 flagella-specific. FliCH6 
flagella from entero-pathogenic E. coli O126:H6 also bound to cofilin-1, very 
slightly to actin and not at all to galectin-4 (figure 5.12(B)). Interestingly, phase-1 





Typhimurium both bound at low levels to cofilin-1 and galectin-4, but very highly to 
actin, showing the opposite phenotype to the E. coli flagella proteins tested. 
 
Looking at the coat only controls in figure 5.12, where no receptor candidate was 
coated to the well, a certain amount of background binding is apparent with FliCH7, 
FliCP1 and FljBP2 flagella. This is despite using Carbo-free blocking (VectorLabs, 
methods 2.5.3) and stringent conditions (0.1% Tween-20). However, binding is dose-
dependent, and some receptors show very efficient blocking of binding, for example, 
cofilin-1 for FliCP1 flagella binding. Also, FliCH7 flagella and FliDH7 binding to 
cofilin-1 correlates with results from other assays.  
Figure 5.12. Far-ELISAs of flagella proteins from enteropathogenic bacteria binding to 
FliCH7-BTRE receptor candidates (methods 2.9.1.4). Actin (ACT), cofilin-1 (CFL) and 













 from S. Typhimurium 
SL1344∆fljB and (E) FljB
P2 
from S. Typhimurium SL1344∆fliC. Flagellins were purified as 
sheared flagella. Left panels show a representative example of an ELISA, with detection 
controls of the probe coated to the plate, with primary antibody (+) and without (-). Right 
panels show the final results. Statistical analysis involved pairwise comparisons with actin; 










5.4 Discussion  
The expectation was that FliCH7 flagella receptors from the BTRE would be 
extracellular, yet initial results identified predominantly intracellular receptor 
candidates. Only galectin-4 is extracellular, and only for some of the time, when it is 
secreted out of cells and associated with membrane-bound proteins (Leffler et al., 
1989). These initial results were quite subtle and may have been discounted as 
artefactual were it not for previous observations of flagella penetration into host cells 
(figure 3.3-3.6). For instance, the lack of extracellular proteins may have related to 
the method cell lysate preparation by freeze-thaw cycles (methods 2.6.3).  
 
Using freeze-thaw cycles to extract cellular proteins may have depleted membrane 
proteins from cell lysates. This is because after five freeze-thaw cycles, cell 
membranes from the lysates were removed by centrifugation. However, cell lysis is 
likely to cause some dissociation of membrane proteins before fractionation. 
Therefore membrane proteins may still be present, but in reduced amounts. Recovery 
of surface-associated proteins that are not membrane-anchored, such as galectin-4, 
should not be affected by this method of cell lysis. It is unknown but the cofilin-1 
detected by far-Western could initially have been associated with the cytosolic leaflet 
of the cell membrane via a phosphatidylinositol 4,5-bisphosphate anchor (Zhan et al., 
2003). 
 
Confidence was gained in the initial results by the fact that under the conditions 
tested, all FliCH7 flagella candidate receptors were actin-binding proteins. Not only 
that, but they appear to be proteins that skew the actin dynamics towards 
lamellipodia and filopodia formation (figure 5.13). This is intriguing, given that E. 
coli O157:H7 are already known to alter actin dynamics in this way to create actin 
pedestals. These results were also reinforced by the ELISA data. These experiments 
not only validated candidate binding interactions, but showed that this type of 
interaction was more generic. Flagella were shown to bind to eukaryotic cytoskeletal 









FliCH7 flagella binding to cofilin-1 and galectin-4 was shown by far-Western, pull-
down and ELISA (figure 5.8, 5.11 and 5.12 respectively). FliDH7 binding to cofilin-1 
and galectin-4 was shown by pull-down and ELISA, but was negative by far-Western 
(figure 5.11, 5.12 and 5.9). This confirmed that FliDH7 binding to initial far-Western 
blots of BTRE cell lysates (figure 5.6) was non-specific. Perhaps FliDH7 only binds 
conformational epitopes that were not present on a Western-blot. The actin binding 
phenotype of FliCH7 flagella and FliDH7 was less clear. FliCH7 flagella were shown to 
bind to actin by ELISA, but probably not by pull-down, whereas FliDH7 was shown 
Figure 5.13. Regulation of actin dynamics by actin-binding receptor candidates. 
Receptor candidates are highlighted in red on an actin dynamics regulation 





to bind to actin by pull-down, but this was not confirmed by ELISA. Candidate 
protein coating levels in the ELISAs were much more consistent than cross-linking 
efficiencies were for pull-downs and therefore more easily comparable. As actin was 
very efficiently cross-linked to the beads, a positive result with FliDH7 by pull-down, 
where it is negative by ELISA, may simply indicate non-specific binding to a highly 
abundant protein.  
 
FliCH6 flagella had a very similar binding phenotype to FliCH7 flagella by ELISA, 
though more experiments are warranted to confirm this. The only difference between 
FliCH6 and FliCH7 flagella binding by ELISA was that FliCH6 flagella did not bind to 
galectin-4. This indicates, unsurprisingly, as cofilin-1 is ubiquitously expressed 
(Vartiainen et al., 2002), that cofilin-1 is not the BTRE-specific receptor for FliCH7 
flagella. Unless galectin-4 is the BTRE-specific receptor in this case, this binding 
assay cannot be used for BTRE-specific epitope mapping of FliCH7. More work is 
necessary to see if galectin-4 is the BTRE-specific receptor for FliCH7 flagella. 
 
Flagella from S. Typhimurium were also tested for their ability to bind actin, cofilin-
1 and galectin-4, to see how generic these binding interactions might be. These 
flagella were also able to bind to these intracellular proteins. However, they did have 
a different binding phenotype compared to FliCH7 and FliCH6 flagella from E. coli. 
Salmonella flagella were able to bind actin directly, at higher levels than cofilin-1 or 
galectin-4. This finding lead colleagues Johanna Elvidge and Amin Tahoun to 
observe by confocal microscopy the coincidence of FliCP1 and FljBP2 flagella with 
cytoskeletal actin in human, porcine and bovine epithelial cells. Salmonella flagella 
bind directly to actin, while E. coli flagella appear to bind to an actin-binding protein 
more than to actin. This is particularly interesting, given the different lifestyles of 
invading S. Typhimurium and attaching and effacing E. coli. Further biochemical 
and phenotypic tests are needed to confirm these binding interactions, but a theme 







The work detailed in this chapter has confirmed FliCH7 flagella binding to some 
candidates in defined conditions, but has not ruled out binding interactions with the 
other candidates in different conditions. That aside, FliCH7 flagella are able to 
interact with cofilin-1 and this protein is intracellular. FliCH7 flagella have been 
observed inside host cells, in areas coincident with BTRE cell actin (chapter 3), have 
pulled down actin from BTRE cell lysates (figure 5.4) and don’t seem to bind to 
cytoplasmic actin as well as cofilin-1 (figure 5.12). Taken together, this indicates that 
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The type of proteins found to bind to flagella in the previous chapter was intriguing, 
and raises a number of questions. This is because the eukaryotic cytoskeleton is such 
a complex, responsive and highly regulated system that it is hard to imagine bacterial 
flagella binding to its components without affecting its homeostasis in some way. So, 
what sort of effects could the penetrating flagella be having on the cytoskeleton? 
Perhaps cytoskeletal proteins have an effect on the bacterial flagella. It is possible 
that either could be beneficial to bacterial colonisation or host innate pathogen 
recognition. 
 
6.1 Effect of cofilin-1 on FliCH7 flagella 
FliCH7 flagella bind to cofilin-1. However, it is not known how this occurs. Both 
FliCH7 flagella and FliDH7 were able to bind to cofilin-1, so it is likely that both are 
involved. It is possible that FliCH7 is more involved than FliDH7, as it is present in 
higher quantities. Also, unlike FliCH7 flagella filaments, FliDH7 did not bind to linear 
epitopes of cofilin-1. Sheared flagella preparations are a mixture of filaments, with 
and without FliD caps, and FliC monomers. It may be that the repeating epitopes of 
an intact FliCH7 flagella filament were required to detect cofilin-1 binding, but it is 
also possible that the binding being detected was just FliCH7 monomer. 
 
Perhaps cofilin-1 is interacting with FliCH7 flagella as it would interact with actin. 
Like actin, FliCH7 flagella are filamentous. Cofilin-1 can bind, depolymerise and 
sever actin filaments (Bobkov et al., 2006). It can also bind actin monomers 
(Andrianantoandro & Pollard, 2006). It may be that cofilin-1 binds to FliCH7 flagella 
filaments, affects their stability and consequently the amount of FliCH7 monomer. 
This is particularly relevant, as FliC monomers are detected by flagella pattern 
recognition receptors with a much greater sensitivity than FliC filaments (Andersen-
Nissen et al., 2007). Or cofilin-1 could be binding directly to FliCH7 monomers, 







6.2 Effect of FliCH7 flagella on the actin cytoskeleton 
By interacting with cofilin-1, FliCH7 flagella may be indirectly affecting actin 
dynamics. This could be passively, simply by reducing the amount of locally 
available cofilin-1 to interact with actin by sequestration. However, FliCH7 flagella 
could play a more active role, by making cofilin-1 more readily available to interact 
with actin, as a scaffold protein might. It is difficult to predict what effects either of 
these modes of action would have on actin dynamics, as the role of cofilin-1 varies 
depending on its stoichiometry with actin (Andrianantoandro & Pollard, 2006). At 
equimolar ratios, cofilin-1 binds and stabilises actin filaments. When there is more 
actin than cofilin-1, cofilin-1 severs filaments, creating more faster-growing (+) ends, 
with a net result of actin polymerisation or depolymerisation, depending on the 
complement of other host factors (Van Troys et al., 2008). When there is more 
cofilin-1 than actin, cofilin-1 coats actin filaments and nucleates monomeric actin; 
the net result is actin polymerisation (Andrianantoandro & Pollard, 2006). Of course, 
FliCH7 flagella may interact with actin directly as suggested by ELISAs in the 
previous chapter. This could also potentially alter actin dynamics. 
 
Results from the previous chapter indicate that other flagella may be able to interact 
with cytoskeletal proteins. The same questions about actin dynamics that have been 
posed about FliCH7 flagella interactions with cofilin-1 and actin are also applicable to 
FliCH6 flagella and Salmonella FliCP1 and FljBP2 flagella. In trying to answer these 
questions, it will be possible to confirm whether these flagella bind actin and cofilin-
1 or not.  
 
6.3 Aims  
 To see whether cofilin-1 binds to FliCH7 monomers or flagella filaments. 
 To see if cofilin-1 affects FliCH7 flagella filament stability. 
 To see if FliCH7 flagella and other types of flagella can affect actin dynamics 







6.4.1 Characterisation of cofilin-1 binding to FliCH7 flagella and flagellin 
To see which component of FliCH7 flagella cofilin-1 binds to, sheared FliCH7 flagella 
preparations needed to be separated into filament and monomer fractions. Whole 
flagella filaments are bigger than flagellin monomers, so ultra-centrifugation was 
used to pellet FliCH7 flagella filaments, while FliCH7 monomers were retained in the 
supernatant. Cofilin-1 is smaller than FliCH7 (18 kDa < 60 kDa); at the centrifugal 
force used and in the absence of any other proteins, it remains in the supernatant. 
This is an ideal basis for co-sedimentation studies; if the smaller protein binds the 
larger protein complex, it would be recovered in the pellet fraction.  
 
The activity of cofilin-1 is very pH dependent; at pH 6.8 cofilin-1 primarily exhibits 
actin binding activity, whereas at pH 8.0 cofilin-1 mainly severs actin (Pavlov & 
Muhlrad, 2006). However, incubation of equimolar concentrations of cofilin-1 and 
FliCH7 flagella preparations at either pH 6.8 or pH 8.0 did not alter the sedimentation 
of cofilin-1 (figure 6.1, left lower panel). It was instead apparent that cofilin-1 altered 
the sedimentation properties of FliCH7 flagella, so that more was present in 









To see if the cofilin-1 would have the same effect on native FliCH7 flagella, co-
sedimentation of cofilin-1 was undertaken with live E. coli O157:H7 (figure 6.2). 
Again, no cofilin-1 was detected in pellet fractions. In all but one of these 
experiments, addition of cofilin-1 resulted in a reduction in bacteria-associated 
flagella. This is particularly apparent at pH 8.0, the pH that enhances cofilin-1 
severing of actin (Bernstein et al., 2000). Perhaps cofilin-1 is severing FliCH7 
flagella. This is in-line with the results from figure 6.1, which also show an increase 
in supernatant FliCH7. These results rule out a high affinity interaction of cofilin-1 
with FliCH7 flagella filaments, as there was no co-sedimentation. However, they do 
Figure 6.1. Effect of cofilin-1 on FliCH7 flagella by co-sedimentation assay 
(methods 2.9.5). Equimolar amounts of FliCH7 flagella (H7) and cofilin-1 
(CFL) were incubated and ultra-centrifuged. Equivalent amounts of 
resulting supernatants (S) and pellets (P) were analysed by 12% SDS-
PAGE and densitometry. The lower panel shows the cofilin-1 bands on 
the left (18kDa) and the FliCH7 bands on the right (60kDa) in an SDS-
PAGE gel that were analysed for the experiment directly above it. FliCH7 
recovery in each fraction is represented as a % of total FliCH7 in the 
specific reactions. The vertical solid line separates reactions which are 
independent experiments – the dashed line separates reactions which 





indicate that cofilin-1 may affect the stability of FliCH7 flagella filaments, either by 






Figure 6.2. Effect of cofilin-1 on bacteria-associated FliCH7 flagella. E. coli 




) were incubated with cofilin-1 (CFL) and 
pelleted by centrifugation (methods 2.9.5). Equivalent supernatant (S) and pellet 
(P) fractions were analysed by Western-blotting (lower panels) and then 
densitometry (upper panel). TUV93-0 cultures with cofilin-1 added but not 
centrifuged were used as a positive control (+) for western blots. FliCH7 (H7) 
recovery was expressed as a percentage of total FliCH7 from TUV93-0 detected 
by α-H7 in each experiment. In the top panel, the vertical solid line separates 
reactions which are independent experiments – the dashed lines separate 





6.4.2 Effect of cofilin-1 on FliCH7 flagella 
Figure 6.3. Cumulative effect of cofilin-1 on FliCH7 flagella at pH 8.0 by size exclusion 
chromatography (methods 2.9.6). (A) Elution profiles of FliCH7 flagella (upper panel) 
and cofilin-1 (CFL, lower panel) size-exclusion chromatography separate test-runs 
during buffer optimisation. 1 ml elution fractions were collected and analysed by 12% 
SDS-PAGE and silver staining (methods 2.5.2). Sample run (S). (B) Size-exclusion 
traces of 3 molar ratios of FliCH7 (H7) to cofilin-1 (CFL) as indicated. Traces represent 
the mean of 10 tests. These traces were normalised to each other at the column void 
volume (4.5 ml) and then the lowest absorbance value was used as a baseline of 0. 
(C) Boxplot of the % area under curve (AUC) of large and small FliCH7 filaments and 






Size-exclusion chromatography separates proteins by size; the time it takes proteins 
to run through a column matrix is related to the inverse of their size. This method 
was carried out in an attempt to clarify how cofilin-1 was interacting with FliCH7 
flagella filaments and monomers. However, 200mM NaCl was required to run 
cofilin-1 through the column without it binding to the resin (methods 2.9.6). Co-
elution of cofilin-1 with FliCH7 was not detected by silver staining of SDS-PAGE 
gels. This is probably because the high salt concentration inhibited interactions 
between FliCH7 and cofilin-1 in the column and therefore co-elution.  
 
Without this clear indicator of which H7 component cofilin-1 was interacting with, 
the FliCH7 elution profile was instead analysed to see how cofilin-1 was affecting 
FliCH7 flagella stability (figure 6.3). Figure 6.3(A) shows the size exclusion profiles 
of FliCH7 and Cofilin-1 when run alone through a 15 ml column (methods 2.9.6). 
FliCH7 elutes at 5-7 ml and 8-9 ml. It is likely that the first elution fractions are 
FliCH7 flagella filaments, while the second lot are FliCH7 monomers. Cofilin-1 elutes 
mainly at 13 ml.  
 
Figure 6.3(B) shows the mean of ten A220 nm traces of FliCH7 flagella incubated with 
cofilin-1 at 1:0, 1:1 and 1:4 molar ratios. The first two peaks in the 1:0 trace agree 
with previous FliCH7 flagella elution profiles, showing that these peaks correspond to 
FliCH7. The elution of cofilin-1 is likely to correspond to the peak at 12.5 ml, but it is 
difficult to confirm this due to the sensitivity of absorbance at 220nm for buffer salts, 
which also appear to be eluting at that point (figure 2.5). 
 
If cofilin-1 was severing FliCH7 filaments, as indicated by figure 6.1 and 6.2, a 
reduction in the area of the FliCH7 filament peak when cofilin-1 was added would be 
observed. However, this was not the case. If anything, cofilin-1 seemed to cause 
more of the filament peak to elute a little earlier and have less of a tail. Qualitatively, 
cofilin-1 seemed to cause a subtle trend towards filament stabilisation. Figure 6.3(C) 
shows this data divided into large filaments, small filaments and monomers, and 





was a trend for the largest filaments to increase in % AUC, and the smallest 
filaments and monomers to decrease in % AUC with increasing amounts of cofilin-1. 
According to Kruskal-Wallis analyses, these trends caused by cofilin-1 were not 
statistically significant for large filaments or monomers (df=2, h=3.68, p=0.16 and 
df=2, h=4.68, p=0.10 respectively) but were for smaller filaments (df=2, h=6.36, 
p=0.04). 
 
The ten column runs of each molar ratio were measured in series, directly after 
cofilin-1 was added to FliCH7 flagella in each case. As such, these experiments can 
be considered as time courses, measured at 30 minute intervals. Figure 6.4 shows the 
same data from figure 6.3(C), over time. Without cofilin-1, the state of FliCH7 
flagella appears to oscillate slightly between 50% large filaments/30% monomers, 
and 60-70% large filaments/10-20% monomers (figure 6.4(A)). This cycle appears to 
take approximately 90 minutes. When cofilin-1 is added 1:1, this pattern becomes 
extended, taking 150 minutes, with generally less monomer present (figure 6.4(B)). 
The pattern is most marked however, at a 1:4 molar ratio (figure 6.4(C)). FliCH7 
filaments and monomers oscillate over the same period of 90 minutes, but from 50% 
large filaments/20% monomer to nearly 100% large filaments/0% monomer. This 
cycle appears to reduce over time, which maybe suggestive of an oscillation towards 
equilibrium. The experiments would have to be repeated to ensure this was the case, 
but the 1:4 ratio results do suggest that cofilin-1 affects the steady-state equilibrium 

















Figure 6.4. Effect of cofilin-1 (CFL) on FliCH7 flagella (H7) 
over time by size exclusion chromatography (methods 2.9.6). 
Samples in figure 6.3(C) were run in series, every 30 minutes 
so the % total AUC from the 3 molar ratios (A) H7 1:0 CFL, 











FliCH7 flagella may be able to affect actin dynamics through its interaction with 
cofilin-1. Cofilin-1 is primarily known for its depolymerising and severing action 
upon actin. Actin depolymerisation assays were therefore carried out to test this 
hypothesis. Figure 6.5(A) shows an average graph of 2 independent experiments with 
Figure 6.5. Effect of FliCH7 flagella on actin depolymerisation +/- cofilin-1 
(methods 2.9.8). (A) Change in pyrene-fluorescence over time of just G-
buffer (G), pyrene-rabbit muscle F-actin 1:5 human platelet F-actin (Actin, 
~5uM), with cofilin-1 added (CFL, ~0.5uM) or FliCH7 flagella (H7, ~1uM) 
or both (CFL+H7). (B) Maximum velocity of actin depolymerisation (Vmax, 





3 technical replicates. Addition of FliCH7 flagella to F-actin or F-actin with cofilin-1 
appeared to have little or no effect. To ensure FliCH7 flagella were not reducing the 
initial velocity of cofilin-1 depolymerisation, maximum velocities (Vmax) for each 
replicate were analysed (figure 6.5(B), methods 2.9.7.3). The more negative the Vmax 
value, the higher the velocity of depolymerisation. Though more work is needed to 
verify this, there were no obvious differences in rate between adding and not adding 
FliCH7 flagella to F-actin or F-actin with cofilin-1. 
 
Cofilin-1 severing of actin filaments can also enhance the rate of actin 
polymerisation in sub-optimal polymerisation conditions, by increasing the number 
of faster-growing (+) ends (Frantz et al., 2008). With this in mind, FliCH7 flagella 
might affect the polymerisation function of cofilin-1 on actin. However, to 
investigate this it was necessary to look at the effect of FliCH7 flagella on actin 
polymerisation rate by itself. In doing this, it was sensible to compare FliCH7 flagella 
with FliCH6, FliCP1 and FljBP2 flagella to see how generic any effects might be. This 
has the added benefit of validating previous actin binding results in the previous 
chapter. 
 
FliCH6, FliCH7, FliCP1 and FljBP2 flagella all appear to increase the rate of actin 
polymerisation.  Figure 6.6 shows one example of this with different concentrations 
of flagella. Qualitatively, FljBP2 flagella appear to be most effective at this, followed 
by FliCP1 flagella, FliCH7 flagella then FliCH6 flagella. This is seems to be dose-
dependent, apart from with FliCH6, where the effect on actin polymerisation rate may 
be limited. To assess these effects more directly, the Vmax of experiments were 
analysed (figure 6.7). FliCH7, FliCP1 and FljBP2 flagella had equivalent effects on 
actin polymerisation rates, and FliCH6 had less of an effect. These experiments would 
have to be repeated a number of times to see if there are any differences in actin 







Figure 6.6. Titration of sheared FliCH6 (H6), FliCH7 (H7), FliCP1 (P1) and FljBP2 (P2) flagella 
effects on actin polymerisation (methods 2.9.7). Serial dilutions of flagella (red) or Cofilin-1 
positive control (CFL, blue) were added to 1 µM pyrene-conjugated rabbit skeletal actin 
(Cytoskeleton Inc., black), polymerisation buffer was added, and fluorescence was 
measured every 30s for 1h. Polymerisation buffer was not added to Actin -C (grey). Data 
were normalised for the polymerisation ability of the G-actin preparation as it was 







   
A separate set of experiments were used to investigate whether interactions between 
flagella and cofilin-1 affect their individual effects on actin polymerisation (figure 
6.8). Adding sub-optimal doses of sheared FliCH6 (df=4, t=5.15, p=0.004), FliCH7 
(df=4, t=7.82, p=0.0002), FliCP1 (df=4, t=9.90, p<0.0001) or FljBP2 (df=4, t=10.84, 
p<0.0001) flagella to G-actin still resulted in a Vmax significantly different from that 
of G-actin alone (0µM). This confirms results from figure 6.7.  
 
Figure 6.7. Effect of sheared FliCH6 (H6), FliCH7 (H7), FliCP1 (P1) and FljBP2 (P2) flagella 
titration on maximum velocity (Vmax) of actin polymerisation. Molar concentrations used are 
indicated. Data is representative of 2 polymerisation experiments (methods 2.9.7). The 
differences between experiments can be explained by the 75% and 90% gains, applied in 
error. Controls (C) include cofilin-1 (CFL) as a positive control and actin with polymerisation 












It is unclear whether increases in rate of actin polymerisation with cofilin-1 and 
FliCP1 or FljBP2 flagella were additive, due to the independent effects of flagella and 
cofilin-1 on actin, or synergistic, due to the effect of flagella-cofilin-1 complexes on 
actin. At a sub-optimal dose of cofilin-1 (250µM), addition of sheared FliCH6, FliCP1 
or FljBP2 flagella, but not FliCH7 flagella, caused a significant increase in Vmax 
compared to cofilin-1 alone. This may be due to experimental variation, but it is also 
possible that cofilin-1 is less effective with FliCH7 flagella at increasing the rate of 
actin polymerisation than it is with other flagella. Perhaps it is their interaction with 
one another that causes this. FliCH6 flagella were also shown by ELISA to bind to 
Figure 6.8. Effect of flagella on actin polymerisation +/- cofilin-1 (CFL). Sub-
optimal concentrations of sheared FliCH6 (H6), FliCH7 (H7), FliCP1 (P1) and 
FljBP2 (P2) flagella (250uM) were tested at 1:0 (0), 1:1 (250) and 1:2 (500) 
molar ratios of cofilin-1 (CFL) according to methods 2.9.7. Error bars 
represent 95% confidence intervals (n=3). Statistical analysis was carried out 
using GLM Tukey pairwise comparisons where p<0.05(*), p <0.001(**) and 
p<0.0001(***). Pairwise comparisons were with actin with polymerisation 
buffer (Actin, *) or cofilin-1 only (CFL only, *). Actin with no polymerisation 





cofilin-1 and actin at roughly equivalent levels to FliCH7 flagella. However, in 
combination with cofilin-1 and actin, FliCH6 flagella did not show the same effect as 
FliCH7 flagella. If anything, addition of cofilin-1 has made the effects of FliCH6 
flagella on actin polymerisation, which alone were fairly limited, more equivalent to 
FliCP1 or FliCP2 flagella under the same conditions.  
 
6.5 Discussion 
The aims of this chapter were to establish whether cofilin-1 binds to FliCH7 flagella 
filaments or monomers, what sort of effect this has on FliCH7 flagella and whether 
FliCH7 flagella affect cofilin-1 function in actin dynamics. It was also to see if FliCH6, 
FliCH7, FliCP1 and FljBP2 flagella alone could affect actin dynamics and in doing so, 
confirm any actin binding interactions. 
 
Co-sedimentation studies showed no clear or direct evidence that cofilin-1 binds to 
FliCH7 filaments. To be unable to detect cofilin-1 in pellets even by Western-blotting, 
any interaction with FliCH7 filaments would have to be transient. However, the 
proportion of FliCH7 that was retained in the supernatant was increased when cofilin-
1 was present. So rather than FliCH7 flagella influencing cofilin-1 sedimentation, 
cofilin-1 was influencing FliCH7 flagella sedimentation. Assuming that ultra-
centrifugation separates flagella into filaments in the pellet and monomers in the 
supernatant, cofilin-1 is either interacting transiently with FliCH7 filaments and 
depolymerising them, or binding to monomers in such a way that affects their 
incorporation into filaments.  
 
The assumption of this co-sedimentation assay is that ultra-centrifugation separates 
FliCH7 flagella preparations into filaments and monomers. However, under these 
conditions this has not been tested. This is a limitation of this assay; it may be that 
only larger FliCH7 filaments are being pelleted, in which case all that can be 
concluded is that cofilin-1 does not interact detectably with large FliCH7 filaments. 
Co-sedimentation of cofilin-1 with FliCH7 flagella-expressing E. coli O157:H7 was 
carried out in an attempt to resolve this issue. In this system, flagella are separated 





associating with it, cofilin-1 somehow reduced the amount of bacteria-associated 
FliCH7 flagella. As this is consistent with the co-sedimentation studies undertaken 
with purified flagella, this is likely to be FliCH7-dependent. 
 
Size-exclusion data also indicates that interaction with cofilin-1 affects FliCH7 
filament stability. However, the data can be interpreted differently, depending on 
whether total or temporal effects are examined. In contrast to co-sedimentation 
assays, the overall effect of cofilin-1 indicates a trend towards filament stability that 
is not statistically significant, apart from the effects on smaller filaments. However, 
looked at over time, this data indicates an increase in FliCH7 flagella polymerisation 
and depolymerisation dynamics. If this were the case, this is more in-line with results 
from co-sedimentation assays, suggesting that cofilin-1 alters the dynamic 
equilibrium of FliCH7 flagella filaments by binding to FliCH7 monomers. This effect 
is likely to be most visible on smaller filaments, as changes in total length are 
proportionally larger, which was the case in these experiments. 
 
Fluorescence microscopy could also be used to examine whether cofilin-1 binds to 
FliCH7 flagella filaments, monomers or both. This was attempted, but all the 
antibodies available at that time exhibited non-specific binding. This issue has 
consequently been resolved with different antibodies and microscopy is currently 
being undertaken by Amin Tahoun, a post-doctoral researcher. TLR5-stimulation 
assays could then be used to assess how cofilin-1 alters the bio-availability of FliCH7 
monomers. However, these experiments are all in artificial conditions; it would be 
interesting to use fliCH7 transfection studies to see if cofilin-1 interactions with 
FliCH7 flagella affect in vivo NLRC4 inflammasome activation. Such a finding raises 
interesting possibilities, as this may affect the innate recognition of FliCH7 flagellin.  
 
For the first time, bacterial flagella have been shown to enhance actin polymerisation 
rates in vitro. That cofilin-1 was not required for FliCH7 flagella to do this was 
unexpected, because previous ELISA data indicated that actin binding, though 
detectable, was much less than cofilin-1 binding. However, ELISAs were done in 





was purified G-actin in solution, rather than the actin being coated onto ELISA 
plates, which was probably mostly F-actin. While these experiments don’t show that 
bacterial flagella can enhance actin polymerisation in cells, they demonstrate that it is 
physically possible. Cell-transfection studies are required to see if this effect actually 
occurs and what the role of cofilin-1 might be in cells. 
 
Results from experiments undertaken to see if bacterial flagella affected cofilin-1 
dependent increases in actin polymerisation rate were unclear. With 3 interactants it 
was difficult to judge which interactions were affecting actin polymerisation rates. 
Adding FliCP1 or FljBP2 flagella to cofilin-1 did significantly increase the actin 
polymerisation rate compared with cofilin-1 alone, but was it was unclear whether 
this was additive or synergistic. Interactions between FliCH7 flagella and cofilin-1 
were possibly preventing one or the other from interacting with actin. Interactions 
between FliCH6 flagella and cofilin-1 may have enabled FliCH6 flagella to interact 
more effectively with actin. More detailed mapping of binding sites and using 
mutagenesis would be useful in validating these results and picking out which 
protein is contributing, when and how.  
 
The effect of flagella on actin dynamics has some degree of specificity to it that 
implies a mode of action. For example, FliCH7 flagella affected the rate of actin 
polymerisation but did not appear to change the rate of actin depolymerisation, with 
or without cofilin-1. Therefore, FliCH7 flagella did not alter F-actin dynamics, 
whereas it did affect G-actin dynamics. FliCH7 flagella and other flagella tested, 
increase the overall rate of G-actin polymerisation without altering the duration of 
the lag phase, unlike cofilin-1, which does. Instead they do this by increasing the 
maximum velocity of actin polymerisation. The specificity showed with FliCH7 
flagella points towards how they and other flagella may be causing this effect on 
actin polymerisation. It implies that flagella are not involved in actin nucleation, but 
perhaps act as G-actin binding proteins, that increase the affinity of G-actin for F-
actin in a manner analogous to Profilin. The effect of other flagella on actin 
depolymerisation would have to be tested and assays that distinguish between F and 






It is also conceivable that flagellin could play a dual role in relation to actin and 
cofilin-1 binding. One function does not necessarily rule out another. For instance, 
FliCH7 flagella could be acting as a bacterial effector protein targeting actin 
dynamics, while the host protects its bacterial invader from flagellin recognition and 




























Andersen-Nissen, E., Smith, K. D., Bonneau, R., Strong, R. K. & Aderem, A. 
(2007). A conserved surface on Toll-like receptor 5 recognizes bacterial 
flagellin. Journal of experimental medicine 204, 393–403. 
Andrianantoandro, E. & Pollard, T. D. (2006). Mechanism of actin filament 
turnover by severing and nucleation at different concentrations of ADF/cofilin. 
Molecular cell 24, 13–23. 
Bernstein, B. W., Painter, W. B., Chen, H., Minamide, L. S., Abe, H. & 
Bamburg, J. R. (2000). Intracellular pH modulation of ADF/cofilin proteins. 
Cell motility and the cytoskeleton 47, 319–36. 
Bobkov, A. A., Muhlrad, A., Pavlov, D. A., Kokabi, K., Yilmaz, A. & Reisler, E. 
(2006). Cooperative effects of cofilin (ADF) on actin structure suggest allosteric 
mechanism of cofilin function. Journal of molecular biology 356, 325–34. 
Frantz, C., Barreiro, G., Dominguez, L., Chen, X., Eddy, R., Condeelis, J., 
Kelly, M. J. S., Jacobson, M. P. & Barber, D. L. (2008). Cofilin is a pH 
sensor for actin free barbed end formation: role of phosphoinositide binding. 
Journal of cell biology 183, 865–79. 
Pavlov, D. & Muhlrad, A. (2006). Severing of F-actin by yeast cofilin is pH-
 independent. Cell motility and the cytoskeleton 63, 533–542. 
Van Troys, M., Huyck, L., Leyman, S., Dhaese, S., Vandekerkhove, J. & Ampe, 
C. (2008). Ins and outs of ADF/cofilin activity and regulation. European 

































This thesis has focussed on the interactions of FliCH7 flagella with the BTR, with two 
purposes in mind. The first was, from a practical standpoint, to find specific FliCH7 
flagella binding epitopes that are distinct from TLR5-activation epitopes for use as 
vaccine antigens. The structurally variable region of FliCH7 is a predicted 88aa 
insertion, which is not post-translationally modified. Because this region is variable, 
it is unlikely to contain TLR5-activation epitopes. Both the recombinant variable 
region of FliCH7 (VrH7180-496) and recombinant FliDH7 contained BTRE binding 
epitopes. Despite attempts with FliDH7, further tests are still required to see if these 
binding epitopes are specific. If VrH7180-496 and recombinant FliDH7 do contain 
specific BTR binding epitopes, these two easily purified proteins become promising 
H7 antigen-based vaccine candidates, for use in cattle.  
 
The second purpose of investigating FliCH7 flagella interactions with the BTR was to 
better understand the role of flagella in the pathogenesis of EHEC, and perhaps more 
broadly, in enteric pathogen infection. FliCH7 flagella were shown to bind across, 
through and probably inside host-cell surfaces. This raised the possibility that 
penetrating flagella could be involved in actin pedestal formation. Further studies 
revealed potential interactions between FliCH7 flagella and a number of actin-binding 
proteins, including cofilin-1. FliCH7 flagella also increased actin polymerisation 
rates, but probably not actin depolymerisation rates, in vitro, in the absence of 
cofilin-1. Furthermore, this effect on actin polymerisation rates was not restricted to 
FliCH7 flagella, but was also shown for EPEC FliCH6 flagella, and Salmonella FliCP1 
and FljBP2 flagella. If these previously unknown functions are in the future shown to 
occur in the context of bacterial colonisation, this study may have revealed a novel 






This study did not uncover many clues to the biological relevance of the FliCH7 
flagella interaction with cofilin-1. It is not likely to alter effects on cofilin-1-
dependent actin depolymerisation, though more work is needed to ascertain this is 
the case for a range of stoichiometric and pH conditions. Cofilin-1 may alter FliCH7 
flagella filament stability, though how this could occur without detectable 
interactions with FliCH7 flagella filaments remains to be seen. This study proposed 
that the dynamics between filaments and monomers are changed as a result of 
cofilin-1 binding FliCH7 monomers, and therefore may affect innate detection of 
FliCH7. 
 
7.2 Proposed model of the role of FliCH7 flagella in EHEC colonisation 
Figure 7.1 summarises the current thinking based on the results from this thesis. In 
this model, the role of FliCH7 flagella changes over time. To begin with, FliCH7 
flagella allow chemotaxis to the BTRE, and initial adherence. If this adherence is 
penetrative, FliCH7 flagella affect actin dynamics. The potential inflammation that 
would be caused by this is dampened by FliCH7 interactions with cofilin-1. With 
time, flagella expression is down-regulated, but the actin recruited under EHEC by 
penetrating FliCH7 flagella can then be remodelled into A/E lesions more efficiently. 
The possibility EHEC uses its FliCH7 flagella to secrete T3S effector proteins at an 
earlier time point has been considered, but as yet there is no direct evidence for this. 
Such is the model, though convincing evidence of all aspects of it occurring at the 
BTR is still some way off.  An understanding of the mechanism of actin 
polymerisation by different flagella would give more weight to this model. For this, 
investigating the conditions in which this occurs artificially and in cells is necessary. 
Also, more definitive evidence for the effect of cofilin-1 on flagellin monomer 
availability is required. Additionally, it is still unknown if the NLRC4 inflammasome 
plays a role in innate recognition of FliCH7 flagella in BTR epithelial cells, or if 











Figure 7.1. Proposed model for the temporal roles of FliCH7 flagella in EHEC 
colonisation of cattle. (A) Bacteria use swimming motility to penetrate the mucus layer. 
FliCH7 flagella expression leads to release of FliCH7 monomers. (B) FliCH7 activates 
TLR5 signalling, resulting in pro-IL-8 expression. EHEC initially bind to the BTRE via 
longitudinal, lateral or penetrative flagellar adhesion. Penetrative adhesion allows 
intracellular flagella to trigger actin polymerisation, setting up A/E lesion formation. 
Cofilin-1 prevents NLRC4 inflammasome activation by free FliCH7, which would 
otherwise result in cleavage of pro-IL-8 and secretion of mature IL-8. (C) Flagella are 
down-regulated as T3S is up-regulated, allowing a more intimate attachment and 
continued actin rearrangement to take place. 








In addition to motility and initial attachment, this study has revealed two surprising 
new functions of flagella from EHEC O157:H7. These are penetration into host cells 
and polymerisation of actin. If these functions are relevant in cellular models of 
infection, flagella become a very logical choice for use in EHEC O157:H7 vaccines 
in cattle. This study has also shown that two recombinant flagellar proteins, FliDH7 
and VrH7180-496, can bind to BTRE. As these are unlikely to contain TLR5-binding 
epitopes, they may provide protection against EHEC colonisation of cattle, as part of 










































































A1.1   Validation of fliC expression plasmids 
Restriction digest validation of expression plasmids detailed in table 2.2 and section 
2.3.13 is shown below (figure A1.1). This confirms the presence of fliC (~2kb) or 
fliD (~1.5kb) coding sequence inserts and correct restriction sites. These plasmids 
were also shown to complement motility deficient fliC and fliD mutants (figure A1.2 
















Figure A1.1. Restriction 
confirmation of expression 
vector construction and insert 
orientation screening. V= 
empty vector (pWSK29 or 
pBAD/Myc-His A). Clones in 
bold used for further study. 
(A) Left panel: BamHI digest 
of pWSKH6 clones to confirm 
insertion of fliCH6 and its 
native promoter. Right panel: 
PstI restriction mapping of 
pWSKH6 to determine 
orientation. Both orientations 
shown; 3 and 5 indicate the 
clone numbers from each 
direction taken forward for 
sequencing and stab motility 
tests. (B) BamHI/SalI double 
digest of pWSKH7tuv to 
confirm directional insertion of 
fliCH7 with its native promoter. 
(C) NcoI/SacI double digest of 
pBADFliDH7 to confirm 
directional insertion of fliDH7 







A1.2   Validation of TUV∆fliC and TUVfliC- 
A1.2.1   Exchange plasmids 
 Engineering the exchange plasmids (table 2.2 and figure 2.3) correctly is critical to 
successful allelic exchange (methods 2.3.12). Figure A1.3(B) shows the restriction 
digest confirmation of pIBXH7tuv, which was the allelic exchange vector used to 
make TUV∆fliC from TUV93-0 (table 2.1). The sacB-kanr cassette insert (~4kb) has 
been cut out of the plasmid backbone (~6kb). The plasmid backbone in this figure, is 
pIBXSKtuv, which is validated in figure A1.3(A). pIBXSKtuv is the allelic exchange 
vector used to make TUVfliC- from TUV∆fliC (table 2.1). Figure A1.3(A) shows the 
restriction digest confirmation of the second fliCH7 flanking region in this vector, 
H7downD (figure 2.3). This is visible in figure A1.3(A) as a 600bp band on 
SalI/BamHI digest or comparative size increase on BamHI digest. The first fliCH7 
flanking region, H7upB, is visible as a size increase in the plasmid backbone (>5kb) 
on SalI/BamHI digest compared to just pIB307 (V, 4.2kb).  
Figure A1.2. Complementation of 
flagella expression in JT1, a 
Tn10::fliC strain, by pWSKH6 and 
pWSKH7tuv. (A) Complementation 
with expression plasmids compared 
to empty plasmid (pWSK29), as 
shown by motility assay (methods 
2.9.2). (B) Immuno-fluorescence of 
JT1 containing pWSKH6 (α-H6) or 
pWSKH7tuv (α-H7) from the outer 















A1.2.2   Intermediate strain TUV∆fliC 
 After allelic exchange of TUV93-0 with pIBXH7tuv, clones were screened as detailed 
in methods 2.3.12.1. The results from kanr, cams clones (that do not contain the 
exchange plasmid but do contain the exchanged cassette) screened by PCR for the 
presence of fliCH7 and sacB are shown in figure A1.4. Clone 10 was fliC
-, sacB+ and 
non-motile. The mutation in clone 10 was non-polar, as the motility was restored by 
plasmid complementation (figure A1.4(D)). Therefore TUV∆fliC10 was used as the 
intermediate strain for further allelic exchanges in this study and in further work. An 
important point to note in figure A1.4(D) is the typical variation of TUV93-0 (WTp) 
in motility assay. 
Figure A1.3. Restriction confirmation of allelic exchange vector construction 
for fliCH7 knock-outs. (A) BamHI digest of pIBXH7tuv (F+S/K) to confirm insert 
of gel purified sacB::kan
r
 cassette (S/K). pIBXSK
tuv
 (vector and flanks, V+F). 
(B) SacI/BamHI and BamHI digests of pIBXSK
tuv
 to confirm insert of 2
nd
 flank 
and presence of 1
st
 flank. pIB307 (empty vector, V). Samples were digested 






























A1.2.3   Isogenic strain TUVfliC- 
 Allelic exchange was carried out between TUV∆fliC10 and pIBXSKtuv and screened 
according to section 2.3.12.2 to make an isogenic fliCH7 deletion. PCR validation of 
some of the kans, cams clones (that do not contain either the exchange plasmid or the 
cassette) is shown in figure A1.5. In particular, figure A1.5(B) shows the size of the 
mutated region in the parent strain (~3kb), pIBXSKtuv (~1.2kb), pIBXH7tuv (~5.2kb) 
and the 4 clones tested (~1.2kb). These sizes are as expected if they were to contain 
the fliCH7 region, just the flanking regions, and the flanking regions and the sacB-
kanr cassette respectively. The clones tested match pIBXSKtuv as expected. They do 
not contain ~1.8 or 4kb between the two flanking regions cloned into pIBXSKtuv, 
(A) fliCH7 (B) sacB (C) orientation sacB-kanr 
Figure A1.4. Validation of TUV∆fliC. Clone 10 (bold) was used as the intermediate strain. 
WT= TUV93-0, EV= exchange vector pIBXH7tuv, a positive control. (A) The absence fliCH7 
(~2.1kb) was screened by PCR using Ct-FliC-SalI - Nt-FliC-BamHI2 primers. (B) The 
presence of sacB (1.2kb) was screened by PCR for with SacB-5 - SacB-3 primers. (C) The 
orientation of the sacB::kanr cassette was screened by PCR using two sets of primers: a 
product with 5’H7upF.SacI - SacB-3 is the same orientation as pIBXH7tuv (EV), shown. PCR 
was done using Quick-Load Taq 2x master mix (New England Biolabs) as detailed in 
methods 2.3.4. (D) Motility of TUV∆fliC10 (∆10) compared to TUV93-0 (WT) and 
complementation by pWSKH7tuv (pfliC) in 0.3% agar after 28ºC for 24 hr (methods 2.9.2); 




Kb  M WT 17 16  13  12  11  10  
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confirming the absence of fliCH7 or the sacB-kan
r cassette between the fliCH7 
flanking regions.  
 
  
 One result from figure A1.5 differs from what was predicted. The PCR reaction of 
the intermediate strain TUV∆fliC10 in figure A1.5(B) has no specific product. 


















Figure A1.5. Validation of TUVfliC-. Clone 1 (bold) was used as the fliCH7 clean 
deletion strain in this study. + = pIBXH7tuv, - = pIBXSKtuv. (A) The absence fliCH7 
(~2.1kb when present) was screened by PCR with Ct-FliC-SalI - Nt-FliC-BamHI2 
primers. B) The size of the region between the external primers was screened by 
PCR with 5’H7upF.SacI – 3’H7downR.SalI primers. PCR was done using Quick-
Load Taq 2x master mix (New England Biolabs) as detailed in methods 2.3.4. C) 
Flagella expression of clone 1 compared to TUV93-0, with and without plasmid 
complementation as assessed by motility assay and immunofluorescence as 
indicated (methods 2.9.2 and 2.7.1). Primers detailed in table 2.3  
(A) fliCH7 (B) size of region 
Kb   M WT  ∆    7    5    2   1    Kb   M   WT  -    +    ∆   7    5    2    1     
TUV93-0:pWSK29 TUVfliC-1:pWSK29 TUVfliC-1:pWSKH7tuv 





This is likely to be the case as previous screening of TUV∆fliC shows this clone to 
contain the sacB-kanr cassette in the same orientation as pIBXH7tuv at the fliCH7 
locus (figure A1.4(C)). TUVfliC-1, highlighted in figure A1.5, was non-motile and 
fliC-, with few base pairs in between the fliCH7 flanking regions. Again this mutation 
was non-polar, as complementation was possible with fliCH7-containing plasmids 
(section A1.1, figure A1.5(C) and data not shown). As such, TUVfliC-1 was used as 
the TUVfliC- strain in this study. 
 
A1.3   Validation of fliC knock-ins 
A1.3.1   TUVfliC-H7 
Using the same strategy as above, a fliCH7 knock-in was designed (section 2.3.12.2, 
figure 2.3). However, by making TUV∆fliC10 with pIBXH7tuv, this strain’s fliC 
Shine-Dalgarno sequence was disrupted by the introduced BamHI site. A new 
exchange vector of similar design to pIBXH7tuv was made, which instead of having 
the sacB-kanr cassette between the flanking regions, contained the fliCH7 coding 
sequence. This was called pIBH7KI. pIBH7KI contained a different upstream 
flanking region that repaired the sequence in TUV∆fliC10 and maintained start 
codon spacing. Allelic exchange was successful with pIBH7KI; fliCH7 was inserted 
in the correct orientation of that region, and the strain no longer contained sacB 








  Kb  M     11        18          22        24        WT      
3 
2 
Figure A1.6. Validation of TUVfliC-H7. Clones 13-16 (bold) were used in 
phenotypic assays. (A) Orientation screening by PCR (methods 2.3.4) of 
pIBH7KI using H7upF.SacI/ 3NtH7F.BamHI primers on the right, and 
3’H7downR.SalI/ 3’NtH7F.BamHI on the left. WT= TUV93-0 genomic DNA. 
(B) The presence of fliCH7 was screened for by PCR using 5’CtH7R.BamHI/ 
3’NtH7F.BamHI primers. (C) The absence of sacB was screened for by PCR 
with SacB-5/ SacB-3 primers. (D) The size of the region between the external 
primers was screened by PCR with 5’H7upF.SacI/ 3’H7downR.SalI primers. 
Primers detailed in table 2.3. 
(B) fliCH7 




(C) sacB  
Kb  M    5    6    7    8    9   10   11  12   13  14   15  16   ∆   KO 
4 
3 
(D) size of region 















 Despite a successful chromosomal complementation of fliC, flagella expression of 
the fliCH7 knock-in strains was very poor compared to the wild-type (figure A1.7). 
























Figure A1.7. Flagella expression of TUVfliC-H7 clone 13 
assessed by motility and immunofluorescence (methods 2.9.2 
and 2.7.1). Clones 13-16 were tested and clone 13 is 
representative. (A) Comparison of flagella expression between 
TUV93-0 with a TUVfliC-H7 knock-in strain. (B) Parent of 
TUVfliC-H713, TUV∆fliC10 (∆fliC10) and plasmid 





strain, but very obviously weak and flagella appeared to be much shorter by 
immunofluorescence (figure A1.7(A)). To rule out any problem with the fliCH7 
transferred by the allelic exchange, motility complementation of the intermediate 
strain TUV∆fliC10 with the exchange plasmid was assessed (figure A1.7(B)). The 
motility halos were slightly larger than the fliCH7 knock-in strains tested and more 
dense and consistent in shape. This indicates that the fliCH7 exchanged is functional 
but that expression levels are compromised, possibly by the changes in the fliCH7 
promoter caused by introducing a BamHI site, as indicated by RNA modelling 
(section 2.4.1, figure 2.4). 
 
A1.3.2   TUVfliCH6F and TUVfliCH7F 
A1.3.2.1    Exchange plasmids 
 New allelic exchange vectors for insertion of fliCH6 and fliCH7 were made based on 
the RNA modelling that contained upstream F flanking regions (table 2.2, figure 
2.4). Both fliCH6F and fliCH7F vectors were made in parallel and used in allelic 
exchange with TUV∆fliC10.  
 
 Figure A1.8 shows validation at each step in the construction of pIBH6KIF and 
pIBH7KIF. The insertion of the first flanking region, H7upB, for both of these 
vectors is confirmed in figure A1.8(A), as the ~600bp insert is cut out of pIB307 
(~4.2kb). The F flanking region, H7downF, was then cloned into this plasmid, as 
shown in figure A1.8(B). Again this is confirmed by a ~600bp insert cut out of a 
plasmid that runs level with the plasmid made in figure A1.8(A) at ~5kb. Figure 
A1.8(C) shows the restriction digest confirmations of the final cloning to make 
pIBH6KIF and pIBH7KIF. fliCH6 and fliCH7 coding sequences are ~1.5 kb; fliCH7 is 
actually larger than this, but the samples have run at an angle so the size estimation is 
inaccurate. The plasmid backbone is >5kb and runs to the same size as the the F24 
plasmid featured in figure A1.8(B), run in figure A1.7(C) on the far left. As the fliC 
coding sequences are not cloned in any particular direction, clones were screened for 





indicates the desired orientation. pIBH6KIF clone 17 (bold) and pIBH7KIF clone 6 





































Kb       M         V+F    H6-17   H6-18    H7-6    H7-7 
Kb          M              F24      F25        [unrelated wells]        V+F1 Kb       M          5     11 
Kb M  20 19 18 17 Kb M 10  9  8  7  6 
(D) pIBH6KIF (E) pIBH7KIF (C) fliCF CDS insertion 
(B) Insertion of ‘F’ flank (A) First flank 
Figure A1.8. Validation of allelic exchange vectors used to make fliCH6F and fliCH7F knock-
ins. (A) SalI/BamHI restriction digest confirmation of the H7upB flanking region insertion 
(used clone 11, bold). (B) SacI/BamHI restriction confirmation of the H7downF flanking 
region  insertion (used clone 24 of the F flank). V+F1= vector plus first flanking region, 
H7upB. (C) BamHI restriction digest confirmation of the fliCH6 and fliCH7 insertion into 
plasmids containing F flanking regions. V+F= allelic exchange vector containing F flanking 
regions. (D) Orientation screening of fliCH6F by PCR using the PIBF – H6Nt4 primer pair. A 
~1.5kb product indicates the correct orientation for expression. (E) Orientation screening of 
fliCH7F by PCR using the H7Ct4 – PIBR primer pair. A ~1.5kb product indicates the correct 
orientation for expression. Samples were digested with the enzymes specified (New England 
Biolabs), loaded into a 0.7% agarose/safe-view gel, electrophoresed at 90 V for 35 min and 
imaged with a UV gel-doc system (methods 2.3.4, 2.3.5, 2.3.1). Primers detailed in table 2.3 
















α-H7 α-H6 28ºC  24hr 
Kb  M   1   2     [n/a]    1    2   [n/a]    ∆  WT 
H7F     [n/a]    H6F    [n/a] 
3 
2.5 
Kb  M    1    2      [n/a]      1     2    [n/a]    ∆   WT 




(A) sacB (B) size of region 
(C) flagella expression 
Figure A1.9. Validation of TUVfliCH6F and TUVfliCH7F. (A) PCR screening for the absence of 
sacB using SacB-5 - SacB-3 primers. (B) PCR screening to compare the size of the 
manipulated region to TUV93-0 (WT) and TUV∆fliC using 5’H7upF.SacI – 3’H7downR.SalI 
primers. Clones highlighted in bold were used for further study. [n/a] describes wells 
unrelated to this study. (C) Flagella expression and sero-specificity of TUVfliCH6F1 and 
TUVfliCH7F1. PCR, immunofluorescence and motility assays were done as in methods 2.3.4, 







 Not only were the allelic exchanges successful, but motility was restored in all 
strains tested. Figure A1.9 shows how the fliCH6F and fliCH7F knock-in strains were 
validated. sacB from the sacB-kanr cassette was not detected by PCR (figure 
A1.9(A)), and the fliC region was the same size as in the wild-type TUV93-0 by PCR 
(figure A1.9(B); again the TUV∆fliC10 PCR reaction across the larger region 
containing the sacB-kanr cassette appears to have failed). Also, strains were all sero-
typed by immunofluorescence as O157 (figure A1.9(C)). The wild-type strain and 
fliCH7F knock-in were also H7
+ and H6-, while the fliCH6F knock-in was H7
- and H6+. 
The fliC- strain was neither H7+ nor H6+. Flagella filaments of knock-in strains were 
not short as with the previous method, but fully formed. Figure A1.9(C) also shows 
that the motility of the fliC knock-ins, while not quite as much as the wild-type, was 
at least comparable.  
 
 
A1.4  Validation of TUV∆fliD and TUVfliD- 
A1.4.1   Exchange plasmids 
Figure A1.10 shows restriction digest confirmation of each insert that was cloned 
into the exchange plasmids (figure 2.2) to make fliDH7 mutants. pIBXFliD was used 
to make TUVΔfliD from TUV93-0 and pIBXSKFliD was used to make TUVfliD- 
from TUVΔfliD. The ~0.6kb fliD flanking region FliDdown has been cut out of the 
4.2kb pIB307 backbone in figure A1.10(A). The ~0.6kb fliD flanking region FliDup 
has been cut out of the 5kb pIB307+FliDdown backbone in figure A1.10(B), which 
is visibly larger than pIB307 alone (V), confirming the construction of pIBXSKFliD. 
Figure A1.10(C) shows the restriction digest confirming the insertion of the 








A1.4.2   Intermediate strain TUV∆fliD 
 After allelic exchange of TUV93-0 with pIBXFliD, clones were screened as detailed 
in methods 2.3.12.1. The results from kanr, cams clones screened by PCR for the 
presence of sacB and the correct sized fliDH7 region are shown in figure A1.11. 
Clone 1 was sacB+ (figure A1.11(A)) and had a fliDH7 region of ~5kb instead of 
~2kb (figure A1.11(B)) and was non-motile (figure A1.11(C)). The mutation in clone 
10 was non-polar, as the motility was restored by plasmid complementation (data not 
shown). Therefore TUV∆fliD1 was used as the intermediate strain for further allelic 
exchanges in this study.  
Figure A1.10. Restriction digest confirmation of inserts in exchange plasmids used to 
make TUV∆fliD (pIBXFliD) and TUVfliC- (pIBXSKFliD). A) BamHI/XbaI digest of 
pIB307 containing FliDdown flanking region (BHI/XI) to confirm its insertion. (B) 
SacI/BamHI digest of pIBXSK
tuv
  (SI/BHI) to confirm insert of 2
nd
 flank, FliDup, and 
presence of 1
st
 flank compared to pIB307 (empty vector, V). (C) BamHI digests of 
pIBXFliD (BHI) to confirm the insertion of gel purified sacB::kan
r
 cassette into 
pIBXSK
tuv
 (vector and flanks, V+F). Samples were digested with the enzymes 
specified (New England Biolabs), loaded into a 0.7% agarose/safe-view gel, 
electrophoresed at 90 V for 35 min and imaged with a Bio-Rad 1000 UV gel-doc 












 Allelic exchange was carried out between TUV∆fliD1 and pIBXSKFliD and 
screened according to section 2.3.12.2 to make an isogenic fliDH7 deletion, TUVfliD
-. 
PCR validation of some of the kans, cams clones, as was done with TUVfliC- is 
Figure A1.11. Validation of TUV∆fliD. Clone 1 (bold) was used as the intermediate strain. 
WT= TUV93-0, EV= exchange vector pIBXFliD, a positive control. (A) The presence of sacB 
(1.2kb) was screened by PCR for with SacB-5 - SacB-3 primers. (B) The size of the altered 
region was screened by PCR using FliDupF.SacI – FliDdownR.XbaI primers. The region is 
the same size as pIBXFliD (EV), shown. PCR was done using Quick-Load Taq 2x master 
mix (New England Biolabs) as detailed in methods 2.3.4. (C) Motility of TUV∆fliC1 compared 
to TUV93-0 in 0.3% agar after 28ºC for 24 hr (methods 2.9.2). Primers detailed in table 2.3. 
Figure A1.12. Validation of 
TUVfliD- clone 1 (1). (A) PCR 
screening for the absence of 
sacB using SacB-5 - SacB-3 
primers. TUV93-0 (WT) was a 
positive control and TUV∆fliD (∆) 
was a negative control. (B) PCR 
screening to compare the size of 
the manipulated region to 
TUV93-0 (WT) and TUV∆fliD (∆) 
using 5’NtFliDHISF – 
FliDdownR.XbaI primers. PCR 
was undertaken as in methods 
2.3.4 and motility validation is 
shown in figure 3.8. Primers 





shown in figure A1.12. Figure A1.12(A) shows that TUV∆fliD1 is sacB+ and 
TUV93-0 and TUVfliD-1 is not. Figure A1.12(B) shows the size of the mutated 
region in TUV93-0 (WT, ~2kb) and TUVfliD-1 (1, ~0.6kb). These sizes are as 
expected if they were to contain the fliDH7 and FliDdown or just FliDdown 
respectively. Once again, the screening PCR for the intermediate strain has failed, as 
in figure A1.5(B), presumably for similar reasons. However, the size of the fliDH7 
region in TUVfliD-1 and its lack of motility (figure 3.8), confirms the absence of 
fliDH7 or the sacB-kan
r cassette next to a fliDH7 flanking region. TUVfliD
-1 was 
therefore used as TUVfliD- for further study. 
 
A1.5   E. coli O157 PCR screening of mutant strains 
The mutant strains made in this study and validated in this appendix were screened 
with O157-specific primers by PCR as described in table 2.3 and sections 2.3.4 and 
2.3.12. In the conditions tested, these primers yield a 259bp product, but only with 
DNA from E. coli O157 strains. Figure A1.13 shows that all strains screened had a 












Figure A1.13. Agarose 
electrophoresis of an O157-
specific PCR screen of cell-
lysates from strains made in 
this study. 
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